- Staat
- -
- Alter
- 93,0
- Geschlecht
- F
- Eingang
- 02.10.2023
- Impfdatum
- 28.01.2022
- Beginn
- 12.09.2023
- Tage bis Beginn
- 592,0
- Dosis
- 3
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: unbekannt
Areflexia
Atrial fibrillation
Bradycardia
COVID-19
Cardiac arrest
Cerebrovascular accident
Chest X-ray abnormal
Death
Dyspnoea
Fatigue
Gastrointestinal haemorrhage
Hypotension
Pain
Pneumonia
Positive airway pressure therapy
Pulse absent
Pupillary light reflex tests abnormal
Pyrexia
Symptomtext
94 y.o. female presenting with shortness of breath. She was COVID-positive. The patient says she really only complains of shortness of breath. Asked if she has any chest pain or any pain at all and she shakes her head no. The patient says she just needs air. The patient feels fatigued and just has aches everywhere. She was sent in from her facility. Patient was recently discharged for stroke and a GI bleed. The patient here as a limited history otherwise because she is in such respiratory distress. She was in the 60s with her oxygen. She was brought in via EMS. Medical Decision Making I saw and evaluated the patient. I have reviewed the chief complaint, triage note, past medical/surgical, family, and social history. She was placed on BiPAP given her respiratory distress. She went from 63% up to 89% while is in the room but she is stabilizing further and is now up to 94% on the BiPAP and she says she does not want intubated and I talked to her son who is power of attorney, and he says that if necessary to intubate her because she does have poor short-term memory. I do not know if she is awake and alert and oriented but she generally speaking responds to questions with a yes or no appropriately. The patient here is in A-fib with RVR which would be new for her. I talked to her son about this and we will go ahead and start Cardizem but will hold off on the blood thinning medication because she recently had a GI bleed and he says that they saw her on Friday and she was totally fine and was doing great and we do not know when this A-fib started so it could have been inside of the window where we do not need blood thinning medication and given the risk benefits of her recent bleed we will hold off on the heparin/Lovenox. Reevaluation at 1228 shows that the patient feels like she is breathing easier. The patient here is answering yes/no questions. Her son is at the bedside. It is her other son who is at the bedside. He says that he does not believe that she would necessarily want to be intubated and put on a ventilator and have medicines in her constantly. He definitely knows she would not want CPR. I asked the patient again in the room if she would want intubated and she said no. I told the son to touch base with the other sinus or both medical power of attorney's and see if they can come to a consensus. At this point we will hold off on intubating her because she feels like she is breathing easier but she is still tachypneic. Heart rate is still tachycardic but she just got her Cardizem started. Patient was reevaluated at 1300 and she is now hypotensive. Cardizem was just bumped from 5-7.5. The patient here was found to have a pneumonia on her chest x-ray. At this point she is febrile with pneumonia and septic so I am going to go ahead and give her a liter of fluid to see if that helps with her blood pressure as well as her heart rate. I did have concerns about fluid overloading her with her A-fib with RVR but this point she is hypotensive. I did talk to the son who is here about doing central line and intubating her but at this point he still does not want to do that and would did like to wait until his brother comes up and go from there. He should be getting close so they are comfortable just holding off at this time. I was called to the bedside at 1300 and the patient was severely hypotensive and was starting to become bradycardic. She did have a pulse when I initially got to the room. Son and grandson were at the bedside. I told him at this point we would have to intubate and most likely do a central line to see if we can get her resuscitated and stable. He at that point decided that his mom would not want all of that which is what we had initially talked about when he was here in the room and to just allow her to pass away peacefully. The patient did lose pulses. She went asystole on the monitor. She had no spontaneous respirations. She had no reaction to her pupils. The patient had no gag reflex. No spontaneous respirations. I could not hear any heartbeat on auscultation with stethoscope. I did clear the patient deceased at 1319 on 9/12/2023. Condolences were given to the family at the bedside. I did discuss think there is anything that they need from us to help them with this process we will be happy to do as much as we can. The son is very comfortable with what has happened and is at peace with his mother passing away given the hardships that she has recently faced with her medical conditions. Patient here was also discussed with her other son the whole scenario and he is also at peace and comfortable with the unfortunate event.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 83,0
- Geschlecht
- F
- Eingang
- 30.05.2023
- Impfdatum
- 15.01.2022
- Beginn
- 06.05.2022
- Tage bis Beginn
- 111,0
- Dosis
- 3
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute myocardial infarction
Symptom recurrence
Symptomtext
ACUTE NON ST ELEVATION MI 5/21/2022 -- RECURRENCE OF SAME SYMPTOMS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 27.03.2023
- Impfdatum
- 11.01.2022
- Beginn
- 20.03.2023
- Tage bis Beginn
- 433,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute respiratory failure
Angiogram pulmonary abnormal
Bronchitis
COVID-19
Chronic obstructive pulmonary disease
Condition aggravated
Dyspnoea
Electrocardiogram abnormal
Hypoxia
Supraventricular tachycardia
Wheezing
Symptomtext
Admission Date: 3/20/2023 Discharge Date: Mar 23, 2023 PRESENTING PROBLEM: Hypoxia COPD exacerbation Acute respiratory failure with hypoxia COVID-19 HOSPITAL COURSE: Patient is a 73 y.o. female with past medical history significant for chronic obstructive pulmonary disease, sustained SVT, and tobacco use disorder who presented with shortness of breath and is found to have COVID-19 infection as well as evidence of acute bronchitis on CTA thorax. No evidence of pulmonary embolism. She was significantly wheezy and felt to be in exacerbation of chronic obstructive pulmonary disease. She was given IV steroids and scheduled nebulizers with significant improvement. She was additionally started on remdesivir and received 4 days of this. She initially required 2 L nasal cannula and was intermittently able to wean down to 1 L. additionally on presentation she had nonsustained SVT. Initial EKGs concerning for possible Wolff-Parkinson-White, electrophysiology team was consulted felt this was less likely. She was started on diltiazem with significant improvement. On day of discharge patient is feeling subjectively improved although still does require 1 L nasal cannula to maintain saturations greater than 92%. Patient is subjectively dyspneic under 92%. Patient does have oxygen at home as she has been using this nightly since her prior hospitalization. She will continue to wean oxygen as able at home. She will follow with our transition to home program. Her daughter is very informed and was updated on plan day of discharge.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- COPD (chronic obstructive pulmonary disease) (HCC) Sustained SVT (HCC) Smoker Hypoxia COVID-19 Arrhythmia
- Andere Medikamente
- albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler atorvastatin (LIPITOR) 40 MG tablet dilTIAZem (CARDIZEM CD) 240 MG 24 hr capsule escitalopram (LEXAPRO) 10 MG tablet hydroCHLOROthiazide (HYDRODIURIL) 25
- Allergien
- Bactrim [Sulfamethoxazole W-trimethoprim]Unknown Dust PenicillinsRash Pollen
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 53,0
- Geschlecht
- M
- Eingang
- 01.02.2023
- Impfdatum
- 07.01.2022
- Beginn
- 27.12.2022
- Tage bis Beginn
- 354,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acidosis
Alanine aminotransferase normal
Angiogram normal
Aspartate aminotransferase increased
Blood bilirubin increased
Blood culture negative
Blood loss anaemia
COVID-19
Cardiac arrest
Cirrhosis alcoholic
Condition aggravated
Electrocardiogram normal
Endotracheal intubation
Haematemesis
Haemoglobin decreased
Hepatic failure
Hepatitis C RNA
Hypovolaemic shock
Symptomtext
54 y.o. male patient of Physician No with history of esophageal varices (last banding 1 year ago), decompensated alcoholic cirrhosis, hepatitis C and HTN. Transferred from Hospital where he initially presented for large volume hematemesis followed by subsequent cardiac arrest, managed in the ICU eventually transferred to the floor. He left AMA saying he had a rehab place line up. He left despite worsening liver failure and without any appropriate follow ups arranged. Decompensated Alcoholic Cirrhosis Hepatitis C Unable to verify extent of alcohol use, was previously sober for 9 months in 2020 but unclear if still drinking Home meds: propranolol, spironolactone, Hep C quant and Ab positive 2020, unclear if treated Repeat Hep C quant 605,000 IV thiamine Encourage cessation, consider addiction med c/s Rising T bili 0.5-- >2.6, rising AST 54-- >107, ALT wnl, will re-consult GI Patient wants to leave but parameters heading in the wrong direction. He eventually signed out AMA knowing the risk. He appeared to have capacity. Cardiac Arrest Suspect 2/2 to hypovolemic shock from esophageal variceal bleeding vs profound acidosis ROSC obtained after two rounds of CPR, Ca, Epi, and Bicarb S/p 2u pRBC EKG no ischemic changes Wean sedation and ventilation as tolerated Post cardiac arrest protocol initiated: Target temperature management, CT head pending, EEG Cardio consulted, signed off 12/29 No further testing per cardiology Neurology consulted, signed off 12/29 Upper GI bleed Acute blood loss on chronic anemia Esophageal varices, secondary to alcoholic cirrhosis as below Patient with history of varices, last banding one year ago; now presenting with large volume hematemesis prior to cardiac arrest, see above. On admission Hgb 11.7, b/l 9.1-10.6 CTA abd/chest/pelvis with no signs of active bleeding S/p 2U pRBC, protonix bolus On Octreotide gtt, discontinued 12/30 S/p CTX in ED for CAP, see below, will continue for SBP prophylaxis Rocephin and Protonix IV x 5 days Gastroenterology consulted EGD 12/28 + stigmata of recent esophageal variceal bleed, s/p band x5 IF rebleeds from varices will need VIR for emergent TIPS Okay from GI for diet Was tolerating diet prior to discharge. Acute Hypercapnic respiratory failure Multifocal Pneumonia COVID-19 2/2 cardiac arrest in the setting of acute COVID infection and imaging c/f CAP Currently sedated and on ventilator Continue dilaudid and propofol gtt, added precedex 12/29 as weaning off other medications Continue Azithro/CTX for CAP coverage Steroids and remdesivir Legionella and strep pneumo antigen negative MRSA nares positive Blood Cx prelim negative Extubated 12/30 on NC PRN cough suppressants for comfort
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- 6,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 46,0
- Geschlecht
- F
- Eingang
- 15.01.2023
- Impfdatum
- 06.02.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: unbekannt
Erholt: nein
Blood test
Cerebrovascular accident
Computerised tomogram head abnormal
Echocardiogram
Magnetic resonance imaging head abnormal
Symptomtext
Left 2 sided stoke
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 7,0
- Labordaten
- Ct scan of brain Blood work Tee Mri
- Aktuelle Erkrankungen
- Fibromyalgia
- Vorgeschichte
- Fibromyalgia
- Andere Medikamente
- Lyrica Soma Qulipa BC Clonazipan
- Allergien
- Reglan Zanaflex Compazine
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 13.01.2023
- Impfdatum
- 01.02.2022
- Beginn
- 07.01.2023
- Tage bis Beginn
- 340,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute kidney injury
Acute respiratory failure
Anion gap increased
COVID-19
Hyperkalaemia
Lactic acidosis
Metabolic acidosis
SARS-CoV-2 test positive
Symptomtext
Patient received Moderna COVID vaccine on 1/4/22 and 2/1/22. On 1/3/23, patient tested positive for COVID. On 1/7/22, patient admitted to our inpatient facility (med/surg unit) with acute respiratory failure with hypoxia secondary to COVID19 infection, lactic acidosis and severe metabolic acidosis with increased anion gap, and AKI with hyperkalemia. As of today (1/13/23), patient is still admitted in the med/surg unit.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 6,0
- Labordaten
- COVID status positive 1/3/23.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- extensive past medical history including chronic kidney disease stage IV, COPD on 2 L O2 at baseline, diabetes mellitus, hypertension, coronary artery disease status post bypass, ischemic cardiomyopathy/chronic systolic heart failure s/p CRT-D placement in 2020, paroxysmal atrial fibrillation status post ablation, and history of vaginal and cervical cancer status post treatment many years ago
- Andere Medikamente
- baby aspirin, atorvastatin, calcium carbonate, doxycycline, ipratropium neb, loperamide, metoprolol er, naloxone nasal ap, ondansetron, oxycodone, pantoprazole, sucralfate, torsemide
- Allergien
- lactose, adhesive, albuterol, chocolate flavor, iodine, latex, levofloxacin, penicillin, seafood
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 29.12.2022
- Impfdatum
- 13.01.2022
- Beginn
- 20.11.2022
- Tage bis Beginn
- 311,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
Ageusia
Angiogram pulmonary abnormal
COVID-19
COVID-19 pneumonia
Cough
Dyspnoea
Lung opacity
Pneumonia
SARS-CoV-2 test positive
Sinus rhythm
Symptomtext
The patient is a 84 y.o. male with a history of CVA, CAD, Atrial fibrillation, Hypertension, Hyperlipidemia, Hypothyroidism, BPH, transferred from facility with COVID-19 pneumonia and found to have high O2 requirements requiring HHFNC. He completed 10 days of steroids, 5 days of remdesivir and CAP antibiotics while admitted. He was able to be weaned to safe levels of O2 for home discharge and was discharged home with home health on 12/4. Acute hypoxic respiratory failure COVID-19 pneumonia Date of onset of symptoms: 11/12/2022 Symptoms present on admission: Cough, dyspnea, loss of taste Date of covid positive test: 11/19/2022 Vaccination status: vaccinated x3 (did not receive 2022 booster) Imaging: CTPA (11/19) diffuse scattered areas of groundglass opacities bilateral lungs, no PE Oxygen requirements on admission: HHFNC 60L Current oxygen requirements: 3L NC Medical therapy: remdesivir (done), ceftriaxone/azithromycin (done), dexamethasone (end 11/30) S/p IV lasix during admission -- > switched to lasix 40 PO daily -- will give for 10 days on discharge Special isolation ended: 11/30/2022 Home O2 eval 12/3 -- requires 3-5L NC continuously Will need to f/u with PCP and consider pulmonary referral if still requiring high levels of O2 Paroxysmal Atrial fibrillation NSR on admission Continue home metoprolol succinate 50mg daily Continue Eliquis Essential hypertension Continue Toprol Hyperlipidemia Continue simvastatin Hypothyroidism Continue Synthroid BPH Continue Flomax and finasteride
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 14,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 28.11.2022
- Impfdatum
- 24.01.2022
- Beginn
- 21.11.2022
- Tage bis Beginn
- 301,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute kidney injury
Acute respiratory failure
COVID-19
COVID-19 pneumonia
Interchange of vaccine products
SARS-CoV-2 test positive
Sepsis
Urinary tract infection
Symptomtext
Patient received Pfizer COVID vaccine on 6/19/21 (lot # EW0180), 7/29/21 (lot # EW0181), and Moderna COVID vaccine on 1/24/22 (lot # 084J21A). On 11/21/22, patient admitted to our inpatient facility (med/surg unit) with acute hypoxic respiratory failure secondary to COVID pneumonia, acute sepsis, acute UTI, and acute kidney injury. As of today (11/28/22), patient is still admitted in the med/surg unit.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 7,0
- Labordaten
- COVID status positive 11/21/22.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Hospice resident with history of lewy body dementia
- Andere Medikamente
- hydroxytryptophan, acetaminophen, melatonin, CBD, polyethylene glycol, sertraline, trazodone
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 25.10.2022
- Impfdatum
- 01.05.2021
- Beginn
- 18.09.2022
- Tage bis Beginn
- 505,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
SARS-CoV-2 test positive
Symptomtext
Death from COVID-19 after COVID-19 vaccination
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 17,0
- Labordaten
- Positive COVID-19 test 09/18/2022
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- 1. Hypertension. 2. Weight loss. 3. Recent COVID-19. 4. Breast cancer. 5. Immunotherapy. 6. Anemia. 7. Severe malnutrition.
- Andere Medikamente
- 1. DuoNeb. 2. Perforomist. 3. Apixaban. 4. Buspirone. 5. Gabapentin. 6. Remeron. 7. Sertraline. 8. Furosemide. 9. Potassium chloride. 10. Budesonide. 11. Magnesium oxide.
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 24.10.2022
- Impfdatum
- 16.09.2022
- Beginn
- 10.10.2022
- Tage bis Beginn
- 24,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acute respiratory failure
COVID-19
Dizziness
Dyspnoea
Respiratory failure
SARS-CoV-2 test positive
Sepsis
Symptomtext
Patient up to date on COVID vaccines who admitted to hospital with COVID detected PCR. Provider d/c note: "Pt is a 78 YO female with a PMHx of COPD, CAD, and HTN who presented with shortness of breath and lightheadedness. Pt was found to have sepsis and acute on chronic hypoxic respiratory failure likely multifactorial in the setting of possible COVID PNA vs bacterial PNA vs COPD exacerbation. Pt was started on Decadron, Remdesivir, Ceftriaxone, and Doxycycline on top of her home inhalers (replaced with what is available at the hospital). Pt initially required HFNC, but was able to be weaned off to 3L NC. Pt was asked about the possibility of skilled nursing rehab, but declined and stated that she has good social support at home. Pt discharged to home in stable condition with 1 day of Cefdinir, doxycycline, and Decadron to finish 5-day course of antibiotics and steroid"
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 5,0
- Labordaten
- COVID Detected PCR on 10/10/2022
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Cardiovascular Aortic stenosis Coronary artery disease involving native coronary artery of native heart without angina pectoris Abdominal aortic aneurysm (AAA) without rupture Bilateral carotid artery stenosis Essential hypertension, benign PAD (peripheral artery disease) Mixed hyperlipidemia Digestive REFLUX, ESOPHAGEAL (530.81) Calculus of gallbladder without cholecystitis without obstruction Integumentary Seborrheic dermatitis Respiratory Dependence on supplemental oxygen Vocal cord nodules Chronic cough Pulmonary emphysema (*) Urinary Stage 3a chronic kidney disease (*) Other Ex-smoker Chronic neck pain LUMBAGO (724.2) Environmental allergies History of CVA (cerebrovascular accident) Trigger middle finger of left hand Restless legs Mixed incontinence Heart murmur Anemia Sjogren's syndrome without extraglandular involvement (*) Medial epicondylitis of left elbow Sagittal band rupture at metacarpophalangeal joint History of aspiration pneumonia History of non-ST elevation myocardial infarction (NSTEMI) Elevated liver function tests Normocytic anemia Palliative care encounter Joint contracture of hand, left Dry eye Peripheral polyneuropathy
- Andere Medikamente
- -
- Allergien
- Chantix, Dust, Seasonal Allergies
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 20.09.2022
- Impfdatum
- 13.01.2022
- Beginn
- 28.08.2022
- Tage bis Beginn
- 227,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Abnormal behaviour
Acute kidney injury
Acute respiratory failure
Ammonia normal
Anaemia
Anticoagulant therapy
Arthralgia
Asthenia
Biopsy bone abnormal
Blood calcium normal
Blood creatinine increased
Blood magnesium normal
Blood parathyroid hormone normal
Blood phosphorus normal
Blood potassium decreased
Brain natriuretic peptide increased
Bundle branch block right
COVID-19
Symptomtext
Clinical Summary This is a pleasant 64 y.o. male patient with history of multiple myeloma on maintenance therapy, cirrhosis, rectal cancer, anemia, and depression. He was recently discharged 8/19 after admission for hypercalcemia and AKI 2/2 to multiple myeloma, metastatic lesions on his femur. Presented again on 8/28 w/ weakness, shortness of breath, and pain. Positive for COVID on 8/25. Treated with steroids, HAP antibiotics. Patient had stable yet altered mental status through this hospitalization with workup unrevealing for etiology, thought likely delirium. Multiple follow ups anticipated on discharge. Problem List Acute respiratory failure Covid-19 Virus Infection Date of onset of symptoms: 8/22/22 Symptoms present on admission: shortness of breath, cough Date of covid positive test: 8/25/22 (home test), positive on admission 8/28/22 Imaging: CXR with multifocal b/l airspace opacities, worse on L>R Weaned from 2L NC to RA Medical therapy: Paxlovid 8/26-8/29, Remdesevir on 8/29-9/2 given increased O2 requirement from baseline Current oxygen requirements: Room air 9/1/22 Decadron for COVID 8/28 - 9/3; stopped short of full 10 day course given improving respiratory status, possible iatrogenic contribution to delirium Anticipated special isolation end date: 9/4/22; masking guidance at home advised HAP Symptoms started 2 days following recent discharge Presented with shortness of breath, cough and increased oxygen requirement CXR 8/28 with worsening atypical multilobar pneumonia, L>R Urine antigens + MRSA probe negative 8/28, sputum culture not yet collected C/f superimposed bacterial HAP in setting of immunosuppression S/p azithromocin and rocpehin in ED Vanc 8/28-8/29; MRSA probe negative Cefepime 8/28-9/3 BCx not collected as initiated on abx prior to opportunity to collect Discharged to complete 2 further days of levaquin for HAP coverage Encephalopathy, improving Persistent waxing-waning encephalopathy, improved with wife present, otherwise abnormal/bizarre behaviors Consistently oriented to self and location, inconsistently oriented to date and situation Ammonia wnl Per wife, new this admission CT head unremarkable Neurology initially consulted, however after discussion wife elected to discharge home with anticipated Neurology follow up; day of discharge patient with some improvement Likely multifactorial with COVID, hypercalcemia, potential delirium component Pancytopenia Likely 2/2 to worsening MM, COVID, chemotherapy On 8/19 Plt 20 and Hgb 7.2 On admission Plt 31 (b/l 40-50s), Hgb 8.3 (b/l 9.0) RUQ U/S with findings consistent with cirrhosis, splenomegaly Held ASA and Lovenox in setting of anemia, thrombocytopenia Never required Plt transfusion for threshold <10 Heme consult Hypercalcemia, stable Likely 2/2 to multiple myeloma Recently admitted and at time of DC 8/19 Ca 9.2 Presented with fatigue, pain, polyuria Calcium 14.7, ionized Ca 8.7 on admission Phos 4.0, mag 1.5, PTH 14.8 IVF, Calcitonin, lasix, pamidronate utilized prn Monitored for signs of hypercalcemia, consider repeat level if present Discharged with stability ~Ca 11s AKI, improved Likely 2/2 hypercalcemia as above Creatinine 1.8 on admission (b/l 0.9) IVF prn BMP trended Cirrhosis Diagnosed 2015 Child Class B, MELD score 16 RUQ U/S 8/29 with cirrhosis, splenomegaly, no focal lesions, no ascites Last EGD with small (< 5 mm) esophageal varices, portal hypertensive gastropathy, erosive gastropathy - 2 year f/u recommended FOBT+ 9/1, GI consult placed in setting of this and anemia GI consult, no procedural intervention undertaken Multiple Myeloma Prior regimen: weekly velcade & dexamethasone Last admission complicated by L hip pain, s/p IMN with Ortho on 8/15 with biopsy showing spread of disease to femur Also with hypercalcemia and AKI as above, pancytopenia as below Oncology consult Acute T7 Vertebral Fracture CT chest 8/24 with fracture of T7, possibly acute. Re-demonstration of compression deformities T9-12 MRI C/T/L spine with no mets, acute T7 fracture, T10, T11 fractures No acute surgical intervention, neuro checks q4h Upright T-spine X-rays stable Neurosurgery consulted given concerns for progression of disease, outpatient follow up planned Chronic DVT of LLE Doppler U/S with partially occlusive chronic DVT of left femoral and popliteal vv. Pt. received 1 dose of 1 mg/kg Lovenox around 0100 on 8/29 Held pharmacologic anticoagulation given anemia and thrombocytopenia, chronicity of DVT Instructed to follow up with Heme/Onc provider for outpatient recommendations on anticoagulation UTI Symptoms of frequency, dysuria that started 8/22 Uclx 8/23 E. Coli and Proteus vulgaris resistant to Ampicillin, Bactrim and Gentamycin HAP coverage with concurrent coverage as well Elevated Troponin Trop 33 on admission, trend to 30 Likely 2/2 to demand ischemia EKG with incomplete RBBB, similar to prior 8/11 Monitored for ischemic signs and symptoms Peripheral edema Similar to exam on prior admission Echo 8/16/22: EF 66%, mild TVR With hypoalbuminemia in setting of cirrhosis as above BNP 2,561, unknown baseline Per wife's report, chronic following prior chemotherapy for rectal cancer BLE U/S with chronic DVT to LLE as above Continued compression stockings Hypokalemia, resolved K 3.3 on 8/30 Addressed as warranted Hx of rectal cancer Hx of rectal cancer with lung and liver mets 2013 Pathologic stage from 7/19/2013: Stage IVA (yT3(m), N0, M1a) S/p FOLFOX and multiple resections S/p chemotherapy, resection of all known hepatic metastases and resection of the primary CT A/P in 7/2022 without obvous mets CEA from prior admission, WNL 1.14
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 6,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 91,0
- Geschlecht
- F
- Eingang
- 29.08.2022
- Impfdatum
- 04.01.2022
- Beginn
- 26.01.2022
- Tage bis Beginn
- 22,0
- Dosis
- 3
- Route/Site
- SYR / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
Diarrhoea
Hypervolaemia
Laboratory test normal
Otitis media
Polyuria
SARS-CoV-2 test positive
Symptomtext
The patient was admitted to the hospital with diarrhea after recently taking antibiotics for otitis media. infectious workup unremarkable. Ultimately amoxicillin was restarted for otitis media. The patient was noted to be oxygen requiring during the hospital stay and felt to be volume overloaded following lV fluid resuscitation and was diuresis not requiring oxygen at the time of discharge. The patient was discharged to a Health care facility. The patient tested positive for COVID-19 on 01/26/2022. The patient expired on 02/23/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 09.08.2022
- Impfdatum
- 07.01.2022
- Beginn
- 05.08.2022
- Tage bis Beginn
- 210,0
- Dosis
- 3
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Acute respiratory failure
Anticoagulant therapy
COVID-19
Chronic obstructive pulmonary disease
Condition aggravated
Coronary artery disease
Cough
Discomfort
Dyspnoea
Electrocardiogram
Headache
Laboratory test
Malaise
Obstructive sleep apnoea syndrome
Orthostatic hypotension
Presyncope
Pyrexia
Rhonchi
Symptomtext
Chief Complaint: Syncopal episode. Cough and shortness of breath. Additional Medical History: This 67-year-old obese female with a history of coronary artery disease, COPD, diabetes mellitus, hypertension, hyperlipidemia, migraine, irritable bowel syndrome, seizure and sleep apnea was brought to the ED by an ambulance after she suffered a syncopal episode in a camper just prior to arrival. The patient states that she has not been feeling well today. She has been having a nonproductive cough and shortness of breath for the last 3 days. She denies any fever, chills, nausea, vomiting, chest pain or diaphoresis. The patient is uncomfortable at the time of this examination. She has a headache. Associated Symptoms: cough, headache, shortness of breath
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 3,0
- Labordaten
- The oxygen saturation of the patient was 85% while breathing room air. She needed supplemental oxygen to keep the saturation above 90%. The patient was given Solu-Medrol 125 mg intravenously upon arrival. She received multiple inhaler treatments using Combivent. The patient tested positive for the COVID-19 infection. I reviewed all the lab results, EKG and radiological findings. The patient was observed in the ED. The physical examination revealed a persistent expiratory wheezing. It was decided to admit her for further care. I discussed the case with Dr. the hospitalist on-call. Problem 1: Acute exacerbation of chronic obstructive pulmonary disease Plan 1: Possibly due to COVID-19 infection however other infectious process cannot be ruled out. Patient has bilateral rhonchi in the lower lobes. Plan: -Start patient on IV antibiotics azithromycin and ceftriaxone. -Obtain respiratory pathogen panel -Start Solu-Medrol 80 mg 3 times daily. -DuoNeb for bronchodilation. -Incentive spirometer -Continue with nasal cannula oxygen, titrate as needed. Problem 2: COVID-19 Plan 2: Patient reported was vaccinated for COVID-19. She has fever now. -We will obtain C-reactive protein. -Patient will be on steroid and azithromycin as above. -Continue with nasal cannula oxygen, titrate as needed. -We will monitor overnight, and if her oxygen requirement worsen by the morning, will consider remdesivir. -Tylenol for fever. -Encourage oral hydration. Problem 3: Acute hypoxemic respiratory failure Plan 3: Secondary to COPD exacerbation COVID-19 infection and management will be the same as above. Problem 4: Coronary artery disease without angina pectoris Plan 4: History of coronary artery disease but was not following up with cardiology lately. She has scheduled echocardiogram as outpatient and has an appointment with a new cardiologist. Patient presented with syncope. -We will trend another troponin -We will obtain cardiogram if the patient stay in the hospital Monday. -Resume home medication Plavix. -Continuous cardiac monitoring. Problem 5: Syncope and collapse Plan 5: Likely vasovagal versus orthostatic hypotension. Patient syncopized from a standing position. Patient reported multiple syncope episode over the last few months. Patient was sick for 3 days, and had fever in the camp. Plan: -Continuous telemetry monitoring overnight monitor for arrhythmias. -Trend another troponin. -Will give gentle IV fluid hydration overnight -Encourage oral hydration. -Continuous cardiac monitoring. Problem 6: Type 2 diabetes mellitus Plan 6: On multiple medication at home. Confirm or resume home medication including Victoza We anticipate her blood glucose level to be elevated especially with steroid use. Problem 7: OSA on CPAP Plan 7: Resume CPAP with home setting. Plan 8: CODE STATUS: Full code DVT prophylaxis: Lovenox GI prophylaxis: Pantoprazole
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- obesity CAD COPD DM HTN IBS Seizure sleep apnea
- Andere Medikamente
- Current Home Medications 1. albuterol 2.5 mg/3 mL (0.083%) inhalation solution : 3 milliliter(s) inhaled 4 times a day 2. clopidogrel 75 mg oral tablet : 1 tab(s) orally once a day 3. glipiZIDE : milligram(s) orally once a day 4. lisinopril
- Allergien
- none known
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 31.07.2022
- Impfdatum
- 24.01.2022
- Beginn
- 22.02.2022
- Tage bis Beginn
- 29,0
- Dosis
- 3
- Route/Site
- SYR / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute respiratory failure
Blood culture negative
COVID-19
COVID-19 pneumonia
Death
Dyspnoea
Endotracheal intubation
General physical health deterioration
Haemofiltration
Hypoxia
Intensive care
Leukocytosis
Positive airway pressure therapy
Renal failure
Shock
Symptomtext
Patient history of renal transplant presneted to hospital on 02/23/2022 as a transfer with SOB, hypoxia in the setting of a recent diagnosis of Covid-19. Patient was admitted to ICU with acute hypoxemic respiratory failure 2/2 Covid PNA. She required high flow nasal cannula, and progressed to needing BIPAP and then required intubation. Patient was treated with steroids. Blood cultures negative for any type of new bacterial infection. Patient was treated empirically with antibiotics for most of her hospital stay as well and amphotericin given persistent shock and leukocytosis. She required CRRT for worsening renal failure. Patient continued to decline and was transitioned to comfort measures. Patient expired on 03/12/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 16.02.2022
- Impfdatum
- 31.01.2022
- Beginn
- 13.02.2022
- Tage bis Beginn
- 13,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute kidney injury
Condition aggravated
Death
Hyperkalaemia
Hypotension
Pneumonia
Sepsis syndrome
Symptomtext
Pt died on 2/13/22. He developed sepsis syndrome with hypotension and nosocomial pneumonia in the setting of severe pulmonary fibrosis. He was started on IV antibiotics and IV solumedrol. Acute renal failure/ hyperkalemia was treated with IV fluids. His oxygen requirement continued to be markedly elevated. Family subsequently requested comfort care and Morphine drip was started for relief of pain and suffering.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- Acute respiratory Failure COVID pneumonia Bacterial pneumonia Pulmonary fibrosis Acute renal Failure Transaminitis Steroid induced hyperglycemia
- Vorgeschichte
- None
- Andere Medikamente
- Vitamin C Aspirin Colace Lovenox Lasix Robitussin Duo-Neb Megace Multivitamin Mira-Lax Klor-Con Prednisone Flomax Thiamine Vitamin D Zinc Seroquel
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 07.02.2022
- Impfdatum
- 26.01.2022
- Beginn
- 31.01.2022
- Tage bis Beginn
- 5,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Activated partial thromboplastin time
Blood loss anaemia
Bradycardia
COVID-19
COVID-19 pneumonia
Cardiac arrest
Cardioversion
Cerebrovascular accident
Death
Ear, nose and throat examination normal
Enterobacter test positive
Full blood count
International normalised ratio
Laboratory test
Life support
Post procedural haemorrhage
Prothrombin time
Pulse absent
Symptomtext
Pt died on 1/31/22 Early in the the morning of 1/31 she developed trach site bleeding and shock requiring a pressor. PRBC and FFP were ordered. MD saw her around 6AM and made numerous changes to her plan of care. She was seen by ENT and bleeding was felt to have stopped. A little later in the morning she suffered brady-PEA arrest, code called, ACLS/BVM, Vfib, defib x1, then persistent brady PEA. No pulse after 17 minutes resuscitation. Cause of death: Strokes Due to: COVID-19 infection Other contributing factors: Acute blood loss anemia, trach site bleeding, COVID-19 pneumonia, sepsis, UTI
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- -
- Labordaten
- 1/31/CBC, Chem profile, PT w/ INR, PTT. Blood transfusion ordered but pt died before it could be given. Sputum culture done 1/29/22 grew Enterobacter Aerogenes
- Aktuelle Erkrankungen
- Acute respiratory failure/trach/vent ischemic strokes encephalopathy R IJ DVT MSSA pneumonia UTI Anemia Rectovaginal fistula
- Vorgeschichte
- HTN High cholesterol DM2 w/ nephropathy, neuropathy and retinopathy renal transplant 2014 GERD thyroid nodules
- Andere Medikamente
- Vancomycin Diflucan Norvasc Eliquis Lipitor Pepcid Lasix Insulin Lopressor Provigil Thera multivitamin Deltasone Prograf Hytrin Vitamin D
- Allergien
- ASA, Clonidine, Metformin
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 13.06.2023
- Impfdatum
- 08.02.2022
- Beginn
- 19.12.2022
- Tage bis Beginn
- 314,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Anaphylactic reaction
Symptomtext
ANAPHYLAXIS, SEQUELA
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Anaphylactic reaction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 26.07.2022
- Impfdatum
- 22.01.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 87,0
- Dosis
- 4
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Biopsy lymph gland abnormal
COVID-19
Chemotherapy
Chest pain
Computerised tomogram abnormal
Diffuse large B-cell lymphoma stage IV
Lymphadenopathy
Neck mass
Pericarditis
Positron emission tomogram abnormal
SARS-CoV-2 test positive
Scan with contrast abnormal
Thyroid mass
Ultrasound scan abnormal
Ultrasound thyroid abnormal
Symptomtext
Noticed neck mass 4/19. Had UltraSound, CT showing swollen lymph nodes and thyroid nodules. Had 2nd US, CT with contrast, and biopsies in hospital. Diagnosed with diffuse Large B Cell Lymphoma 5/9/2022. Had PET scan indicating Stage IV. Started R-CHOP chemotherapy 5/23/2022. On 6/25/2022 had chest pain and in hospital diagnosed with pericarditis. On 6/30 tested positive for covid
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pericarditis
- Hospital-Tage
- 3,0
- Labordaten
- 4/25 US. 4/27 CT., 4/29 US and CT, 4/30 biopsies 6/25 entered hospital for chest pain had CT. Diagnosed with pericarditis
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Myasthenia Gravis, GERD, high cholesterol, past atrial fibrillation, cardiac artery disease
- Andere Medikamente
- Cellcept, IV immunoglobulin, metoprolol, buspirone, nexlizet, Praluent, cimetidine, vitamin D3, Zyrtec
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 02.05.2022
- Impfdatum
- 05.01.2022
- Beginn
- 01.01.2022
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Anticoagulant therapy
Thrombosis
Ultrasound Doppler abnormal
Symptomtext
I woke up on morning and saw that I had a blood clot that was an inch and a half long and inch wide. The doctor took a an ultrasound and it showed two blood clots. I am now taking Eliquis for it.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Thrombosis
- Hospital-Tage
- -
- Labordaten
- Ultrasound
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Type II Diabetic Non-Insulin; High Cholesterol
- Andere Medikamente
- Metformin Atorvastatin Omeprazole Vitamin C Garlic Calcium Multivitamin
- Allergien
- Biaxin All fish
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 14.04.2022
- Impfdatum
- 13.04.2022
- Beginn
- 13.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Seizure
Symptomtext
Patient received the Moderna vaccine. About 5 mins after receiving the vaccine patient started to have seizures. Patient had episodes of seizures off and on for several minutes. Patient was taken to ER for further treatment.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- UNKNOWN- PATIENT WAS TRANSFERRED TO THE ER.
- Aktuelle Erkrankungen
- UNKNOWN
- Vorgeschichte
- UNKNOWN
- Andere Medikamente
- UNKNOWN
- Allergien
- CODEINE, MORPHINE, INFLUENZA VIRUS VACCINE, EFFEXOR
- Vorherige Impfungen
- Pneumoccocal Polysaccharide
- Staat
- GA
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 16.03.2022
- Impfdatum
- 10.02.2022
- Beginn
- 15.02.2022
- Tage bis Beginn
- 5,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: ja
Erholt: nein
Bell's palsy
Computerised tomogram
Ear pain
Electrocardiogram
Eye swelling
Facial pain
Facial paralysis
Headache
Neuralgia
Ophthalmological examination
Pain in jaw
Symptomtext
EAR AND LEFT SIDE SKULL PAIN STARTING 02/15/22 2/19/22 LEFT SIDE FACE PARALYSIS. IMMEDIATE TRIP TO ER RESULTING IN BELL'S PALSY DIAGONISIS WHICH MAY LAST WEEKS, MONTHS OR YEARS IMMEDIATE TREATMENT INCLUDED ANTIVIRAL AND STERIODS FOLLOW UP TREATMENT 2/22/22 - LEFT SIDE JAW AND FACE PAIN 3/11/22 - GP PRESCRIBED GABAPENTIN FOR NERVE PAIN 3/14/22 - NUROLOGIST CONSULT 3/15/22 - OPTHOMOLIGIST FOR EYE SWELLING - BEGIN TO MONTIOR FOR EYE DAMAGE OUTCOME STILL PARALIZED ON LEFT SIDE OF FACE
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- 3/19/22 - VISUAL EXAM / EKG CT SCAN - NO RESULTS PROVIDED
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- TACHYCARDIA
- Andere Medikamente
- OMEPRAZOLE, CITALOPRAM, ATENOLOL
- Allergien
- CIPRO
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 37,0
- Geschlecht
- F
- Eingang
- 04.03.2022
- Impfdatum
- 03.03.2022
- Beginn
- 03.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Fall
Nausea
Syncope
Symptomtext
The patient received a Moderna booster. She sat down on a chair. She was fine the first 10 minutes after the vaccine, but she started to slip out of the chair. She fainted for about less than 1 minute and regained consciousness quickly. She fell to the floor. She didn't hit her head. Pharmacist and technician rushed to the patient's side when she fell. We called 911. After she regained consciousness, she was alert and oriented. We brought her to a private room while we were waiting on emergency services. The patient stated she felt nauseated and dizzy because she didn't sleep well the night before. She also hadn't eaten any food the day before the vaccination.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- Unknown.
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- Unknown
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 22,0
- Geschlecht
- F
- Eingang
- 01.03.2022
- Impfdatum
- 01.03.2022
- Beginn
- 01.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Fall
Immediate post-injection reaction
Syncope
Unresponsive to stimuli
Symptomtext
Patient received the Moderna booster. Immediately after receiving vaccine, patient had a syncopal episode. Patient slumped over on chair and was unresponsive for approximately 5 seconds. When patient regained became responsive she was immediately moved to a bed and vitals were taken on site. BP 103/56, HR 50, SPO2 98%, A&Ox4. Patient was given water and juice and was monitored for the next 30 minutes. Repeat vitals BP 110/68, HR 70, SPO2 98. Per patient this has happened before in the past. Patient was discharged without further incident.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- Following syncopal episode (03/01/2022), BP 103/56, HR 50, SPO2 98%, A&Ox4. Patient was given water and juice and was monitored for the next 30 minutes. Repeat vitals BP 110/68, HR 70, SPO2 98.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Patient reported history of syncope following vaccine administration.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 07.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cardiac function test
Dyspnoea
Electrocardiogram
Fatigue
Myocardial necrosis marker
Palpitations
Pyrexia
Sleep disorder
Syncope
Symptomtext
Palpitations; Fatigue; Difficulty breathing/dyspnoea; syncope (fainting from drop in BP); Fever 103?F; Altered sleeping habits; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Palpitations), PYREXIA (Fever 103?F), SLEEP DISORDER (Altered sleeping habits), FATIGUE (Fatigue), DYSPNOEA (Difficulty breathing/dyspnoea) and SYNCOPE (syncope (fainting from drop in BP)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 vaccination. No Medical History information was reported. On 07-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2022, the patient experienced PALPITATIONS (Palpitations) (seriousness criterion hospitalization), FATIGUE (Fatigue) (seriousness criterion hospitalization) and DYSPNOEA (Difficulty breathing/dyspnoea) (seriousness criterion hospitalization). In February 2022, the patient experienced PYREXIA (Fever 103?F) (seriousness criterion hospitalization), SLEEP DISORDER (Altered sleeping habits) (seriousness criterion hospitalization) and SYNCOPE (syncope (fainting from drop in BP)) (seriousness criterion hospitalization). The patient was hospitalized on 09-Feb-2022 due to DYSPNOEA, FATIGUE, PALPITATIONS, PYREXIA, SLEEP DISORDER and SYNCOPE. The patient was treated with DILTIAZEM HYDROCHLORIDE (CARDIZEM [DILTIAZEM HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PALPITATIONS (Palpitations), PYREXIA (Fever 103?F), SLEEP DISORDER (Altered sleeping habits), FATIGUE (Fatigue), DYSPNOEA (Difficulty breathing/dyspnoea) and SYNCOPE (syncope (fainting from drop in BP)) was resolving. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Cardiac function test: abnormal (abnormal) Abnormal. On an unknown date, Electrocardiogram: abnormal (abnormal) Abnormal. On an unknown date, Myocardial necrosis marker: abnormal (abnormal) Abnormal. Patient was not taking any concomitant medication. Patient had no history of COVID positive. No other vaccines received within 1 month prior to Moderna COVID-19 vaccine. Batch number for second dose was reported as 037C21A. Patient started having severe symptoms of palpitations, fatigue, difficult breathing the same night she received the booster. Patient also experienced fever, altered sleeping habits and syncope (fainting from drop in BP). Chest pain or chest discomfort was not observed. Patient was hospitalized on 09-FEB-2022. It was reported symptoms lasted for almost two weeks. Not specified which symptoms. It was reported some symptoms improved some are still ongoing. Specifically mentioned fever of 103-degree Fahrenheit, altered sleeping habits, fatigue, palpitations were improved. Patient never had heart problem or similar symptoms like this before receiving the Moderna COVID-19 vaccine. Patient had no history of Myocarditis/Pericarditis. Company comment: This is a spontaneous case concerning a female patient of unknown age with no medical history reported, who experienced the unexpected, serious (hospitalization) events of palpitations, dyspnoea and syncope. The events started the same day after the third dose of mRNA-1273 and continued for two weeks, after which they started to improve. Treatment included diltiazem which could be a confounder for syncope. Diagnostic tests such as cardiac function tests, ECG and myocardial necrosis markers are reported as abnormal (not further specified). The benefit-risk relationship of mRNA-1273 COVID 19 Vaccine, is not affected by this report. Most recent FOLLOW-UP information incorporated above includes: On 18-Feb-2022: Follow up received includes: Event 'feeling bad' added On 22-Feb-2022: Events, lab data and treatment drug was added.; Sender's Comments: This is a spontaneous case concerning a female patient of unknown age with no medical history reported, who experienced the unexpected, serious (hospitalization) events of palpitations, dyspnoea and syncope. The events started the same day after the third dose of mRNA-1273 and continued for two weeks, after which they started to improve. Treatment included diltiazem which could be a confounder for syncope. Diagnostic tests such as cardiac function tests, ECG and myocardial necrosis markers are reported as abnormal (not further specified). The benefit-risk relationship of mRNA-1273 COVID 19 Vaccine, is not affected by this report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- Test Name: cardiac test; Result Unstructured Data: Abnormal; Test Name: ECG; Result Unstructured Data: Abnormal; Test Name: cardiac enzymes; Result Unstructured Data: Abnormal
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 22.02.2022
- Impfdatum
- 13.01.2022
- Beginn
- 13.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Bell's palsy
Computerised tomogram
Hemiplegia
Hypoaesthesia oral
Paraesthesia
Paraesthesia oral
Symptomtext
patient stated tingling in lips began soon after injection, although she did not report at the time. Within 5 days she had developed facial Bell's Palsy which is mostly resolved after 28 days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none reported
- Vorgeschichte
- none reported
- Andere Medikamente
- not known
- Allergien
- none reported
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 14.02.2022
- Impfdatum
- 11.02.2022
- Beginn
- 14.02.2022
- Tage bis Beginn
- 3,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Feeling cold
Myalgia
Partial seizures
Symptomtext
"Chills, couldn't get warm." Patient believes she had partial seizure possibly two partial seizures where "her spine arch up backwards and she had no control of it." No LOC or incontinence with episode. It happened during Friday night ; unknow time. Patient's muscles were sore next day and temp was 99.0 F on Saturday
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Partial seizures
- Hospital-Tage
- -
- Labordaten
- None. Patient has epilepsy. Patient is already on medications for this
- Aktuelle Erkrankungen
- Colonscopy 2/3
- Vorgeschichte
- Buerger disease Vasculitis Scoliosis Temporal lobe epilepsy
- Andere Medikamente
- Keppra 750 4 tablets nightly Trileptal 150 1 tablet BID Trileptal 600 1 tablet BID
- Allergien
- Bee sting Citric Acid Lamictal
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 28,0
- Geschlecht
- M
- Eingang
- 14.02.2022
- Impfdatum
- 12.02.2022
- Beginn
- 12.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Amnesia
Confusional state
Disorientation
Fall
Head injury
Hyperhidrosis
Loss of consciousness
Mydriasis
Nausea
Pallor
Skin abrasion
Syncope
Vomiting
Symptomtext
The first 3 minutes from the time of vaccination, client did not have adverse event. RN was doing rounds checking on other vaccinated clients when client waved for RN?s attention. RN approached client and immediately thereafter, client fell off the chair and landed on the sidewalk face first hitting left side of his head on the floor. RN repositioned the client to supine position supporting him from the back. Client was out for approx. 5sec, RN attempted to arouse him and was successful. Client woke up, eyes dilated, diaphoretic, unaware of his location, appeared disoriented. At 1000, first vital reading was performed BP 142/60, P102, O2sat 97%, R20. RN reoriented client explaining what happened and informed him that we will activate EMS, client refused at this time. At 1005, second vital reading was performed BP 136/62, P72, O2sat 99%, R18. Client was verbally engaging with staff, RN attended to a mild abrasion on his left temple cleansed with alcohol swab and placed a band aid. Client was offered water but declined. RN was supporting client in supine position and continued assessing his health status. At 1006 EMS was activated by staff and informed client. Client continues to verbalize refusal and provided teaching and safety protocol, verbally understands. At 1010, third vital reading was 120/52, P70, O2sat 98%, R18. Client was feeling nauseated and was diaphoretic upon assessment. Client requested to stand up to walk to the trash can. Assisted in a standing position with two additional staff surrounding him and assisted him to the trash can where he had x1 vomit of emesis. RN was beside the client monitoring his status. At 1017, fourth vital reading was performed 115/60, P78, O2sat 98%, R18. Client had a second episode of vomiting in the trash and continue to be diaphoretic, pale in color. Client called his friend to pick him up. RN maintained in proximity of client and assessed his memory of the event for possible concussion. Client appeared to remember his vaccination experience leading up to syncopal episode. Client could not remember where he?s at. At 1027, EMS arrived on the scene and RN gave report. EMS conducted their assessment, client refused services. At 1035, client?s friend arrived at the event and picked him up. Provided education to client to go to PCP and get checked out for possible concussion, verbally acknowledge.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- none. EMS activated at 1006 and arrived the scene at 1027.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- NKDA
- Vorherige Impfungen
- Client is known to experience aversion from receiving vaccinations in the past.
- Staat
- CO
- Alter
- 30,0
- Geschlecht
- F
- Eingang
- 09.02.2022
- Impfdatum
- 08.01.2022
- Beginn
- 20.01.2022
- Tage bis Beginn
- 12,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Axillary pain
Chronic spontaneous urticaria
Erythema
Insomnia
Lymphadenopathy
Pruritus
Rash
Sleep disorder
Syncope
Urticaria
Symptomtext
1. Chronic spontaneous urticaria -12 days after booster. Itching, hives, red marks etc all over body besides breasts. Went to ER 5-6 days later and received loratadine (10mg) 1x a day for 10 days, MethtylPrednisolone (4mg) 21 tablets over the course of 6 days Famotidine (20mg) 2x a day for 5 days Hydrocortisone (tube for application) IV during ER visit of steroids which reduced redness and rash. Meds reduced rash significantly but once meds were finished rash and itchiness has returned. 2. Vasovagonsyncope the morning after booster, 10 minutes after waking. Woke up in middle of the night and trouble sleeping prior to incident. 3. Swollen lymph nodes and painful armpit. Was resolved 5 days post vaccine by receiving a lymphatic drainage massage.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- alopecia areata (past) 3 years and doxycycline helped 1 bout of it, the next time it went away on it's own.
- Andere Medikamente
- birth control
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 41,0
- Geschlecht
- F
- Eingang
- 26.01.2022
- Impfdatum
- 18.01.2022
- Beginn
- 18.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: unbekannt
Anxiety
Flushing
Hyperhidrosis
Hyperventilation
Pyrexia
Respiratory distress
Symptomtext
Pt had Pfizer primary series and Moderna Booster Pt reported respiratory distress, hyperventilation, anxiety, flushing/sweating, low fever 99.9F Vitals: 136/88, 98, 22 Pt continues to present as anxious and denies all questions pertaining to relavant hx. Pt denies new medications but admits to not eating "fasting". Pt admits to panic attack "years ago... but never like this". Pt continues to hyperventilate w/ continued encouragement from staff. Pt taken to ED @16:55. In ED: Vitals: 132/87, 82, 16, 98.2F, 98% Pt diagnosed w/ chest heaviness. Pt recovered and discharged @19:12.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Respiratory distress
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- PMH: Migraines, cluster HA
- Andere Medikamente
- unknown
- Allergien
- Allergies: latex (hives)
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 40,0
- Geschlecht
- F
- Eingang
- 23.01.2022
- Impfdatum
- 23.01.2022
- Beginn
- 23.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 7+
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Adverse reaction
Syncope
Symptomtext
2nd moderna vax, during 15 minute waiting period pt complained 'something wrong' 'having an adverse reaction'. after discussion with pt, there were no signs of anaphylaxis, pt did not have dizziness, sweatiness, n/v, or other signs for vasovagal sycope. After discussion and coming into our IMZ room, pt was much more relaxed. pt waited 30 minutes and left after.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- pt took a blood pressure after her 30 minute waiting period. BP was approximately 120/80, pulse 69.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 21.01.2022
- Impfdatum
- 19.01.2022
- Beginn
- 20.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenia
Fatigue
Headache
Paralysis
Symptomtext
Headache, lower body paralyzed for 8 hrs very week and tierd
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paralysis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Type 2 diabetes, clinical depression
- Andere Medikamente
- Trazodone, Escitalopram, Pantoprazole, Allopurinol, Bupropion XL
- Allergien
- None
- Vorherige Impfungen
- Mederna
- Staat
- HI
- Alter
- 46,0
- Geschlecht
- F
- Eingang
- 21.01.2022
- Impfdatum
- 16.01.2022
- Beginn
- 18.01.2022
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Seizure
Symptomtext
Systemic: Seizure-Mild, Additional Details: Seizure monitored by husband and lasted approx 30 minutes. The seizure subsided before EMS arrived and patient sent them away without receiving additional evaluation. I advised the patient to seek additional medical evaluation from their PCP to determine if there may have been another cause for this event.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 19.01.2022
- Impfdatum
- 19.01.2022
- Beginn
- 19.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Impaired driving ability
Presyncope
Symptomtext
Pharmacist went over form with patient. She circled "heart" but said it was just hypertension. She thinks she may be prediabetic, but not confirmed with doctor yet. Administered dose of Moderna Booster 0.25mL. Patient felt ok during administration and was advised to wait 15 minutes in the chairs next to the pharmacy per CDC guidline. Pharmacist went to check on patient at about 10 minutes, she was gone. Patient came back to pharmacy a few minutes later and said she'd almost fainted while trying to check out her purchases. Pharmacist had her sit down and got some water for her. Patient then went to Health machine and checked her BP with pharmacist -was 181/115. Advised pt to sit still for 5 minutes and try again - then was 153/??. Patient decided she wanted to go to urgent care, was advised by pharmacist to have someone else drive, grand daughter came and took patient to uc. Patient called later and said urgent care was not concerned by her reaction to the vaccine and advised her on some things to look for and sent her home.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Presyncope
- Hospital-Tage
- -
- Labordaten
- Blood pressure 181/115 01/19/2022
- Aktuelle Erkrankungen
- Hypertension. possible undiagnosed pre-diabetes per patient form
- Vorgeschichte
- Hypertension
- Andere Medikamente
- unknown
- Allergien
- NKA per patient form.
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 26,0
- Geschlecht
- M
- Eingang
- 19.01.2022
- Impfdatum
- 08.01.2022
- Beginn
- 08.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Syncope
Unresponsive to stimuli
Symptomtext
Systemic: Fainting / Unresponsive-Mild, Additional Details: Pt received Moderna COVID-19 Booster dose & Fluzone Quad 2021-2022 shots in the same arm. Administered Moderna COVID-19 booster first, & then flushot 1 inch apart. After administering flushot & as I was applying the bandaid, pt fainted a little by leaning forward. I caught pt & loudly called their name, & pt came too right away. Event only lasted a few seconds. Pt then admitted to fear of needles & 2nd shot (flu shot) scared them & they fainted. Had pt sit for 30 mins & pt had no other reactions
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 21,0
- Geschlecht
- F
- Eingang
- 19.01.2022
- Impfdatum
- 06.01.2022
- Beginn
- 06.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Asthenia
Dizziness
Flushing
Hyperhidrosis
Syncope
Tremor
Unresponsive to stimuli
Symptomtext
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Shakiness-Mild, Systemic: Weakness-Mild, Additional Details: Emergency services was called; pt was given water and ice pack for back of her neck, and put in chair... EMTs and pts mother arrived with counsel to go to ER for eval
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- 21,0
- Geschlecht
- F
- Eingang
- 14.01.2022
- Impfdatum
- 12.01.2022
- Beginn
- 13.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Feeling abnormal
Loss of consciousness
Symptomtext
Pt phoned office to report that by the next day after vaccination, 1/13/2022, she was feeling generally poorly and then later in the day at school she had a brief loss of consciousness. Reports that a familly friend who is a nurse to her by her work place and checked her vital signs which she said were fine; and she stayed with her that night and had started feeling a bit better this morning. At the nurse friends recommendation pt is going to get tested for covid
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- CONCERNED ABOUT SWOLLEN THYROID
- Vorgeschichte
- ANXIETY
- Andere Medikamente
- BUSPAR PROZAC
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 45,0
- Geschlecht
- F
- Eingang
- 13.01.2022
- Impfdatum
- 13.01.2022
- Beginn
- 13.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Dizziness
Gaze palsy
Generalised tonic-clonic seizure
Loss of consciousness
Pruritus
Seizure
Throat tightness
Symptomtext
Pt was given original dose at another location. Patient stated to pharmacist that she did not have any issues with first dose but had a long list of allergies. All of which we have on file. She came in at 4:19 pm and the dose was administered at 4:35 pm she was kept 30 min due to allergies, at 5:08 the technician (who is CPR trained) gave the patient her card and was walking along side patient just past the pharmacy the patient said she felt light headed. The technician brought her back into the clinical services area and knocked on window to alert pharmacist she was slumped over. The pharmacist instructed staff to call 911 and a code white. I ran out and when I arrived the patient was not alert and slumped back into the technician. The pharmacist and technician at that time helped the patient to the floor gently as to not hit her head and remove the chair. An ice pack was brought out and place behind the patients neck. . I checked for pulse and asked the patient if they could hear me. The patient kept opening her eyes and closing them but had airway and pulse. The store Coach showed up and was assisting. The patient then stated she was itchy and felt her throat closing. She said her husband was in the pharmacy parking spots so the technician went to look for him in his car. At 5:13 an Epi pen was administered into the patient and a second retrieved in case of necessity. The patient was talking and alert and stated she felt her airway was tightening. She then lost consciousness again in which I checked for pulse and tried to check airway. Pt started having what seemed a seizure with eye movement back and forth and slight head movement. I did feel a faint pulse. I instructed (Coach) that I thought patient was having a seizure and that most important thing is to keep patient from hitting her head on ground. We removed the clinical services room and table and chairs. Pt started with full tonic clonic seizure movement and moved at least 2-3 feet from original position. At times it seemed patient would almost vomit so moved her to her side and just made sure she did not hit her head on cement. I instructed not to fight the movement just keep her head from hitting ground. At 9:17 I instructed staff to call 911 again to verify coming. During this time coach and myself just kept her from hitting her head. I did not feel it safe to administer an second dose of Epi as the patient had too much movement. The paramedics arrived at 9:18 slowly walking to the scene and took over. At the time the paramedic saw the epi pen and asked why we administered. I stated to the paramedic that the patient was telling us her throat was closing and had multiple allergies and received a second dose of COVID just before so it was part of our protocol. The husband came in at the same time as paramedics and also told paramedics that the patient always has epi pen and uses for situations. The EMT showed up a few minutes later and an IV was administered and patient was taken to hospital. She was able to speak a few times but was unconscious most of the time.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Generalised tonic-clonic seizure
- Hospital-Tage
- -
- Labordaten
- Unknown
- Aktuelle Erkrankungen
- None according to patient,
- Vorgeschichte
- high blood pressure, crohns, diabetes
- Andere Medikamente
- Unknown husband was not a good historian
- Allergien
- Paroxetine, Fluoxetine, Clavulanic Acid, Doxapram, Fentynl, Yellow, green, blue and red dye, Quetipine, beta blockers, nitrofurantoin, Macrolides, clindamycin, Ace inhibitors, quinolones, calcium channel blockers, tetracycline, sulfa, penicillin and cephlasporins
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 30,0
- Geschlecht
- F
- Eingang
- 12.01.2022
- Impfdatum
- 12.01.2022
- Beginn
- 12.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Muscle spasms
Syncope
Symptomtext
PATIENT FAINTED FOR ABOUT 2 MINUTES AFTER THE VACCINATION; PATIENT SAID BOTH OF HER HANDS AND FEET CRAMP UP; AFTER 10-15 MINUTES RESTING PATIENT FELT BETTER AND WENT HOME
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- DIPHENHYDRAMINE (RASH)
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 12.01.2022
- Impfdatum
- 08.01.2022
- Beginn
- 11.01.2022
- Tage bis Beginn
- 3,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Loss of consciousness
Symptomtext
Patient passed out in car.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- Ace inhibitors
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 26,0
- Geschlecht
- M
- Eingang
- 11.01.2022
- Impfdatum
- 11.01.2022
- Beginn
- 11.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Immediate post-injection reaction
Syncope
Symptomtext
Patient administered booster dose of the Moderna vaccine 1/11/22. Patient reported history of fainting prior to administration be said it has not had an episode in a while and he did just fine with his Moderna primary series (doses 1 and 2). Immediately upon administration patient began to faint. Patient was move to the floor laid supine and feet where elevated above his head. Patient immediately started to feel better once placed in supine position with feet elevated. patient remained in that position for about 7 minutes and requested to sit up in the chair. Patient was observed for 30 minutes before being allowed to leave the pharmacy. Patient was well when he left pharmacy.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- Not applicable
- Aktuelle Erkrankungen
- NOT KNOWN
- Vorgeschichte
- HISTORY OF FAINTING
- Andere Medikamente
- NOT AVAILABLE
- Allergien
- NO KNOWN DRUG ALLERGIES
- Vorherige Impfungen
- Unknown: Not disclosed just stated history of fainting.
- Staat
- -
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 13.09.2023
- Impfdatum
- 18.01.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Dyspnoea
Urticaria
Symptomtext
pt reported adverse reaction of hives and shortness of breath
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NE
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 22.08.2023
- Impfdatum
- 19.07.2021
- Beginn
- 20.07.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Laboratory test
Paraesthesia
Symptomtext
Continuous tingling in both legs. Occasional tingling in the rest of my body.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- I have had to see a heart specialist, a vascular surgeon and have tests for my heart and my lungs.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Centrum daily vitamin, calcium supplement, fish oil capsule, D3 supplement, B12 supplement
- Allergien
- Sulfa
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 07.08.2023
- Impfdatum
- 14.02.2022
- Beginn
- 01.02.2023
- Tage bis Beginn
- 352,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Hypotension
Hypoxia
Symptomtext
HYPOTENSION HYPOXIA
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypotension
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 31,0
- Geschlecht
- F
- Eingang
- 27.07.2023
- Impfdatum
- 10.02.2022
- Beginn
- 10.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Cyclic vomiting syndrome
Dizziness
Tachycardia
Symptomtext
Tachycardia (HR>200), light headed, dizzy, cyclical vomiting
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tachycardia
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 09.06.2023
- Impfdatum
- 25.01.2022
- Beginn
- 02.11.2022
- Tage bis Beginn
- 281,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Hypotension
Symptom recurrence
Symptomtext
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE HYPOTENSION 2/8/2023RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypotension
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 23.04.2023
- Impfdatum
- 21.01.2022
- Beginn
- 21.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Condition aggravated
Fatigue
Headache
Hyperhidrosis
Mobility decreased
Pain
Pyrexia
Tinnitus
Tremor
Symptomtext
Fever, chattering teeth, shaking, extreme sweating, severe headache, severe body pains, extreme fatigue, severe tinnitus
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- none as I was unable to get out of bed for 3 days
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- polymyalgia rheumatica, endometriosis, tinnitus, unilateral hypovestibular dysfunction, history of MI
- Andere Medikamente
- none
- Allergien
- bee stings, Ceftin, seasonal allergies
- Vorherige Impfungen
- Covid Moderna 1/14/2021 Dizzy, SOB, facial and throat swelling, extreme fatigue, fever, severe headache, body pains Covid Modern
- Staat
- UT
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 24.03.2023
- Impfdatum
- 11.04.2022
- Beginn
- 01.07.2022
- Tage bis Beginn
- 81,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Balance disorder
COVID-19
Dizziness
Magnetic resonance imaging head abnormal
Musculoskeletal stiffness
Pain in extremity
Parkinson's disease
Reflex test
Tremor
Symptomtext
I already had some tremors in one of my legs, and I developed COVID19 after my 3rd COVID19 vaccination, it was pretty mild. Then I started to have leg tremors in both legs over the summer, in July 2022. I also experienced some toe pain in both feet, the third and forth toes. I started to get some muscle stiffness and lightheadedness. I'm an avid skier and I noticed in the fall that I was no longer able to balance correctly which was alarming. The lightheadedness started to get worse as well. In January 2023 I finally went to the doctor, and they gave me a referral to a neurologist. I had an MRI last month and it was determined that I had Parkinson's. I have started taking medication, the last day of February. I tried skiing about a week ago since the medication and was finally able to balance on my skis.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tremor
- Hospital-Tage
- -
- Labordaten
- 2023Feb6 Vitals, reflex tests; 2023Feb23 MRI (verified Parkinson's)
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Parkinson's
- Andere Medikamente
- Multivitamin; calcium; vitamin D3; BOTOX
- Allergien
- Sulfa
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 41,0
- Geschlecht
- M
- Eingang
- 06.02.2023
- Impfdatum
- 04.02.2022
- Beginn
- 25.01.2023
- Tage bis Beginn
- 355,0
- Dosis
- 3
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood pressure increased
Blood test normal
Chest discomfort
Dizziness
Dyspnoea
Electrocardiogram normal
Headache
High density lipoprotein decreased
Hot flush
Low density lipoprotein normal
Urine analysis normal
Symptomtext
The adverse event was tightening of chest, dizziness, shortness of breath, increased blood pressure, hot flashes, and a slight headache. I don't know if the vaccine is the cause or not but I cannot rule it out.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- Blood profile, EKG, UA. All results were normal. Bad cholesterol was normal good cholesterol was lower than it should have been. A Stress test is to be scheduled.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Acid reflux
- Andere Medikamente
- Hydroxyzine
- Allergien
- Scallops
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 36,0
- Geschlecht
- F
- Eingang
- 12.12.2022
- Impfdatum
- 22.01.2022
- Beginn
- 22.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- SYR / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: ja
ER: unbekannt
Erholt: nein
Biopsy kidney
Blood urine present
Condition aggravated
IgA nephropathy
Laboratory test
Proteinuria
Renal function test
Urine analysis
Urine protein/creatinine ratio increased
Symptomtext
After receiving my third dose of Moderna vaccine for Covid-19, my IGa Nephropathy flared up within hours of receiving the shot - and my proteinuria numbers rose to higher ranges than it has ever been. My urine protein/creatinine output rose above 7000 mg/g. Normal range is under 200 mg/g, and my average has remained at 500mg/g regularly. I began to see blood in my urine, beginning on 1/22/22. To date, my urine protein/creatinine output remains above 3000 mg/g. I have been taking Budesonide EC for treatment.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- 2,0
- Labordaten
- LAB URINE TESTS AND RENAL PANELS: 1/24/22, 1/27/22, 2/10/22, 2/28/22, 3/21/22, 3/22/22, 4/8/22, 4/21/22, 5/2/22, 6/7/22, 7/26/22, 8/8/22, 8/22/22, 9/20/22, 11/16/22 KIDNEY BIOPSY: 3/14/22
- Aktuelle Erkrankungen
- Superficial blood clot in left arm
- Vorgeschichte
- IGa Nephropathy with protenuria below 1.0
- Andere Medikamente
- Omega-3 Fish oil, zinc, Vit C, Vit D
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 05.12.2022
- Impfdatum
- 22.01.2022
- Beginn
- 25.11.2022
- Tage bis Beginn
- 307,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Dyspnoea
SARS-CoV-2 test positive
Symptomtext
Patient with COVID vaccines who admitted to hospital with dyspnea and COVID detected PCR. Patient started on decadron and discharged home.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 2,0
- Labordaten
- COVID Detected PCR on 11/25/2022
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Cardiovascular Paroxysmal atrial fibrillation with rapid ventricular response (HCC) HTN (hypertension) CAD (coronary artery disease) Respiratory Chronic obstructive pulmonary disease with acute exacerbation (HCC) Pneumonia due to COVID-19 virus Bilateral pleural effusion Acute respiratory distress, multifactorial Other Adrenal nodule (HCC) Weight loss Tobacco use
- Andere Medikamente
- -
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 27.10.2022
- Impfdatum
- 10.02.2022
- Beginn
- 19.10.2022
- Tage bis Beginn
- 251,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenia
COVID-19
Cardiac failure
Cardiac failure acute
Cardiac failure congestive
Chest X-ray abnormal
Condition aggravated
Decreased appetite
Diuretic therapy
Dyspnoea
Echocardiogram abnormal
Ejection fraction normal
Electrocardiogram normal
Hypoxia
Left ventricular failure
Mitral valve calcification
Mitral valve stenosis
Prohormone brain natriuretic peptide increased
Symptomtext
Admission Date: 10/19/2022 Discharge Date: 10/21/2022 PRESENTING PROBLEM: Hypoxia Acute on chronic congestive heart failure, unspecified heart failure type COVID-19 virus infection Acute on chronic systolic heart failure HOSPITAL COURSE: The patient is an 80-year-old male with a history of chronic systolic heart failure, atrial fibrillation on Eliquis, hypertension, dyslipidemia and coronary artery disease who presented on 10/19 with increased shortness of breath. Patient's symptoms had been present since 10/18, and had not improved, prompting him to come to the ER on 10/19. The patient does weigh himself daily, and states that his weight had been stable. In the emergency room the patient was noted to be mildly hypoxic, requiring 2 L/min per nasal cannula. Patient was also positive for COVID infection. ProBNP was elevated at 35 95, with chest x-ray showing mild pulmonary venous congestion. Patient was started on Decadron as well as IV Lasix and admitted to the hospital service. In the ER, the patient was also noted to have intermediate troponins with positive delta, although EKG was nonischemic. After admission, the patient was treated with Decadron and remdesivir. He was also treated with IV Lasix. Echocardiogram was performed showing and EF of 55% with moderate mitral annular calcification and mild mitral stenosis. With Decadron, remdesivir and diuresis the patient had significant improvement in his dyspnea, energy level and appetite. The patient did have improvement in his O2 requirements. He was evaluated by pulmonary rehab prior to discharge, and found to have no O2 requirements. As patient was clinically stable, he was discharged to home on 10/21/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Longstanding persistent atrial fibrillation Acute on chronic systolic heart failure Essential hypertension Coronary artery disease involving native coronary artery of native heart without angina pectoris Cardiac pacemaker in situ Chronic combined systolic and diastolic heart failure Symptomatic bradycardia Bilateral carotid artery stenosis Rt (50-69%) > LT Secondary hypercoagulable state Gross hematuria Mixed hyperlipidemia
- Andere Medikamente
- Ascorbic Acid (VITAMIN C PO) aspirin 81 MG enteric coated tablet atorvastatin (LIPITOR) 40 MG tablet Cholecalciferol (VITAMIN D3 PO) Cyanocobalamin (B-12 PO) dexamethasone (DECADRON) 6 MG tablet ELIQUIS 5 MG tablet ferrous sulfate 325 (65 F
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 39,0
- Geschlecht
- M
- Eingang
- 19.08.2022
- Impfdatum
- 02.02.2022
- Beginn
- 26.04.2022
- Tage bis Beginn
- 83,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Atrial fibrillation
Cardiac stress test normal
Chest discomfort
Chest pain
Echocardiogram normal
Electrocardiogram abnormal
Symptomtext
Chest pain and tightness same night as the shot on 2/2/2022 that lasted for over a week. Then on 4/26/2022 I developed atrial fibrillation for the first time in my life.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- 1,0
- Labordaten
- EKG, Echo, Stress Test. EKG showed AFib on 5/23/2022 during 2nd AFib event. Echo and stress test normal
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 40,0
- Geschlecht
- F
- Eingang
- 28.07.2022
- Impfdatum
- 01.02.2022
- Beginn
- 22.03.2022
- Tage bis Beginn
- 49,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Migraine
Symptomtext
Migraine; Received first dose on 01-Feb-2022 and second dose on 22-Mar-2022 which was more than 25-35 days; This spontaneous case was reported by an other health care professional and describes the occurrence of MIGRAINE (Migraine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received first dose on 01-Feb-2022 and second dose on 22-Mar-2022 which was more than 25-35 days) in a 40-year-old female patient who received mRNA-1273 (Spikevax) (batch nos. 084J21A and 084J21A) for COVID-19 prophylaxis. The patient had no known drug allergies. The patient's past medical history included Migraine (no recent changes in condition status) on 01-Mar-2018 and Migraine (no recent changes in condition status) on 29-Oct-2021. Concomitant products included FAMOTIDINE, IBUPROFEN (DUEXIS) from 29-Oct-2021 to an unknown date, IBUPROFEN from 01-Mar-2018 to an unknown date and FAMOTIDINE from 18-Mar-2022 to an unknown date for an unknown indication. On 01-Feb-2022 at 12:47 PM, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 22-Mar-2022 at 10:25 AM, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to .5 milliliter. On 22-Mar-2022 at 10:25 AM, after starting mRNA-1273 (Spikevax), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received first dose on 01-Feb-2022 and second dose on 22-Mar-2022 which was more than 25-35 days). On 18-May-2022, the patient experienced MIGRAINE (Migraine). At the time of the report, MIGRAINE (Migraine) had not resolved and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received first dose on 01-Feb-2022 and second dose on 22-Mar-2022 which was more than 25-35 days) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. Patient weight was reported as 180. No treatment medications were reported. This case was linked to MOD-2022-503443 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Migraine
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Migraine (no recent changes in condition status); Comments: The patient had no known drug allergies.
- Andere Medikamente
- DUEXIS; IBUPROFEN; FAMOTIDINE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 25.07.2022
- Impfdatum
- 22.04.2022
- Beginn
- 17.07.2022
- Tage bis Beginn
- 86,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Cough
Musculoskeletal chest pain
Pain
Pyrexia
Rhinorrhoea
SARS-CoV-2 test positive
Sneezing
Symptomtext
On Wednesday July 20, 2022, my symptoms were coughing, sneezing, runny nose and body aches The following day I had a low grade fever. On the 20th we went to the pharmacy to get our COVID-19 test and it was positive. On Friday I reached out to my doctor but was only able to talk to PA and she said I didn't qualify for Paxlovid. She did prescribed Benzonatate for my cough. As of today, July 25th, I am coughing less than I was and I have some body aches. My ribs are really sore from so much coughing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Musculoskeletal chest pain
- Hospital-Tage
- -
- Labordaten
- COVID-19 test, positive
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- Multi Vitamin
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 19.07.2022
- Impfdatum
- 12.04.2022
- Beginn
- 01.05.2022
- Tage bis Beginn
- 19,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Endometrial thickening
Fatigue
Mobility decreased
Pain
Pain in extremity
Postmenopausal haemorrhage
Sciatica
Ultrasound pelvis abnormal
X-ray of pelvis and hip normal
Symptomtext
I was walking in the evening and walked about a block and a half. All the sudden I had excruciating pain form my hip to my leg and had to basically drag myself home. It was like that for over a day so I called my doctor and they had me come in. They did hip X-rays of both hips. They couldn't see anything so he did a physical exam and found the most pain in my bursa and it's causing sciatica down my leg. I sued to be a morning person and now I wake up tired and need coffee. I feel 80 years old when I wake up and it takes a lot of walking around and stretching to feel okay again. After a few weeks, I was still in pain everywhere so my doctor referred me to an Orthopedic doctor who gave me a cortisone injection in my hip. The next morning I was able to walk like a normal person again. My doctor explained that a pain somewhere in the body can go through your joints and cause pain all over. I got 600mg Motrin but I don't like to take medication. He told me it would heal in a few weeks. He also gave me physical exercises to do to help heal it. I am still waiting to feel like myself again and it's been three months. I am still having issues. A few weeks ago , I also started spotting. I haven't had my period in many years so it was freaky. Now, they want to do a biopsy. I didn't have any other symptoms but the spotting lasted about 3-4 days. My doctor did an ultrasound and found the lining of my uterus was thicker than normal.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- Hip X-Rays- 06/2022; Pelvic Ultrasound- 06/2022
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- B Vitamins; Collagen; Vitamin E; Vitamin A; Fish Oil; Turmeric; Magnesium; Vitamin D3
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 15.07.2022
- Impfdatum
- 14.03.2022
- Beginn
- 14.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Injected limb mobility decreased
Injection site pain
Pain in extremity
Sleep disorder
Symptomtext
Left and Right arm extremly sore after 4 months. Difficulty lifting and using arm. Difficulty to sleep on left and right side of body due to shoulder pain at injection site.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injected limb mobility decreased
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- knee replacement consisent pain in both arms 4 months after taking booster and influenza vaccine. I can barely lift arms or sleep on either side of arms /shoulder at night
- Andere Medikamente
- sulidac
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 59,0
- Geschlecht
- M
- Eingang
- 15.07.2022
- Impfdatum
- 13.01.2022
- Beginn
- 10.06.2022
- Tage bis Beginn
- 148,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Cough
Dyspnoea exertional
Ear discomfort
Fatigue
Malaise
Nasal congestion
Oropharyngeal pain
Productive cough
Rhinorrhoea
SARS-CoV-2 test positive
Sinus congestion
Symptomtext
COVID-19 symptoms started on 06/10/2022; tested positive on 06/11/2022 but the official date I was diagnosed, since I was on a cruise ship, was on 06/13/2022. Symptoms started with common sinus conditions like runny nose and stuffy nose and then ear blockage and congestion. Eventually I had sore throat and that went into chest from coughing. Symptoms lasted until the 13th or 14th because I was put on a drug treatment and was negative on the 17th, 5 days probably from first onset. Medication was Molnupiravir. I have lingering effects which include a productive cough, fatigue, and sometimes shortness of breath upon exertion but other than that I'm good and get tired easily.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea exertional
- Hospital-Tage
- -
- Labordaten
- COVID-19 Positive 06/11/2022
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- High blood pressure; COPD
- Andere Medikamente
- Blood Pressure Medications; Vitamins
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 12.07.2022
- Impfdatum
- 09.01.2022
- Beginn
- 26.06.2022
- Tage bis Beginn
- 168,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Amino acid level
Antinuclear antibody negative
Asthenia
Blood folate normal
Blood homocysteine normal
Blood iron decreased
Bronchoalveolar lavage abnormal
Bronchoscopy
CD4 lymphocytes
COVID-19
Computerised tomogram thorax abnormal
Condition aggravated
Cytomegalovirus test positive
Decreased appetite
Device dislocation
COVID-19 pneumonia
Cachexia
Cataract
Symptomtext
Discharge Provider: MD Primary Care Provider: NP Admission Date: 6/26/2022 Discharge Date: Jul 11, 2022 PRESENTING PROBLEM: Hypoxia Severe sepsis COVID-19 virus infection COVID-19 HOSPITAL COURSE: Patient is a 61-year-old female with PMH significant for iron deficiency anemia (and later determined- positive HIV status-off treatment > 10 years), recent recent issues with pancytopenia (WBC 2, hemoglobin 11, platelets 118, pneumonia in 03/2022 presents to the hospital on 06/26 with a symptom complex including steady decline at home, with generalized weakness, reduced oral intake, continued weight loss, worsening mental status, intermittent fevers. She appeared cachectic, oriented x1. Was febrile, tachypneic and hypoxic in ER. She was tested positive for COVID-19, chest x-ray showed increased diffuse bilateral interstitial prominence, started on IV antibiotics and admitted. Patient was admitted with bilateral pulmonary infiltrates, hypoxic respiratory failure likely related to COVID-19 pneumonia and possible superimposed bacterial pneumonia. Infectious Disease was consulted. Patient finished 5 day course of Rocephin/azithromycin. Completed a 10 day course course of dexamethasone and 5 days of remdesivir. As concern for PCP was high in setting of positive HIV status patient was started on Bactrim. CT thorax showed diffuse ground-glass opacities bilaterally and a 7 mm left upper lobe pulmonary nodule. Pulmonology consulted and patient underwent bronchoscopy. BAL returned positive for Pneumocystis cm the and HSV. Patient was continued on Bactrim Decadron was transition to prednisone with plan to complete a 21 day course. Per ID patient was started on Biktarvy after CD4 count returned 8 viral load >7 million. Patient complained of blurry vision ophthalmology was consulted to ensure no CMV retinitis. Left eye clear however right eye has significant cataract limiting examination. Patient noted to have waxing and waning mental status. MRI of the brain was obtained which showed diffuse white matter changes hence neurology consultation was obtained. EEG was negative. LP was negative for infection. Repeat MRI with and without contrast also reiterated above findings. Neurology suggested brain biopsy given her HIV status. Patient with several intervals of lucidity, was able to identify her husband be her decision maker if needed. Care management requested for DPOA paperwork. After further discussion with Neurology and Infectious Disease it was felt that patients encephalopathy was likely secondary to the HIV itself. Patient will need periodic reassessment regarding improvement of encephalopathy while on the Biktarvy. Id considered possible involvement of HSV meningitis/encephalitis. Patient had already been started on valganciclovir for positive CMV. This will be continued and for now is considered to provide coverage. If patient does not continue to improve could consider repeat LP for additional CSF to test for HSV. Id will continue to monitor this and follow up after discharge. Pharmacy is recommending cbc again in one week for monitoring and ID states weekly CMV titers. She had outpatient follow-up with Hematology for ongoing pancytopenia, hematology consultation was requested . Patient was noted to be HIV positive, test done on 06/21 however not noticed until 6/28. History was not available at admit however after further including, patient was previously diagnosed to have HIV, was on anti-retroviral but stop taking more than 10 years ago. Previous workup elevated inflammatory markers serum free light chains elevation but normal ratio, negative ANA negative rheumatoid factor , iron level 9 iron binding capacity 136 saturation 7% ferritin 623 folate/B12 normal normal methylmalonic acid and homocystine Per Hematology no plans to pursue bone marrow biopsy at this time Patient has received 4 doses of Venofer recently. Patient was previously noted to have a porta hepatis mass 28 mm and this was evaluated with an ultrasound on MRI of the abdomen. NO MASS. Patient with obvious failure to thrive with a significant amount of weight loss 25- 30 lb this year. Patient presented with cachexia and anorexia and discontinued during the hospital stay. Corpak was placed for tube feeds. On the day of discharge KUB showed Corpak was in the proximal gastric body. Discussed with MD Nutrition Service who stated if patient has been tolerating gastric feeds okay to continue to use tube with current placement however if patient pulled out further will likely need to readvance/replaced.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- 15,0
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Community acquired bilateral lower lobe pneumonia Iron deficiency anemia Pneumocystis pneumonia complicated by acute hypoxic respiratory failure COVID-19 virus infection Anemia, macrocytic Thrombocytopenia Fever Tachypnea Hypoxia Pancytopenia Unspecified severe protein-calorie malnutrition AIDS (acquired immune deficiency syndrome) HIV encephalopathy Cataracts Cytomegalovirus (CMV) viremia HSV (herpes simplex virus) infection
- Andere Medikamente
- benzonatate (TESSALON) 200 MG capsule Bictegravir-Emtricitabine-Tenofovir Alafenamide (BIKTARVY) 50-200-25 MG ferrous sulfate 325 (65 Fe) MG tablet Fluticasone-Umeclidin-Vilant (TRELEGY ELLIPTA INH) Multiple Vitamin (MULTIVITAMIN ADULT)
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 31,0
- Geschlecht
- F
- Eingang
- 17.06.2022
- Impfdatum
- 27.01.2022
- Beginn
- 27.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: unbekannt
Blood pressure increased
Dizziness
Hypoaesthesia
Muscle spasms
Paraesthesia
Headache
Nodule
Pyrexia
Paraesthesia oral
Tremor
Symptomtext
Had COVID booster on January 27. After her second booster had a little bit of numbness in the hand that her injection was given but after the third booster within 5 minutes had numbness and tingling of the entire hand that spread up into the arm and down into the leg. Also affected the side of her face. She was given an EpiPen although denied any shortness of breath presyncope and was transported to the hospital where she was given Benadryl numbness eventually improved after about 2-hour. Headache since inj and lump on arm. Low grade fever.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 48,0
- Geschlecht
- F
- Eingang
- 17.05.2022
- Impfdatum
- 05.05.2022
- Beginn
- 05.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Arthralgia
Blood test
Chest X-ray
Decreased appetite
Dizziness
Dyspnoea exertional
Electrocardiogram
Fatigue
Full blood count
Metabolic function test
Nausea
Paraesthesia
Pyrexia
SARS-CoV-2 test
Symptomtext
5/5/2022 11 am: Vaccination Booster Moderna (3rd dose) 5/5/2022 11:30 am: lightheadedness, tingling of left fingers and spine for a short time 5/5/2022 evening: Fatigue, nausea, decreased appetite, lightheadedness, joint pain, fever (took Tylenol) 5/6/2022 all day: Fatigue, nausea, decreased appetite, lightheadedness, joint pain, fever (took Tylenol) 5/7/2022 morning: Fatigue, nausea, decreased appetite, lightheadedness, fever (took Tylenol) 5/7/2022 evening: decreased appetite SOB on exertion 5/8/2022 until now 5/17/2022 SOB on exertion 5/9/2022 Urgent Care: (X-ray chest, EKG Covid rapid test) advised to go to ER immediately 5/9/2022 ER for SOB on exertion : (EKG, ECG, PCR, CBC, CMP,... blood work x 4)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea exertional
- Hospital-Tage
- -
- Labordaten
- 5/9/2022 Urgent Care: (X-ray chest, EKG Covid rapid test) advised to go to ER immediately 5/9/2022 ER for SOB on exertion : (EKG, ECG, PCR, CBC, CMP,... blood work x 4)
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- History of Asthma
- Andere Medikamente
- Tylenol, Pepcid
- Allergien
- No know allergy
- Vorherige Impfungen
- fever, fatigue, lightheadedness
- Staat
- UT
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 17.05.2022
- Impfdatum
- 16.04.2022
- Beginn
- 10.05.2022
- Tage bis Beginn
- 24,0
- Dosis
- 4
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Chills
Cough
Fatigue
Headache
Mobility decreased
Myalgia
Nasal congestion
SARS-CoV-2 test positive
Throat irritation
Tremor
Symptomtext
On May 10th, I had a scratchy throat and nasal congestion and thought it was allergies. I did a home test that was negative. At 2AM on May 11th, I woke up with shaking chills, severe myalgias, cough, nasal congestion, headache. I rechecked a home test. It was still negative but went ahead and scheduled a PCR later that afternoon which turned out positive. I was in bed from Tuesday night, May 10th, and didn't really move until Sunday, May 15th. I also had significant fatigue. My PCR results came back on May 14th and I had one dose of Paxlovid on that day. As of the afternoon of the 16th, I started to feel a little better, but I'm still recovering.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- TWO at home Covid tests, negative. PCR Covid test, positive.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Diabetes Type 2; Anticardiolipin Antibody; Kidney Stones; Polycystic Ovary Disease; Bigeminy
- Andere Medikamente
- Trulicity 75mg 1xweek; baby aspirin 81mg 1xday; Crestor 10mg 1xday; vitamin D 2000 units 1xday
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 05.05.2022
- Impfdatum
- 28.04.2022
- Beginn
- 02.05.2022
- Tage bis Beginn
- 4,0
- Dosis
- 4
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal pain
Back pain
Condition aggravated
Feeling abnormal
Headache
Hypertension
Symptomtext
Started with headache late morning on 05/02/22 it came and went. Then I started having abdominal pain and back pain. I felt like my blood pressure was getting high and I took a reading it was up to 145. Later that night I felt worse took another reading and it was up to 179. Called my cardiologist on the phone directed me to take another amlodipine later it went down to the 150s. Took reading in the morning it was in the 130s. On Tuesday had mild HA, abdominal pain and back pain. End of Tuesday I felt better expect for back and abdominal pain. Episodes of back and abdominal pain do come and go but when they are here they are very painful. I have an appointment with my general doctor today.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- High Blood Pressure Low Thyroid
- Andere Medikamente
- Synthroid Amlodipine
- Allergien
- Lisinopril Polycillin (form of Penicillin)
- Vorherige Impfungen
- Moderna dose 2, chills/body aches.
- Staat
- NJ
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 20.04.2022
- Impfdatum
- 13.04.2022
- Beginn
- 13.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Fatigue
Headache
Immediate post-injection reaction
Mobility decreased
Pain in extremity
Pyrexia
Tenderness
Symptomtext
My arm was in extreme pain immediately after the shot that lasted for 7 days. I was barely able to lift my arm up and any kind of touch would be very painful. I was also extremely fatigued and had a low grade fever of 101 degrees for day. I also have been having a lulling headache that has been going on and off. My doctor told me to take Tylenol and ice my arm.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- COPD; High Cholesterol; Kidney Disease; Heart Disease; Borderline Diabetic
- Andere Medikamente
- CBD; Medical Marijuana; Potassium; Vitamin D 2; Calcium Plus D3; Magnesium; Carvedilol; Entresto; Levocetirizine; Simvastatin; Valacyclovir Hydrochloride; Olopatadine; Hydrochloride
- Allergien
- Aspirin
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 20.04.2022
- Impfdatum
- 04.04.2022
- Beginn
- 04.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Chills
Headache
Mobility decreased
Nausea
Neck pain
Symptomtext
Chills, headache neck and shoulder ache, naoses and could not get out of bed, no treatment, took a couple of Tylenols. I have a virtual appt. with my internist today regarding it.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- not yet
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- no
- Andere Medikamente
- calcium, vit. D3
- Allergien
- no
- Vorherige Impfungen
- Very Mild symptoms on all the other Covid & Booster vaccine
- Staat
- TX
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 05.04.2022
- Impfdatum
- 02.03.2022
- Beginn
- 02.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Condition aggravated
Immediate post-injection reaction
Injection site pain
Pain
Pyrexia
Symptomtext
More pain at injection site than previous 2 vaccines immediately. Body aches later that night. Low grade fever the next morning. Fever of 101 early afternoon and extreme body aches.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Allergies, proclivity to respiratory issues, upset stomach
- Andere Medikamente
- Lamotrigine, zolpidem, probiotics
- Allergien
- Sulfa, neomycin, topical benadryl, corn, nickle
- Vorherige Impfungen
- Flu vaccine many years ago - not sure of any particulars.
- Staat
- -
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 01.04.2022
- Impfdatum
- 14.01.2022
- Beginn
- 03.02.2022
- Tage bis Beginn
- 20,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Akinesia
Aneurysm
Anticoagulant therapy
Chest pain
Echocardiogram abnormal
Electrocardiogram abnormal
Percutaneous coronary intervention
Systolic dysfunction
Symptomtext
Patient presented with CP and concern for repeat STEMI. PCI showed clean coronaries and pain resolved. Echo showed low normal systolic function with akinetic and aneurysmal apex. No thrombus. ECG changes thought to be due to apical aneurysm. Per cardiology okay to dc on 2/4/22. She was sent on ASA & Plavix (instead of Brilinta), warfarin, and colchicine (total 3 months as per previous) along with previous BB & statin. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- 1,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 16.03.2022
- Impfdatum
- 09.02.2022
- Beginn
- 10.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Blood test
Body height decreased
Chest pain
Chronic obstructive pulmonary disease
Condition aggravated
Decreased appetite
Disturbance in attention
Dry mouth
Dry skin
Dysuria
Energy increased
Fall
Fatigue
Head injury
Headache
Hypersensitivity
Incorrect dose administered
Symptomtext
She got her vaccine, had no reaction initially. The next day had fever, fatigue, lack of appetite, she has lost 12# throughout the month without trying. For a while she felt like no matter what she ate that she would have an allergic reaction to it, to the point that she wondered whether she needed to get her EpiPen. Her immune system blew up after the 3rd vaccine, which was a full dose vaccine. She had trouble urinating sometimes, but now is better and was having accidents. Felt like she was in a perpetual state of allergic reactions.. She had acute dry mouth, itching. She thinks without warning she became manic and started running around like a lunatic in her own apartment. Still has pretty acute dry skin and dry mouth. She is very careful about what she eats and what she does. She would have wild energy and lack of sleep and sometimes no ability to focus mentally and couldn't get it together. Her chest started hurting as she felt mucous in her chest. She was having a COPD attack caused by the vaccination and prayed it was not COVID. Her lungs are still hurting. She went to her pulmonologist who gave her a prescription for Cephalexin. Within minutes her body reacts to this medicine and her lungs stop hurting (within 20 minutes). She slept a lot after the vaccine, and always has pain in her neck from having lumbar surgery, she has lost 4 1/2" in height. Her left shoulder which has a torn rotator cuff was hurting, as well as other parts of her body. She switched to vegan, and a book and using organic foods. She does not feel like she is waking up in a blind panic which is most days, and she does not know why. She started getting a growth/lump under her right eye on 3/4/22. Took her morning antibiotics and her lungs cleared. She knows with her immune system that when she gets a lump or bump you don't touch it. Was shopping and all of a sudden fell on her back and her head landed on a dolly carrying heavy boxes for no reason. She did not go to the hospital for this. Her ex-husband checked her head, but she was OK. She had a lot of pain but nothing broke. Due to her cervical pain she sleeps on tennis balls in an old sock and put that under her neck and lean on it and the balls gets relief from that. She saw her dermatologist who did not want to hear about the reaction she may have had due to the vaccine, but has photochemotherapy three times a week which helps her pain. At the beginning of her treatment she had slits in her right hand and feet had deep slices, and whatever she did with a pumas stone or moisturizer had disappeared and was told to get Urea, which fixes the dryness in her fingers and feet.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- Blood work.
- Aktuelle Erkrankungen
- None.
- Vorgeschichte
- Eosinophilia, asthma, allergies, hypertension, high cholesterol, COPD.
- Andere Medikamente
- Allisine, 2 inhalers twice a day, Babaevesky, Alvesco (prescribed by pulmonologist), Sertraline 2 100 mg tablets, 1 Atorvastatin 10 mg, Liothyronine, Bupropion hydrochloride 150 mg XL 3 in the am., Atenolol 50 mg, Xanax 1 mg prn, Azolestine
- Allergien
- All fish and shellfish, nuts, Codeine, Latex.
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 12.03.2022
- Impfdatum
- 21.02.2022
- Beginn
- 22.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Axillary pain
Blood test normal
Chest discomfort
Chills
Electrocardiogram normal
Fatigue
Headache
Heart rate increased
Hyperhidrosis
Injection site pain
Lymphadenopathy
Myocardial necrosis marker normal
Oedema peripheral
Pain
Palpitations
Pyrexia
Thyroid function test normal
Symptomtext
Covid booster given at aprox 1:45pm on 2/21/22. At aproximatly 4pm, I started to feel fatigued, achey, chills and pain at injection site. The next morning, (2/22/22) I woke up with a fever of 101 degrees F, I also had body aches, head ache, chills/sweats, pain at injection site, pain/swelling in axilla in the side of injection, and increased heart rate. The fever broke the next morning but I still had chills/sweats, aches, pain at injection site, swelling of the lypmh nodes, fatigue, increased heart rate, these symptoms lasted untill 2/25/22. My heart rate still has not gone down. I also experince feeling of my heart racing, palpatations, and heaviness in my chest. I also occasionally feel fatigued. On 3/8/22 at 8:40am, I went to the urgent care and saw dr. He did the EKG and blood work and advised me to follow up with my primary care dr and possibly a cadiologist if symptoms persist. On 3/11/22 I saw my primary care dr, He ordered an echocardiogram and follow up after. I am self monitoring my heart rate using watch and at home automated blood pressure cuff. My normal (prevaccine) heart rate averaged 65-70 bpm at a resting rate. Post Vaccine I am averaging 85-92 bpm. When having palpatations my heart rate jumps up to around 102-105. The palpatations do not seem to be triggered by anything, they happen randomly. My average blood pressure (prevaccine) was 117/80. My post vaccine blood pressure is 133/85.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Palpitations
- Hospital-Tage
- -
- Labordaten
- 3/8/22 - EKG - Normal 3/8/22 - blood work - heart enzymes and thyroid - normal Scheduled for 3/18/22 echocardiogram
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- asthma - well controlled have not used inhalers in 1 year plus
- Andere Medikamente
- zyrtec, multivitamin, probiotics, vitamin d, albulterol (prn)
- Allergien
- theophellin, gluten, dairy, sensitive to Ceftin
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 10.03.2022
- Impfdatum
- 12.01.2022
- Beginn
- 02.02.2022
- Tage bis Beginn
- 21,0
- Dosis
- 3
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Cardiac telemetry normal
Catheterisation cardiac normal
Chest X-ray normal
Chest discomfort
Dyspnoea exertional
Echocardiogram normal
Full blood count normal
Metabolic function test normal
Myocardial necrosis marker normal
Palpitations
Symptomtext
Patient developed severe dyspnea on exertion, chest tightness, and palpitations
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea exertional
- Hospital-Tage
- 3,0
- Labordaten
- Hospitalized on 2/16-2/18. Had CXR, echocardiogram, telemetry, and LHC. All benign. CBC, cardiac enzymes, BMP benign.
- Aktuelle Erkrankungen
- Sick with upper respiratory infection a couple of weeks prior
- Vorgeschichte
- HTN
- Andere Medikamente
- -
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 07.03.2022
- Impfdatum
- 19.01.2022
- Beginn
- 20.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Back pain
Pain in extremity
Paraesthesia
Symptomtext
I still have the arm pain (Left) the second day I had lower back pain and tingling on my legs at the same time. The tingling it is still ongoing. my back is better now and occasionally I have the tingling in my arms but not all the time. I feel the tingling mostly on right leg. as I'm speaking to you I'm feeling the tingling.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- I will have an appointment for brain and spinal MRI 03/14/2022 and 03/15/2022
- Aktuelle Erkrankungen
- Graves disease
- Vorgeschichte
- Graves disease
- Andere Medikamente
- Vitamin E
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 04.03.2022
- Impfdatum
- 15.02.2022
- Beginn
- 26.02.2022
- Tage bis Beginn
- 11,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: unbekannt
Erholt: nein
Condition aggravated
Tinnitus
Symptomtext
Tinnitus occurred after all three doses, increasing intensity with each dose. It is extreme now and 24 hours a day, every day. I asked about this at vaccine site prior to booster dose and they denied any reports or relationship noted prior. I was told I had to get the booster to maintain employment. I went to ENT a few months ago and he stated that the tinnitus was not from the vaccine and there was no treatment but to use a sound machine at night to sleep. He said that some people get a little relief from hearing aids but did not feel I qualified for hearing aids.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- None done
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Albuterol inhaler MVI Vitamin D3
- Allergien
- Metals: Gold Methyl Methacrylate
- Vorherige Impfungen
- tinnitus after Moderna 013L20A on 01/14/2021 tinnitus after Moderna 016M20A on 02/12/2021
- Staat
- CA
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 03.03.2022
- Impfdatum
- 18.02.2022
- Beginn
- 18.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Anticoagulant therapy
Back pain
Chest pain
Electrocardiogram abnormal
Fatigue
Pain in jaw
Stent placement
Troponin increased
Symptomtext
Severe headaches for 3 nights prior to vaccine (same as headaches periodically following COVID-19 illness), "hauled butt" for 90 minutes after vaccine moving furniture, then fatigue, back pain, jaw pain, light chest pain, given 3 - 81 mg ASA, taken to ED, transferred to care center, eventually 3 stents placed 2/19, discharged 2/20.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- 2,0
- Labordaten
- Troponin max was 2217,8 on 2/19, EKG with evidence of old inferior infarct
- Aktuelle Erkrankungen
- INTRACTABLE HEADACHES FOLLOWING COVID-19 INFECTION
- Vorgeschichte
- HIGH BLOOD PRESSURE, ACID REFLUX
- Andere Medikamente
- LISINOPRIL, ESOMEPRAZOLE, VIT C, D3, B12, GLUCOSAMINE
- Allergien
- AMOXICILLIN
- Vorherige Impfungen
- -
- Staat
- UT
- Alter
- 29,0
- Geschlecht
- F
- Eingang
- 02.03.2022
- Impfdatum
- 28.01.2022
- Beginn
- 05.02.2022
- Tage bis Beginn
- 8,0
- Dosis
- 3
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Chest discomfort
Chest pain
Hypoaesthesia
Insomnia
Palpitations
Paraesthesia
Pruritus
Sensation of foreign body
Throat tightness
Urticaria
Symptomtext
Hives began appearing on February 5, 2022. The itching was intense and the hives were dispersed throughout my body (from my scalp to the soles of my feet and all over in-between). Visited with a general practitioner on February 7, 2022. Doctor was able to recognize hives but could not determine origin of hives. He prescribed a 10 day taper of Prednisone along with Benadryl and/or Allegra. After 3 days there was no improvement. I called the doctor's office and the doctor suggested, in addition to what I was already taking, to begin taking 40mg of Pepcid and increase Allegra. This alleviated my itchiness but the hives were still present. While taking these medications I felt my chest tighten and I also felt my throat closing. I had the feeling of a "lump in my throat" and went to the E.R. on February 10, 2022. I was treated with epinephrine at the hospital. This calmed my hives, itchiness, and my throat felt better. I returned to the same primary care physician I saw prior, on February 15, 2022 for a follow-up. I continued with hives. He suggested I add Singulair to my list of medications and also recommended I see a dermatologist. I began Singulair and took it for a few days but it seemed to cause headaches. I still have hives and now struggle with random heart palpitations, chest pain on many days, feelings of a lack of oxygen, numbness and tingling in my hands almost daily, and some insomnia.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None prior. Hives began after vaccination.
- Andere Medikamente
- Olly brand probiotic
- Allergien
- Sulfa drugs
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 35,0
- Geschlecht
- F
- Eingang
- 28.02.2022
- Impfdatum
- 28.02.2022
- Beginn
- 28.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Nausea
Tremor
Symptomtext
Patient began to get dizzy about 3 minutes after administration. Then began to feel nauseated, light-headed and shaky. Patient placed head between legs and a cold compress was applied to head and neck. Patient began to feel better after about 10 minutes and was observed for an additional 30 minutes. Patient left feeling normal.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tremor
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 25,0
- Geschlecht
- M
- Eingang
- 26.02.2022
- Impfdatum
- 16.01.2022
- Beginn
- 20.01.2022
- Tage bis Beginn
- 4,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Anion gap
Blood 25-hydroxycholecalciferol
Blood chloride increased
Blood creatine phosphokinase normal
Blood magnesium normal
Blood thyroid stimulating hormone normal
C-reactive protein normal
Chest discomfort
Chest pain
Differential white blood cell count normal
Dyspnoea
Echocardiogram normal
Electrocardiogram T wave abnormal
Electrocardiogram abnormal
Epstein-Barr virus antibody negative
Fatigue
Full blood count normal
Metabolic function test
Symptomtext
Shortness of breath, fatigue, pounding heart beat, chest pain, heaviness in chest - onset ~4 days after vaccine. Swelling in calves - onset ~10 days after vaccine. Given prednisone 20mg for 5 days, swelling in calves resolved and other symptoms improved, but still present as of 2/26/22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- 1/28/22: Monospot/EBV antibody (negative), CBC w/ differential (normal), Comprehensive metabolic panel (normal except chloride of 111mmol/L), Magnesium (normal), TSH (normal), CRP (1.5 mg/dL) 2/1/22: ECG (normal sinus rhythm, nonspecific T wave abnormality), Vitamin D-25 Hydroxy (normal), Creatine Kinase (normal), CBC w/ differential (normal), Comprehensive metabolic panel (normal except anion gap of 9 mmol/L) 2/15/22: Echocardiogram (interpreted as normal)
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Adderall XR 25mg, Adderall IR 5mg
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 17.02.2022
- Impfdatum
- 15.02.2022
- Beginn
- 15.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Dizziness
Nausea
Paraesthesia
Pyrexia
Symptomtext
Within 5 minutes I had tingling in the bottom of my feet spreading upto my knees. Also had tingling in my hands. Almost fainted with heavy curtain coming down over my eyes. During that night my fever shot to 104, respiration was 111, and I had bad chills with nausea. 2 days later (today) I still have a fever of 101.1
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- Long COVID
- Vorgeschichte
- none
- Andere Medikamente
- Crestor
- Allergien
- wool, sulfa
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 39,0
- Geschlecht
- F
- Eingang
- 15.02.2022
- Impfdatum
- 08.01.2022
- Beginn
- 09.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injected limb mobility decreased
Injection site swelling
Peripheral swelling
Pyrexia
Symptomtext
My arm swole from the injection site all the way down to my fingers . I couldn?t lift my arm without assistance from my right hand. It was very fevered I took ibproufen and placed an ice pack on the injection site on and off 10 hours. It wasn't until that afternoon that the swelling went down. For over a week it was very hard to move my arm.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injected limb mobility decreased
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/a.
- Vorgeschichte
- Hypothyroidism.
- Andere Medikamente
- Levothyroxin
- Allergien
- Sulfa; Keflex; Levaquin
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 44,0
- Geschlecht
- F
- Eingang
- 15.02.2022
- Impfdatum
- 12.02.2022
- Beginn
- 12.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Arthralgia
Asthenia
Dizziness
Fatigue
Headache
Disorientation
Pyrexia
Heart rate increased
Hypoaesthesia
Nausea
Pain
Pain in extremity
Paraesthesia
Urinary incontinence
Rash
Tachycardia
Symptomtext
Dizziness, disorientation, headache >36 hours, tachycardia, neck rash, loss of bladder control, fever, fatigue. Patient reported to ER same day as vaccination.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- Felt bad after the first dose of Moderna
- Staat
- MN
- Alter
- 44,0
- Geschlecht
- F
- Eingang
- 15.02.2022
- Impfdatum
- 12.02.2022
- Beginn
- 12.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Arthralgia
Asthenia
Dizziness
Fatigue
Headache
Disorientation
Pyrexia
Heart rate increased
Hypoaesthesia
Nausea
Pain
Pain in extremity
Paraesthesia
Urinary incontinence
Rash
Tachycardia
Symptomtext
Dizziness, disorientation, headache >36 hours, tachycardia, neck rash, loss of bladder control, fever, fatigue. Patient reported to ER same day as vaccination.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- Felt bad after the first dose of Moderna
- Staat
- AZ
- Alter
- 50,0
- Geschlecht
- F
- Eingang
- 12.02.2022
- Impfdatum
- 22.01.2022
- Beginn
- 26.01.2022
- Tage bis Beginn
- 4,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dermatitis contact
Discomfort
Dry skin
Erythema
Pain
Paraesthesia
Sensitive skin
Skin burning sensation
Urticaria
Symptomtext
Initially contact dermatitis to urine, nitrile gloves, and lemon soap. Skin turned red, rough, and small painful hives at site of contact.. When irritants were eliminated, it became a burning sensation encompassing all skin. It is now becoming less painful and red, and slowly lessening in degree of pain. Now it is sensitive to sunlight and clothing. Benadryl was used initially before irritants were identified. Intermittent painful tingling, mild reddening, and discomfort with clothing is the current status.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Diabetes, diet controlled
- Andere Medikamente
- None
- Allergien
- Tetracycline, tomatoes
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 27,0
- Geschlecht
- F
- Eingang
- 11.02.2022
- Impfdatum
- 12.01.2022
- Beginn
- 13.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Chest pain
Dyspnoea
Heavy menstrual bleeding
Injection site bruising
Menstruation irregular
Migraine
Muscle spasms
Symptomtext
Bruising at injection site (1 month later) Irregular menstrual cycle (bleeding over a month) shortness of breath Severe debilitating migraines chest pain severe cramping in ovaries and lower back
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- NA
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 09.02.2022
- Impfdatum
- 07.02.2022
- Beginn
- 08.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Condition aggravated
Fatigue
Lethargy
Tremor
Symptomtext
Systemic: Exhaustion / Lethargy-Medium, Systemic: Shakiness-Medium, Additional Details: Patient's wife called letting us know that he was very tired and shaking after receiving the vaccine. However, he has a condition that causes shakiness anyways, but it was worse today, one day after he received the vaccine booster dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 24,0
- Geschlecht
- F
- Eingang
- 03.02.2022
- Impfdatum
- 02.02.2022
- Beginn
- 02.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cough
Dyspnoea
Rash
Symptomtext
I asked patient if she had experience any symptoms to previous Moderna vaccine. Patient stated, "I got hives and my arm got swollen days later after getting the vaccine." I asked the patient did you go to the hospital or receive epinephrine due to not being able to breath. Patient stated, "no." I told the patient I was going to verify with another nurse about the vaccine. I then administered the vaccine on the patient's left arm. Patient was fine after getting the vaccine she went to sit down with her husband. Then patient stated that she couldn't breath and was coughing. I then administered a standard epi-pen on the patient's right thigh. The patient did have a rash on her chest. Vital signs were stable throughout the event, patient was talking, and wasn't cyanotic. EMS came to evaluate the patient. Patient stated, " I feel fine." Patient was given water and refused to be transferred to EMS. Patient was then advised to follow up with her doctor.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- unknown
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- asthma
- Andere Medikamente
- unknown
- Allergien
- unknown.
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 43,0
- Geschlecht
- M
- Eingang
- 02.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Hypoaesthesia
Hypoaesthesia oral
Interchange of vaccine products
Paraesthesia
Symptomtext
Client came in and said he experienced tingling and numbness on his face and lips for 8 hours post vaccine injection on 07/27/21 with Pfizer, Lot# EW0175 and on 08/17/21 Pfizer, Lot # EW0168. He did not take any medication or consult with a doctor afterwards. Today he is here for his Booster vaccine and wants Moderna. After a med consult, he was administered 0.25 ml of Moderna, Lot # 084J21A. The client was advised to wait 30 minutes in observation today. After the 30 minutes, he left without any symptoms or any type of tingling or numbness. He said he felt perfectly fine. We educated the client to look out for any adverse reactions.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- He said after his Tetanus shot he experienced swelling at the injection site and up his neck.
- Staat
- CA
- Alter
- 39,0
- Geschlecht
- F
- Eingang
- 02.02.2022
- Impfdatum
- 02.02.2022
- Beginn
- 02.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Hypoaesthesia
Paraesthesia
Symptomtext
Patient received Moderna booster shot 0.25ml at 0852 on left arm. 20 mintues after patient experiencing numbness and tingling on left deltoid, travelling upward to left face. This RN arrived at 0920 and performed Befast. Negative BEFAST. 132/74 (95) P 85 RA 98% RR20. Pt was anxious about reaction. Dr arrived. Care handed off to RN.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- Vital Sign 132/74 (95) P 85 RA 98% RR20
- Aktuelle Erkrankungen
- Vitamin D Deficiency
- Vorgeschichte
- Prediabetes Vitamin D Deficiency
- Andere Medikamente
- Vit D2, D3
- Allergien
- Codeine
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 51,0
- Geschlecht
- M
- Eingang
- 01.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Burning sensation
Erythema
Paraesthesia
Symptomtext
tingling/burning/hot sensation to posterior scalp within a few minutes of vaccine administration. then sensation spread to body, arms, and legs. then noticed red hands, arms, and legs.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- Niacin
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 25,0
- Geschlecht
- F
- Eingang
- 31.01.2022
- Impfdatum
- 30.01.2022
- Beginn
- 30.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Chest discomfort
Condition aggravated
Dizziness
Erythema
Euphoric mood
Chest pain
Dyspnoea
Feeling hot
Flushing
Feeling cold
Head discomfort
Hypoaesthesia oral
Interchange of vaccine products
Headache
Hyperhidrosis
Malaise
Metamorphopsia
Ocular discomfort
Symptomtext
Patient presented to the vaccination site on 01/30/22 accompanied by her husband. The client reported that they received a 1st dose of Janssen COVID vaccine on 04/06/21. Client reported onset of "tingling in my body, dizziness, weakness, heart racing, feeling disoriented, and vision changes" a few minutes after receiving the Janssen COVID vaccine. The client stated she was given oral Benadryl at the vaccination site and took Tylenol at home. The client stated the symptoms lasted about one day. The client denied any chronic conditions, current medications, or known allergies. The client reported a history of syncope after donating blood in 2018. RN 1 submitted a medical consult via text message to Clinical Project Coordinators requesting to proceed with the COVID vaccine Moderna booster. The client stated she had not eaten today, was provided a snack, and began eating it while waiting a response from the medical consult. Per Dr., approval to proceed with COVID vaccine Moderna was obtained from medical consult team via text message from Clinical Project Coordinator. RN 1 educated client on possible adverse reactions, when to seek medical care and to register with V-Safe. Client received COVID vaccine Moderna booster Lot# 084J21A on 01/30/22 at 1148 while seated in a high fowler's position in the anti-gravity chair. The client reported pressure in her head and stated "it's not like anything I've felt before" to EMT. RN 1 and RN 2 responded. The following was obtained with RN 2 translating intermittently. The client reported that she felt "high" to RN 1 and reported pressure in her head. The client was alert and oriented to person, place, time, and situation. RN 1 noted the client resting her head on the anti-gravity chair with her eyes closed while responding to questions. Vitals obtained at 11:58AM were as follows: HR 78, O2 100%, automatic BP 120/87. The client stated she was unable to move her head because it would make her dizzy and stated she felt tight in her body. The client reported pressure in her chest. Respirations were 18 at 12:05PM. RN 3 responded for additional assistance. The client reported feeling "warm." The client reported "something" in her throat. The client was provided a cool pack placed on her chest. The client reported after her first dose of Janssen COVID vaccine that she also had swelling of her body. She first noticed the swelling on her hands and said her rings were tight. Vitals obtained at 12:10 PM were as follows: HR 78, O2 100%, automatic BP 121/88. The anti-gravity chair was reclined to a semi-fowler's position. The client reported persistent feeling "light" in her head. Reported the feeling of "something" still in her throat that comes and goes. RN 1 evaluated the client's skin on her arms and chest. No redness or discoloration was noted. RN 1 noted the client rubbing her lips together and touching them with her hands. RN 3 inquired about symptoms on the client's lips. The client stated her lips felt, "like when given an anesthetic." Vitals obtained at 12:21 PM were as follows: HR 76, O2 100%, automatic BP 126/86. RN 1 showed the client her reflection in a phone camera. The client stated her lips looked slightly swollen. RN 1 and RN 3 recommended administration of oral Benadryl. The client stated she was able to swallow without difficulty. RN 3 provided education regarding possible adverse reactions regarding the Benadryl. The client voiced understanding of this education and consented to receiving oral Benadryl. The client consumed 50mg Benadryl Oral Solution without difficulty at 12:22 PM. The client began drinking water after taking the Benadryl. The client stated her lips felt "dry." The client denied any tightness in her throat and drank some more water. Vitals obtained at 12:29 PM were as follows: HR 78, O2 99%, automatic BP 119/90. The client stated she felt "cold." The icepack was removed from her chest. At 12:31PM the client stated her lips felt better, her head felt "light," and denied any dizziness. The client reported pressure in her chest and described it as "tingling." The client denied any pain on inspiration, palpation, or shortness of breath. Vitals obtained at 12:31 PM were as follows: HR 75, O2 99%, automatic BP 121/95. RN 1 noted normal lung sounds upon auscultation and no murmurs, gallups, or rubs with auscultation of the heart. The client stated she felt "normal but cold." At 12:45PM the client reported little red bumps on her arms and chest that were not present previously. RN 1 noted small red spots on her left forearm. RN 1 noted an area of redness on the client's chest about 1 inch in diameter that was not previously present. The client denied any symptoms including itchiness. The anti-gravity chair was adjusted to a high fowler's position per request of the client. The client denied any dizziness. Vitals obtained at 12:48 PM were as follows: HR 71, O2 100%, automatic BP 132/95. RN 1 and RN 3 provided education regarding possible adverse symptoms and when to seek care. The client voiced understanding of this education. The client stood up unassisted, ambulated unassisted with a steady gait, and left the vaccination site 12:55 PM. The client stated her husband was going to drive her home. VAERS completed for adverse symptoms after second dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 48,0
- Geschlecht
- F
- Eingang
- 29.01.2022
- Impfdatum
- 29.01.2022
- Beginn
- 29.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Dyspnoea
Throat tightness
Vomiting
Symptomtext
Patient 48y/o female was injected with Moderna 0.25ml IM to Left deltoid at Approximately 1030am . Patient then complains of difficulty breathing and throat closure. Patient presents with persistent vomiting. Initial VS B/P 160/67, HR 102, 02 Sat 97% @1035. Epinephrine 0.3ml injected to left thigh, and Benadryl injected to right arm by RN. EMS called. VS at 1040 114/83 HR 98, 02 sat 100%. EMS Arrived at approximately 1100 Received report from RN, assessed patient and then transported Patient to ER.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- Covid-19 Vaccine, Mrna, Bnt162b2, Lnp-s (Pfizer)
- Vorherige Impfungen
- Pfizer- difficulty breathing and throat closing
- Staat
- -
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 28.01.2022
- Impfdatum
- 15.03.2021
- Beginn
- 07.11.2021
- Tage bis Beginn
- 237,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Cough
Dyspnoea
Human rhinovirus test positive
Nasal congestion
SARS-CoV-2 test positive
Symptomtext
11/07/21: Pt admitted to the hospital for SOB. Onset was in the morning. reports she had an ongoing cough for a couple weeks, assoc nasal congestion. She states she had COVID a month ago, but also tested positive to this visit. Pt requiring 5L O2 for 98%, 69% on room air. Given 10mg IV decadron. 11/08: Pt down to 2L with O2 sats in mid 90's. continuing empiric abx - vancomycin. 11/09: Pt tested positive for rhinovirus, continue supportive care. 11/10-11: Continue supportive care 11/12: pt discharged. continue with steroids
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 5,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PR
- Alter
- 47,0
- Geschlecht
- F
- Eingang
- 28.01.2022
- Impfdatum
- 12.01.2022
- Beginn
- 24.01.2022
- Tage bis Beginn
- 12,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Antinuclear antibody
Blood creatine phosphokinase
Blood test
Chest pain
Dyspnoea
Electrocardiogram
Erythema
Full blood count
Joint swelling
Metabolic function test
Nodule
Pruritus
Skin warm
Swelling
Tenderness
Troponin
Symptomtext
Started itching on the neck, spreading all over belly, lower belly, fore arms, wrists, back and lower back and all face. All areas became very swollen, red and hot. My wrists were very swollen and painful to the touch and a swollen nodule on the neck. Started having Benadryl and Atarax at home. After 4 days no improvement started with chest pain and short breath. Went to the ER. Had solumedrol, Benadryl and Pepcid IV. EKG, CBC, BMP, CK and Troponin done.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- All blood work came back normal but the EKG showed pre matures. Sent home with Medrol pack and Atarax prescription , blood work for ANA test and a consult with a Cardiologist.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- acetaminophen
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 50,0
- Geschlecht
- F
- Eingang
- 25.01.2022
- Impfdatum
- 21.01.2022
- Beginn
- 21.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Bone pain
Chills
Fatigue
Feeding disorder
Feeling abnormal
Headache
Injection site erythema
Injection site pain
Injection site pruritus
Injection site swelling
Injection site warmth
Mobility decreased
Oropharyngeal pain
Pain
Pain of skin
Pyrexia
Rhinorrhoea
Vomiting
Symptomtext
FEVER STARTED FRIDAY NIGHT WOKE UP WITH FEVER AND A SEVERE HEADACHE. BODY SKIN BONES HAIR HURTED. RUNNY NOSE SORE THROAT . VOMITING COULDN'T EAT. SITE OF SHOT WAS RED HOT PAINFUL ITCHY. SIZE OF TENNIS BALL IN ARM WHERE I RECEIVED THE SHOT. FELT LIKE THIS UNTIL SUNDAY MORNING. SUNDAY FELT PRETTY BAD WITH FEVER HEADACHE AND BODY ACHE BUT WAS LESS INTENSIVE. GRADUALLY GETTING BETTER. * SATURDAY FELT FATIGUE LITURGY COULDN'T MOVE. VOMITING CONSTANTLY. CHILLS WITH FEVER. WENT TO DOCTOR 1/24/2022
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- VIRUS IN JANUARY,
- Vorgeschichte
- THYROID
- Andere Medikamente
- SYNTHROID 50 MICRO GRAMS, MULTIVITAMIN , 50 MIL BENADRYL DAY OF VACCINE.
- Allergien
- VANCOMYCIN, LEVAQUIN, MINOCYCLINE, PENICILLIN, KEWI, FIRE ANT VENOM.
- Vorherige Impfungen
- FLU SHOT MULTI DOSE VILE - ARM GOTTEN EXTREMLY SWOLLEN /2004
- Staat
- MO
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 21.01.2022
- Impfdatum
- 20.01.2022
- Beginn
- 21.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Discomfort
Pain
Paraesthesia
Symptomtext
Patient called the pharmacy 1-21-2022 in the afternoon and wanted to speak with the pharmacist who administered her vaccine yesterday. She was concerned about some possible side effects she may have been experiencing. She then explained that she had a vaccine yesterday and was having some intense side effects. I asked what was happening and she explained that she was have experiencing significant pain and discomfort from head to toe and was also having tingling down her body and legs. I expressed concern that this was not in the normal expectation and that should be addressed immediately. She also sounded like she was in pain and was struggling. I asked her if I needed to call 911 for her and she stated that she would call the doctor herself. I made it clear that this may be serious and that she definitely needed to be evaluated by a physician before I hung up so she could call them.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- None noted
- Aktuelle Erkrankungen
- None noted
- Vorgeschichte
- None explicitly noted
- Andere Medikamente
- Duloxetine 30 mg Gabapentin 300 mg
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 44,0
- Geschlecht
- F
- Eingang
- 20.01.2022
- Impfdatum
- 13.01.2022
- Beginn
- 13.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Blood test
Dizziness
Dyspnoea
Electrocardiogram
Flushing
Hyperhidrosis
Hypersensitivity
Symptomtext
Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Dizziness / Lightheadness-Severe, Systemic: Flushed / Sweating-Severe, Additional Details: Patient got the vaccine in left deltoid and seemed fine. She stayed in waiting area and suddenly developed symptoms of light headedness difficulty breathing and sweating. Benadryl was given and symptoms monitored. Blood pressure, heartrate were monitored. Husband took her to ER where blood panel and EKG were done. EpiPen was not admistered. She recovered and went home. ER told her not to get 2nd shot and to contact her PCP for followup.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 40,0
- Geschlecht
- M
- Eingang
- 17.01.2022
- Impfdatum
- 13.01.2022
- Beginn
- 14.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dyspnoea
Heart rate increased
Hyperhidrosis
Tremor
Symptomtext
I woke up at 11:30 pm with massive sweating and shaking. My heart rate was over 140 BPM and did not go back to normal until about 5 am. I was short of breath for about the first hour from waking up. I thought I was dying.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 25,0
- Geschlecht
- M
- Eingang
- 14.01.2022
- Impfdatum
- 14.01.2022
- Beginn
- 14.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Condition aggravated
Nausea
Retching
Vomiting
Symptomtext
Patient became severely nauseated after receiving medication. Pt stated that it was probably due to his anxiety of receiving vaccine. Approximately 3 minutes after receiving vaccine, patient started to gag/dry heave. Shortly after that, patient started to vomit. Nausea and Vomiting occurred for approximately 10 minutes. We gave patient water and an ice pack. His nausea and vomiting eventually resolved on its own. No medication taken/given.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- Patient said that he normally gets so anxious when receiving vaccines/immunizations that he will get very nauseated.
- Staat
- AL
- Alter
- 39,0
- Geschlecht
- M
- Eingang
- 14.01.2022
- Impfdatum
- 10.01.2022
- Beginn
- 12.01.2022
- Tage bis Beginn
- 2,0
- Dosis
- 2
- Route/Site
- SYR / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chest pain
Dyspnoea
Symptomtext
Chest pain, shortness of breath
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- NA
- Vorgeschichte
- NA
- Andere Medikamente
- NA
- Allergien
- Shrimp
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 10.11.2023
- Impfdatum
- 01.02.2022
- Beginn
- 04.09.2023
- Tage bis Beginn
- 580,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Blood pressure systolic increased
COVID-19
Cardiomyopathy
Chest X-ray normal
Computerised tomogram abdomen normal
Cough
Echocardiogram normal
Ejection fraction normal
Hypertensive emergency
Hypertensive urgency
Nausea
SARS-CoV-2 test positive
Troponin increased
Vomiting
Wall motion score index normal
Symptomtext
BRIEF OVERVIEW: Admission Date: 9/4/2023 Discharge Date: Sep 7, 2023 Discharge Disposition: home or self care DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypertensive emergency [I16.1] HOSPITAL COURSE: Patient is a 73 y.o. female with past medical history significant for MI, takotsubo cardiomyopathy, HTN, Afib, Aortic stenosis, CAD who presents to the ED for N/V, cough. In the emergency department she was hypertensive with systolic blood pressure of 220, also found to be COVID-positive. CT abdomen and pelvis showed no acute process, chest x-ray did not show evidence of an acute infiltrate. Patient was started on remdesivir x 3 days for treatment of her COVID. Hypertensive urgency likely secondary to nausea/vomiting of home anti-hypertensive and COVID. Cardiology consulted given elevated troponin on admission, thought to be likely secondary in setting of marked hypertension and resultant global myocardial strain, along with her noted COVID infection. Echocardiogram obtained and revealed EF 66%, no regional wall motion abnormalities. Patient resumed on home anti-hypertensives and started on losartan with significant improvement of her blood pressure. Patient medically stable for discharge home on 9/7.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Nausea
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- Acute Conjunctivitis of Left Eye 2/2/2022
- Vorgeschichte
- Essential hypertension, benign Takotsubo cardiomyopathy AF (paroxysmal atrial fibrillation) Arthritis UTI (urinary tract infection) Anemia, unspecified type Labile hypertension Right hip pain Zoster ophthalmicus Aortic stenosis Coronary artery disease involving native coronary artery of native heart without angina pectoris Iron deficiency anemia Anemia, unspecified COVID-19
- Andere Medikamente
- albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler aspirin 81 MG chewable tablet carvedilol (COREG) 6.25 mg tablet DULoxetine (CYMBALTA) 60 mg delayed release capsule furosemide (LASIX) 20 mg tablet gabape
- Allergien
- Macrodantin [Nitrofurantoin]Rash
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 42,0
- Geschlecht
- M
- Eingang
- 19.08.2023
- Impfdatum
- 05.04.2022
- Beginn
- 29.04.2022
- Tage bis Beginn
- 24,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Rash
SARS-CoV-2 test
Urticaria
Symptomtext
Rash moving all over, migrating, intermittent, urticarial. Treated with Kenalog 40mg IM x 1, Cetirizine,
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- COVID Tests,
- Aktuelle Erkrankungen
- R Eye Pterygium,
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- NKDA, No known other allergies
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 21.07.2023
- Impfdatum
- 05.06.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dizziness
Erythema
Headache
Rash pruritic
Skin burning sensation
Urticaria
Vaccination site discolouration
Vaccination site pain
Vaccination site swelling
Symptomtext
I had burning skin/burning of the skin is continuing and progressively getting worse/Leg and feet and arms burning. My skin burned. I got skin burning from all of them; skin red; Injection-site-reactions (left arm), Pain, Tenderness Swelling, black and blue, I got all that, I got the swelling the soreness and still sore today; Hives on skin on feet, legs, and arms; Itchy rash; She had injection site soreness, arm soreness/Injection-site-reactions (left arm), Pain, Tenderness Swelling, black and blue, I got all that, I got the swelling the soreness and still sore today; Injection-site-reactions (left arm), Pain, Tenderness Swelling, black and blue, I got all that, I got the swelling the soreness and still sore today; Headache; Dizziness; This spontaneous case was reported by a patient and describes the occurrence of SKIN BURNING SENSATION (I had burning skin/burning of the skin is continuing and progressively getting worse/Leg and feet and arms burning. My skin burned. I got skin burning from all of them), ERYTHEMA (skin red), VACCINATION SITE DISCOLOURATION (Injection-site-reactions (left arm), Pain, Tenderness Swelling, black and blue, I got all that, I got the swelling the soreness and still sore today), DIZZINESS (Dizziness) and URTICARIA (Hives on skin on feet, legs, and arms) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Stroke (Stroke on Fall 2020.) in 2020. Previously administered products included for Product used for unknown indication: CLONIDINE. Past adverse reactions to the above products included No adverse event with CLONIDINE. Concurrent medical conditions included Allergy (Patient was sensitive to a lot of things had a lot of allergies). Concomitant products included VARICELLA ZOSTER VACCINE (VARICELLA VACCINE) and CLONIDINE for an unknown indication. On 05-Jun-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SKIN BURNING SENSATION (I had burning skin/burning of the skin is continuing and progressively getting worse/Leg and feet and arms burning. My skin burned. I got skin burning from all of them), ERYTHEMA (skin red), VACCINATION SITE DISCOLOURATION (Injection-site-reactions (left arm), Pain, Tenderness Swelling, black and blue, I got all that, I got the swelling the soreness and still sore today), DIZZINESS (Dizziness), URTICARIA (Hives on skin on feet, legs, and arms), RASH PRURITIC (Itchy rash), VACCINATION SITE PAIN (She had injection site soreness, arm soreness/Injection-site-reactions (left arm), Pain, Tenderness Swelling, black and blue, I got all that, I got the swelling the soreness and still sore today), VACCINATION SITE SWELLING (Injection-site-reactions (left arm), Pain, Tenderness Swelling, black and blue, I got all that, I got the swelling the soreness and still sore today) and HEADACHE (Headache). At the time of the report, SKIN BURNING SENSATION (I had burning skin/burning of the skin is continuing and progressively getting worse/Leg and feet and arms burning. My skin burned. I got skin burning from all of them), ERYTHEMA (skin red), VACCINATION SITE DISCOLOURATION (Injection-site-reactions (left arm), Pain, Tenderness Swelling, black and blue, I got all that, I got the swelling the soreness and still sore today), URTICARIA (Hives on skin on feet, legs, and arms), RASH PRURITIC (Itchy rash), VACCINATION SITE PAIN (She had injection site soreness, arm soreness/Injection-site-reactions (left arm), Pain, Tenderness Swelling, black and blue, I got all that, I got the swelling the soreness and still sore today) and VACCINATION SITE SWELLING (Injection-site-reactions (left arm), Pain, Tenderness Swelling, black and blue, I got all that, I got the swelling the soreness and still sore today) had not resolved and DIZZINESS (Dizziness) and HEADACHE (Headache) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medications were not reported. Patient had health problems. Patient was homebound. Patient confirmed that she did not received a 2nd primary dose a month after the first shot. Patient had been placing icepacks on skin for each episode of burning skin. Patient believed that she received a Shingle shot about 6 months ago. Treatment information was not reported. This case was linked to US-MODERNATX, INC.-MOD-2023-733254 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-733254:Bivalent case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Allergy (Patient was sensitive to a lot of things had a lot of allergies)
- Vorgeschichte
- Medical History/Concurrent Conditions: Stroke (Stroke on Fall 2020.)
- Andere Medikamente
- VARICELLA VACCINE; CLONIDINE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 11.04.2023
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: unbekannt
Erholt: nein
Dental restoration failure
Immediate post-injection reaction
Nausea
Neck pain
Symptomtext
After vaccine given pt. immediately c/o severe neck pain and nausea. The physician's assistant examined her & felt she was stable. Pt was asked to rest in exam room for 45 mins. Then felt better. Left in good condition. Later had OV 3/29/23 & c/o fillings fell out of bottom teeth.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Nausea
- Hospital-Tage
- -
- Labordaten
- N/A She feels teeth issues are related to vaccine reaction.
- Aktuelle Erkrankungen
- See below.
- Vorgeschichte
- Obesity, asthma, GERD, OSA, OA, major depression, chronic methamphetamine abuse episode
- Andere Medikamente
- Albuterol Inhaler Abilify 5mg/day Symbicort Inhaler Clonazepam 0.5mg gtts Lexapro 20mg/day Esomeprazole 40mg/day Hydroxyzine 95mg BID Metoprolol 25 mg qday ER Topamax 100mg BOD Trazadone 50mg PO qHS
- Allergien
- Nuts, prilosec, Tape, sulfa drugs
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 15.02.2023
- Impfdatum
- 14.02.2022
- Beginn
- 21.09.2022
- Tage bis Beginn
- 219,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal pain
Symptomtext
Around September 21, 2022 I started having the pain in my abdomen that I knew was pancreas. I have chronic pancreatitis, so I know the pain all too well. I called and made an appointment with my gastroenterologist. We discussed what I was experiencing, he decided not to run any test or change my medication and that together we would wait and watch what happens. I do not feel any better since September, I feel that this is an ongoing issue for me.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal pain
- Hospital-Tage
- -
- Labordaten
- No
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- Chronic Pancreatitis
- Andere Medikamente
- N/A
- Allergien
- AUGMENTIN; LEVAQUIN; sulfa
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 23,0
- Geschlecht
- F
- Eingang
- 18.01.2023
- Impfdatum
- 08.01.2022
- Beginn
- 31.10.2022
- Tage bis Beginn
- 296,0
- Dosis
- 3
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Chills
Cough
Fatigue
Pain
Pyrexia
Rhinorrhoea
SARS-CoV-2 test positive
Symptomtext
My COVID-19 infection symptoms started on 10/31/2022 in the evening. I had a runny nose, fever, chills, body aches, cough, and tiredness. I took a COVID-19 home test which was positive. After 1 month later I did an online call with a doctor because I still had cough from COVID-19. The doctor recommended to get FLONASE over the counter and to do nasal rinses.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- 31OCT2022 COVID-19 test positive
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- TMJ
- Andere Medikamente
- ZOLOFT
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 01.11.2022
- Impfdatum
- 17.03.2022
- Beginn
- 28.07.2022
- Tage bis Beginn
- 133,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
COVID-19
Cough
Exposure to SARS-CoV-2
Fatigue
Malaise
Nasopharyngitis
SARS-CoV-2 test positive
Symptomtext
I received my second Moderna booster for COVID-19 on 3/17/2022. On about 7/28/2022, I developed a really bad cough and a general feeling of un-wellness. My husband was admitted to the hospital for treatment for COVID-19 at this time, so most of my energies were devoted to ensuring that he received proper care. On 7/30/2022, I took a home test for COVID-19 and got a positive result. I went to the local hospital and was prescribed PAXLOVID. I self-isolated at home for a few days and stayed in a separate room from my husband. My aforementioned cough subsided after a short time and was similar to a mild cold. However, I did have extreme fatigue, which lasted maybe two or three days; of all my COVID-19 symptoms, the fatigue was the most noticeable symptom. After a few days, the symptoms subsided and everything returned to normal.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- 7/30/2022 home COVID-19 test positive result.
- Aktuelle Erkrankungen
- None.
- Vorgeschichte
- History of Diaphragm Spasm (75% of Stomach Excised); History of Splenectomy; Hypertension; Osteopenia; Hypercholesterolemia.
- Andere Medikamente
- Levothyroxine; amlodipine; FOSAMAX; ezetimibe; calcium; vitamin C; vitamin D; multivitamin; fish oil; baby aspirin.
- Allergien
- ANCEF; FLAGYL; levofloxacin; CEFTIN; doxycycline hyclate.
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 40,0
- Geschlecht
- F
- Eingang
- 25.10.2022
- Impfdatum
- 01.04.2022
- Beginn
- 01.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: unbekannt
Erholt: nein
Dizziness
Gait inability
Magnetic resonance imaging
Muscle disorder
Poor peripheral circulation
Symptomtext
Muscle and tissue breakdown, poor circulation, extreme constant dizziness, becoming unable to walk
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- MRI on September 2022
- Aktuelle Erkrankungen
- Lupus and mild gastroparesis
- Vorgeschichte
- Lupus and mild gastroparesis
- Andere Medikamente
- Metoclopramide, Bentyl, Lorazepam, fenofibrate, ibuprofen
- Allergien
- Aspirin, biaxin, fish, apples, oranges, tramadol
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 19.10.2022
- Impfdatum
- 19.04.2022
- Beginn
- 19.07.2022
- Tage bis Beginn
- 91,0
- Dosis
- UNK
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Fatigue
Headache
Hyperhidrosis
Malaise
Night sweats
Oropharyngeal pain
Pyrexia
SARS-CoV-2 test positive
Symptomtext
*** THIS REPORT IS NOT ABOUT A REACTION TO THE VACCINATION BUT RATHER MY COVID INFECTION. Thus the adverse events were the symptoms of Covid: sore throat, fever, fatigue, night sweats, armpit sweating, headache.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- *** THIS REPORT IS NOT ABOUT A REACTION TO THE VACCINATION BUT RATHER MY COVID INFECTION. I stated on the vSafe survey that I saw a doctor about my condition. This was not about a reaction to the vaccine. Instead, I contacted my primary physician when I tested positive for Covid with an at-home test. Since she was not immediately available but I wanted to take Paxlovid I checked for adverse interactions with Tamsulosin which I take regularly for enlarged prostate gland. I found online credible sources that suggest that Paxlovid and Tamsulosin do not mix well. I called my urologist who said he was unfamiliar with the problem and did not want to offer an opinion. Once I reached my primary care physician, she recommended again Paxlovid (as a general rule, not because of Tamsulosin) and instead suggest a course of medication (see below). I AM SUBMITTING THIS REPORT BECAUSE I THINK IT IS IMPORTANT THAT 65+ MEN LIKE MYSELF, MANY WHO TAKE "FLOMAX (TAMSULOSIN)" SHOULD BE AWARE OF THE POTENTIAL OF AN ADVERSE REACTION TO TAMSULOSIN WHEN PAXLOVID IS ADMINISTERED. That's anyway my unprofessional opinion, but something I want to share. The vitamins I took, just for making this report complete, were: vitamin D3 5,000iu 2x/day for 10 days with food and then decreasing to 5,000iu/day, Quercetin 500mg, zinc 10mg and lots of vitamin C
- Vorgeschichte
- None, I believe. However, off-and-on issues with fatigue that I believe are part of the Covid infection are still occurring but with less frequency and intensity.
- Andere Medikamente
- *** THIS REPORT IS NOT ABOUT A REACTION TO THE VACCINATION BUT RATHER MY COVID INFECTION. MEDICATIONS * Tamsulosin HCL 0.4 MG every morning (prescription) SUPPLEMENTS * Acetyl L-Carnitine, 1000mg every day * Occuvite +50 (Vitamin C, Vita
- Allergien
- None.
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 18.10.2022
- Impfdatum
- 15.04.2022
- Beginn
- 06.09.2022
- Tage bis Beginn
- 144,0
- Dosis
- 4
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenia
COVID-19
Malaise
Pyrexia
SARS-CoV-2 test positive
Symptomtext
When I was positive for covid-19 I didn't feel that sick but I did have a fever and low on energy
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Malaise
- Hospital-Tage
- -
- Labordaten
- covid-19- positive
- Aktuelle Erkrankungen
- No illnesses at the time of vaccination and up to one month prior
- Vorgeschichte
- Asti proses
- Andere Medikamente
- Alendronate
- Allergien
- No allergies to medications food or other products
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 10.10.2022
- Impfdatum
- 07.04.2022
- Beginn
- 07.09.2022
- Tage bis Beginn
- 153,0
- Dosis
- 4
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
COVID-19
Fatigue
Respiratory tract congestion
SARS-CoV-2 test positive
Symptomtext
It was fatigue, congestion that was pretty much it. I did get Paxlovid and I took some over the counter cough suppression medicine. I probably had some Motrin during that time as well. My symptoms lasted for maybe about four days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- COVID-19 test- Positive
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 03.10.2022
- Impfdatum
- 01.04.2022
- Beginn
- 06.09.2022
- Tage bis Beginn
- 158,0
- Dosis
- 4
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Cough
Oropharyngeal pain
Pyrexia
SARS-CoV-2 test positive
Symptomtext
Started having a high fever, sore throat and a cough. Took a home test COVID-19 test, positive. Was prescribed PAXLOVID. Helped within a few days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Oropharyngeal pain
- Hospital-Tage
- -
- Labordaten
- Home test COVID-19 test, positive.
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- CLARITIN generic; iron; vitamin C; fish oil; multivitamin; CRESTOR; NORVASC.
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 30.09.2022
- Impfdatum
- 15.04.2022
- Beginn
- 27.06.2022
- Tage bis Beginn
- 73,0
- Dosis
- 4
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Aphonia
Cough
Decreased appetite
Diarrhoea
Fatigue
Head discomfort
Nausea
Oropharyngeal pain
Pain
Pyrexia
Respiratory tract congestion
Rhinorrhoea
SARS-CoV-2 test positive
Sinusitis
Sneezing
Thirst
Throat clearing
Symptomtext
This adverse event wasn't immediate, but County officials were very interested in this story and requested I file the VAERS form. While on vacation in (country withheld), I began to feel very ill on May 26, 2022 (<6 weeks after my Covid vax #4), with sore throat, cough, fatigue, runny nose, & congestion. On May 27, our tour group had to take mandatory lab and rapid tests for Covid to get on a small cruise ship in the (place withheld). I was negative for both. On May 28, on the ship, another passenger felt a sore throat coming on, and tested himself with a rapid test brought from home. He tested positive. His wife did not. They had to leave the ship to quarantine. The rest of the ship had to take another Covid test..the next day May 29 as soon as they could bring a lab tech aboard. That man's positive test was confirmed. The rest of the ship tested negative on the rapid test. However, all remaining 14 guests left on the ship still had to eat at the same dinner table for every meal. It was a small ship and there was no way to maintain distance with our masks on. We continued the cruise. However, two days after that (5/31), we received news that the lab test found another guest, another man who had spent time with the first positive man on the ship, had also tested positive. That man's wife was also negative. He had no symptoms. He and his wife, too, left the ship. At that point, nearly all 12 passengers left on the ship were beginning to come down with my same symptoms -- most of them, including me, were convinced *I* must have Covid, in spite of 4 negative tests. When I approached, people quickly put their masks on, even outdoors. In addition, I lost my voice. Whatever it was, it was a terrible head and chest virus (note: I never had a fever). Leaving the trip on June 3, two other passengers from our ship tested positive for Covid at the airport and were unable to fly home that day. So at least four out of 16 original guests from the cruise tested positive over the course of 10 days. All had been vaccinated and boosted before the trip. My husband and I tested negative yet again and proceeded to fly home June 9. Okay, skip to Jun 14. My husband and I were still feeling tired and coughing, (3 weeks), and now add traveler's diarrhea (day 3 for me). On Jun. 16th, I started Cipro antibiotics for the diarrhea. As of Jun 18, the diarrhea finally cleared and a few days later, so did the rest of my symptoms. NOW. Here's where it gets even more interesting: On Monday, June 27th, evening, only a week after I had recovered, I began to feel the virus coming back! Nooo! Sneezing, sneezing, sneezing, runny nose, congestion, and the next day a terrible cough and chest congestion. A home test on Jun. 28 showed I was positive for Covid! So after 4 vac. doses (2 Pfizer and 2 Moderna), I contracted Covid 5.5 weeks after my last booster. This was my first and only time having Covid since the onset of the pandemic, at least the only time I tested positive if you don't count the illness in specific area as Covid. In addition to the severe head & chest congestion symptoms, I had fever, extreme fatigue, aches & pains, and another 4 days of diarrhea. I was also very thirsty, was nauseated, and had no appetite. I started Paxlovid on Day 2 (the day after testing positive). After five days of isolating, my symptoms had mostly resolved, except for the cough. I had lost 10 lbs. The chest congestion and runny nose returned after I stopped Paxlovid. Rebound Covid? On July 19th, STILL SICK -- headache, facial pain, phlegm in throat and constantly clearing throat, pain upon bending over -- my PCP prescribed antibiotics for a sinus infection, which ended almost two months of being very sick.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- All laboratory tests (2) and rapid tests (4) from May 17 - Jun. 9 showed I was negative for Covid. Only one home test found that I was positive, on 6/28/2022.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- GERD, menopause, chronic allergies
- Andere Medikamente
- Estradiol, Progesterone, testosterone, spironolactone, Resveratrol (Grape skin extract), black cohosh, Vit E, Vit B complex, Glucosamine chondroitin, Probiotic, biotin, turmeric, and Gingko biloba.
- Allergien
- Penicillin, apple, pear, peach, nectarine, apricot, hazelnuts, Orange peel and orange oil, melon, raspberries, cats, dust mites, mint oil, cinnamon oil, teatree oil, fennel oil (and all other oils in toothpaste), fluoride, fentanyl &propofyl (suspected), parabens (Iso-, propyl-,ethyl-, benzo-, etc.), tree pollen, ragweed, weed pollen, sage, weeds, and xylitol.
- Vorherige Impfungen
- 36 hrs post flu shot, extreme nausea, HR 131 bpm, food caused throat to burn and lymph nodes to swell. Fluarix Lot #B49F7. Submi
- Staat
- CA
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 06.09.2022
- Impfdatum
- 04.03.2022
- Beginn
- 21.06.2022
- Tage bis Beginn
- 109,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Nasopharyngitis
Pain in extremity
SARS-CoV-2 test positive
Symptomtext
I had a sore arm for about two days. I tested negative for COVID-19 via home test on 06/20/22 but tested positive on 06/21/22 via PCR test at clinic. I had symptoms of a head cold. I was given the prescription of Paxlovid and it helped with the symptoms. It left a terrible metallic taste in my mouth.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- Home test was negative for COVID-19 on 06/20 and positive at 06/21.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Morphea
- Andere Medikamente
- Vitamins
- Allergien
- Sulfa
- Vorherige Impfungen
- -
- Staat
- NH
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 26.08.2022
- Impfdatum
- 24.02.2022
- Beginn
- 28.07.2022
- Tage bis Beginn
- 154,0
- Dosis
- 4
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
COVID-19
Malaise
SARS-CoV-2 test positive
Symptomtext
Covid symptoms for two days 7/28+29/2022 with negative home tests, tested positive on July 30, 2022. Treated with Monoclonal Antibodies on 7/30/2022
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Malaise
- Hospital-Tage
- -
- Labordaten
- Tested negative for Covid on 8/4/2022.
- Aktuelle Erkrankungen
- Sarcoidosis since 1984, pneumonia early July 2022
- Vorgeschichte
- Sarcoidosis since 1984, oxygen dependent due to pulmonary fibrosis, NASH, obesity, vitiligo
- Andere Medikamente
- Gabapentin, atenolol, amlodipine, Duloxetine, AREDS2, multivitamin, Metformin, tizanidine, tumeric, CBD,
- Allergien
- Crustaceans, Swiss and Blue cheese, insect stings
- Vorherige Impfungen
- Tetanus, 1976, extreme swelling, redness and pain at injection site and surrounding tissues/joints.
- Staat
- CA
- Alter
- 50,0
- Geschlecht
- F
- Eingang
- 21.08.2022
- Impfdatum
- 08.04.2022
- Beginn
- 01.06.2022
- Tage bis Beginn
- 54,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site discolouration
Injection site indentation
Skin atrophy
Symptomtext
Patient reported a hypopigmented indentation in the skin overlying her deltoid started after her COVID-19 booster vaccination. Unclear on exact timeframe. She also stated she received a general "allergy shot" in primary care clinic around the same time. I am unable to verify documentation of this but if it was a steroid injection, could explain the observed skin atrophy.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site discolouration
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- History of MVA on 4/8/2022
- Vorgeschichte
- History of multiple sclerosis, chronic pain, anxiety
- Andere Medikamente
- Albuterol, Cyanocobalamin, Norco, Hydroxyzine, Zofran, Tizanidine
- Allergien
- Celebrex, Bactrim, Sulfa, Baclofen, dairy, Duragesic, Flexural, Gabapentin, Ibuprofen, Latex, Naproxen, strawberry
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 08.08.2022
- Impfdatum
- 31.01.2022
- Beginn
- 20.07.2022
- Tage bis Beginn
- 170,0
- Dosis
- 4
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Chest discomfort
Cough
Fatigue
Headache
Respiratory tract congestion
SARS-CoV-2 test positive
Sneezing
Symptomtext
Sneezing, headache, fatigue , cough, congestion, tight chest
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- Positive COVID by home rapid test 07/22/2022
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Crohn?s disease, HTN, depression
- Andere Medikamente
- Imuran, amlodipine, hctz, bupropion, sertraline, pantoprazole, MVI, Ca,
- Allergien
- Sulfa
- Vorherige Impfungen
- -
- Staat
- PR
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 04.08.2022
- Impfdatum
- 02.02.2022
- Beginn
- 22.07.2022
- Tage bis Beginn
- 170,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Asthenia
Bronchitis
COVID-19
Chills
Cough
Exposure to SARS-CoV-2
Impaired work ability
Malaise
Respiratory tract congestion
SARS-CoV-2 test positive
Symptomtext
I was traveling and returned Saturday July 16, 2022, and I started with symptoms Friday July 22, I took a home test on July 23 and it came out Positive. I felt congestion, weakness, cough and chills, no fever (my body does not respond to fever, I have never had). I called my rheumatologist and she told me that she told me to go to the emergency room to get the antibodies and I went to the hospital and they gave me the treatment. I have continued with congestion, despite having the antibodies, on Friday July 29 I took the test again and it came out positive; So I called my doctor again to see if I could get out of isolation and he said yes, but at work they didn't allow me. I relapsed again and visited the doctor again because I had developed Bronchitis, this was Wednesday, July 27, and they gave me an antibiotic for 3 days and a cough suppressant for 6 days. But since I did not improve, the doctor gave me Molnupiravir and Cortisone again to deflate the Bronchi.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- JULY 2022 COVID19 - Positive
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Rheumatoid Arthritis, diabetes, High Blood Pressure.
- Andere Medikamente
- Vitamin C, Rinvoq, Methotrexate, Metformin, Topamax, Inderal, Neurontin, Crestor.
- Allergien
- Sulphur, Penicillin, Cephalexin, Aspirin.
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 02.08.2022
- Impfdatum
- 29.04.2022
- Beginn
- 21.07.2022
- Tage bis Beginn
- 83,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Cough
Headache
Oropharyngeal pain
Pyrexia
Rhinorrhoea
SARS-CoV-2 test positive
Symptomtext
Came down with Covid on 7/21. Very sore throat, headache, cough, thick sinus mucus and cough. Slight fever.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- Home Covid test; Covid test at urgent care.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Asthma, type II diabetes
- Andere Medikamente
- -
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 01.08.2022
- Impfdatum
- 29.04.2022
- Beginn
- 24.06.2022
- Tage bis Beginn
- 56,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Full blood count normal
Idiopathic urticaria
Injection site rash
Laboratory test normal
Urticaria
Symptomtext
At time of vaccination 4/29/2022, red rash noted at site of injection. Resolved within 5 days. About two months later, on 6/24,2022 hives covering abdomen, back, upper thighs and arms noted. Have persisted and not resolved.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Idiopathic urticaria
- Hospital-Tage
- -
- Labordaten
- Saw ER doctor via telehealth on 6/27/ 2022. Diagnosis of uticaria of unknown origin. Instructed to take Zyrtec 10 mg daily. Rash persisted and saw covering primary physician on 6/29/2022. He also diagnosed it is idiopathic urticaria. Took blood tests for autoimmune diseases and blood count. All results came back normal. He instructed me to take Zyrtec 10 mg twice daily and referred me to dermatologist. Saw covering dermatologist 6/30/2022. Diagnosis the same. Continue with Zyrtec twice daily and Clobetosol cream. Not resolved. Follow up derm appointment next week. All physicians from the local Medical Center.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- hypertension
- Andere Medikamente
- Losartan 50 mg daily
- Allergien
- none known
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 01.08.2022
- Impfdatum
- 13.04.2022
- Beginn
- 03.07.2022
- Tage bis Beginn
- 81,0
- Dosis
- 4
- Route/Site
- SYR / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
COVID-19
Cough
Headache
Oropharyngeal pain
Rhinorrhoea
SARS-CoV-2 test positive
Symptomtext
I had a bad headache, sore throat, runny nose. I was beginning to get a cough but I got the Paxlovid in time to shortcut that.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- 7/4/2022 PCR COVID-19- Positive
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Low thyroid.
- Andere Medikamente
- Levothyroxine; Rosuvastatin
- Allergien
- Morphine; Red yeast rice
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 45,0
- Geschlecht
- F
- Eingang
- 29.07.2022
- Impfdatum
- 27.01.2022
- Beginn
- 28.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Fatigue
Feeling abnormal
Muscular weakness
Nausea
Pain
Pyrexia
Symptomtext
I experienced a fever of 103.3, body aches, weakness in my legs, brain fog, nausea, and fatigue. I was advised to treat my symptoms with over the counter medication. The symptoms began to resolve after 3 days. It took me 7 days to fully recover from the booster.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Epilepsy
- Andere Medikamente
- Vimpap; Lumixel; Keppra
- Allergien
- Penicillin; Stadol; Codeine; Keflex; Topamax
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 26.07.2022
- Impfdatum
- 21.04.2022
- Beginn
- 13.07.2022
- Tage bis Beginn
- 83,0
- Dosis
- 4
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Apathy
COVID-19
Cough
Fatigue
Malaise
Nasal congestion
Pain
Rhinorrhoea
SARS-CoV-2 test positive
Sneezing
Symptomtext
Covid-19 symptoms: cough beginning on 7/13/22 (Day 0). Fairly intense runny nose, sneezing, fatigue, body aches, lack of motivation from about 7/14/22-7/17/22 (Days 1-4). Symptoms began lessening on 7/18/22 (Day 5). Gradual improvement through Day 10 (July 23,2022). As I fill out this form on 7/26/2022 (Day 13) I still have some nasal congestion and a little cough (infrequent). Only treatment was rest, keeping hydrated, taking Excedrin Extra-Strength occasionally.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- On 7/13/2022 (Day 0) I had a PCR test administered through our county health system mobile unit. The result showed negative, so I assumed I had a bad cold and not covid. Around Day 4 or 5 I took a home antigen test and it was positive, so I realized I actually did have covid. My last home test taken was July 23, 2022 (Day 10) and I was still positive. I did contact a advice nurse via phone around July 19 and was told I was past the 5-day window when Paxlovid would have been a possible treatment. Other treatment advice given was stay hydrated, get rest, etc.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Diabetes type 2, high blood pressure
- Andere Medikamente
- Amlodipine, Aspirin 81 mg, Glipizide, Metformin, Atorvastatin, Tamsulosin
- Allergien
- Penicillin, Lisinopril, Terazosin Hcl
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 22.07.2022
- Impfdatum
- 21.04.2022
- Beginn
- 03.07.2022
- Tage bis Beginn
- 73,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Laboratory test abnormal
Oropharyngeal pain
Rhinorrhoea
Symptomtext
On 7/3 I developed a sore throat and runny nose. Symptoms worsened on 7/4 and I tested positive. Reached out to my doctor on 7/4 and received PAXLOVID. After 4 days of medication I felt much better. After day 6 my symptoms returned and gradually lessened over the following 2 weeks.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Oropharyngeal pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- FLOVENT; irbesartan; glucosamine; ubiquinol; turmeric
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 22.07.2022
- Impfdatum
- 21.04.2022
- Beginn
- 02.06.2022
- Tage bis Beginn
- 42,0
- Dosis
- 4
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Cough
Fatigue
Injection site pain
Rhinorrhoea
SARS-CoV-2 test positive
Throat irritation
Symptomtext
My arm hurt at the injection site for a day and it got better. I tested positive on 06/07/2022 for COVID-19 via PCR test. The home test showed that I was negative for COVID-19. Symptoms: runny nose, scratchy throat, cough and fatigue. I was switching my epilepsy medication at the time of vaccination which could contribute to the fatigue. I went to a COVID clinic for the PCR test. When I was diagnosed positive, I had a telehealth visit with my primary doctor and was given the prescription molnupiravir.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- PCR for COVID-19 was positive. Home test prior to PCR test was negative.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Epilepsy
- Andere Medikamente
- TEGRETOL; CRESTOR; calcium with vitamin D3; CENTRUM silver; PRESERVISION ARED 2
- Allergien
- Erythromycin
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 46,0
- Geschlecht
- F
- Eingang
- 21.07.2022
- Impfdatum
- 19.01.2022
- Beginn
- 10.06.2022
- Tage bis Beginn
- 142,0
- Dosis
- 3
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Cough
Oropharyngeal pain
Pulmonary congestion
Pyrexia
Respiratory tract congestion
SARS-CoV-2 test positive
Symptomtext
It started out with head congestion felt like allergies and felt like I had a fever but did not have a fever until the next day and my fever was 99.4 and I had a mild cough with chest congestion wasn't coughing anything up more like a dry cough and I also had a sore throat and on Day 9 I was prescribed an albuterol inhaler for chest congestion. I also was still testing positive for 9 days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Oropharyngeal pain
- Hospital-Tage
- -
- Labordaten
- Covid testing
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Bipolar; Hypothyroid; HDHD; Anxiety
- Andere Medikamente
- Levothyroxine; CYTOMEL; LATUDA; lamotrigine; BUSPAR; STRATTERA; WELLBUTRIN; trazodone; ZYRTEC
- Allergien
- Erythromycin
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 85,0
- Geschlecht
- F
- Eingang
- 19.07.2022
- Impfdatum
- 12.04.2022
- Beginn
- 25.06.2022
- Tage bis Beginn
- 74,0
- Dosis
- 4
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
COVID-19
Exposure to SARS-CoV-2
Extra dose administered
Fatigue
Headache
Oropharyngeal pain
Quarantine
Rhinorrhoea
SARS-CoV-2 test positive
Sneezing
Symptomtext
I received my second Moderna booster for COVID-19 on 4/12/2022. On 6/25/2022, I developed a runny nose, and it continued running for the next couple of days. I had just recently gotten back from a trip with my son. He called me to let me know that he had tested positive for COVID-19. On 6/27/2022, I took a home test for COVID-19, and I got a positive result. I called the clinic where I normally go and spoke to a NP. She tried to arrange for me to have a telemedicine appointment with a doctor, but none was available. She then suggested that I should go to a stand-alone clinic to obtain a prescription for Paxlovid. Since my symptoms weren't severe, though, I decided not to do this. She instructed me to stay home for 5 days. She told me that if I felt well enough after those 5 days were up, I could go out, but I should wear a mask. However, I stayed at home longer than 5 days before I got out. Along with the aforementioned runny nose, I had a little bit of sneezing, a slightly sore throat and a mild headache. I also felt more tired than usual and didn't have much energy. The symptoms altogether lasted maybe 5-6 days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- 6/27/2022---home antigen test--positive
- Aktuelle Erkrankungen
- None.
- Vorgeschichte
- Hypothyroidism; Osteopenia.
- Andere Medikamente
- Levothyroxine; Caltrate; Famotidine; Aleve.
- Allergien
- Sulfa Drugs; Penicillin.
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 06.07.2022
- Impfdatum
- 04.04.2022
- Beginn
- 13.06.2022
- Tage bis Beginn
- 70,0
- Dosis
- 4
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
COVID-19
Chills
Cough
Decreased appetite
Fatigue
Feeling abnormal
Full blood count normal
Influenza like illness
Pain
Pyrexia
SARS-CoV-2 test positive
Symptomtext
When I caught COVID-19 I had flu like symptoms, chills, and body aches for about 4 or 5 days. Since then I have had a lingering dry cough and fatigue. I have mental fuzziness and a diminished appetite. I took TYLENOL because I also had a fever. At the highest it was 100.8 degrees.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- 6/28/2022 CBC, normal; PCR COVID-19 test positive.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Vitamins; calcium
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 30.06.2022
- Impfdatum
- 02.04.2022
- Beginn
- 26.06.2022
- Tage bis Beginn
- 85,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
COVID-19
Cough
Oropharyngeal pain
Pyrexia
SARS-CoV-2 test positive
Sinus congestion
Vertigo
Symptomtext
I had a sore throat and head congestion so I took a home rapid test on June 26th and it was positive. I went to an urgent care and they did a rapid test which was negative then a PCR test and it was positive. I was not able to get PAXLOVID because I was not at risk. I was advised to take cough medicine over the counter. I took ibuprofen and decongestant. My symptoms became worse. I had fever and feelings of vertigo from the head congestion. I also developed a cough that is not bad. I got worse for 2 days but have been improving since then.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Oropharyngeal pain
- Hospital-Tage
- -
- Labordaten
- COVID-19-06-26-2022 positive. COVID-19 Rapid test-06-26-2022 negative. COVID 19-PCR test- 06-26-2022 positive.
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- Vitamin D
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 09.06.2022
- Impfdatum
- 05.04.2022
- Beginn
- 01.05.2022
- Tage bis Beginn
- 26,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Contusion
Haemorrhage subcutaneous
Hyperaesthesia
Laboratory test
Pain in extremity
Swelling face
Tenderness
Symptomtext
I started bleeding under my skin on my right arm. It then moved to my left arm. My left arm is not as severe as my right arm. My right arm is the arm that had the injection. It is somewhat painful to the touch and sensitive. I rub arnica lotion on it to help with bruising which does not do anything. It looks like an injury and the bleeding is blackish/purple in color and is from my elbow to my wrist. The doctors can not explain anything. I have not been on aspirin, blood thinner, and steroids. My face has also got swollen and puffy. I have went to 2 different doctors over this with no explanation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- Lab work
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Ramsey Hunt Syndrome not active at the time; IVIG
- Andere Medikamente
- CYMBALTA; LINZESS; SYNTHROID; ESTRATEST
- Allergien
- Morphine; CIPRO; latex
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 07.06.2022
- Impfdatum
- 25.04.2022
- Beginn
- 26.05.2022
- Tage bis Beginn
- 31,0
- Dosis
- 3
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Bronchial secretion retention
COVID-19
Feeling abnormal
Hyperhidrosis
Oropharyngeal pain
SARS-CoV-2 test positive
Upper respiratory tract congestion
Vaccine breakthrough infection
Symptomtext
Breakthrough case of COVID, I had a sore throat, stuffy head, foggy head, I had some sweats. Still have some mucus in my chest so the Dr. prescribed promethazine cough syrup. I also took PAXLOVID for five days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Oropharyngeal pain
- Hospital-Tage
- -
- Labordaten
- COVID test
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Multivitamin
- Allergien
- Sulfa drugs
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 41,0
- Geschlecht
- F
- Eingang
- 02.06.2022
- Impfdatum
- 08.02.2022
- Beginn
- 14.02.2022
- Tage bis Beginn
- 6,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abortion spontaneous
Arthralgia
Bone pain
Intermenstrual bleeding
Maternal exposure before pregnancy
Menstruation irregular
Symptomtext
I had a miscarriage in December. After receiving my vaccine in February my period became very light. From February-May I only spotted. I didn't have a normal period. My period did not return to normal until June 2022. I also experienced pain my shoulders after receiving the vaccine. The pain felt like it was in my bones and not in the muscle. I am still experiencing pain.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- Unknown
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Migraine Headaches
- Andere Medikamente
- Tylenol as needed
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 25.05.2022
- Impfdatum
- 12.01.2022
- Beginn
- 20.05.2022
- Tage bis Beginn
- 128,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Asthenia
COVID-19
Nausea
SARS-CoV-2 test positive
Sick relative
Symptomtext
She received Moderna COVID vaccines: the first dose on 4/7/21, the second dose on 5/5/2021, and the third dose on 01/12/2022. She presented to the ED with generalized weakness and nausea on 5/20.. She also noted her sons who lived with her were also sick. She was tested positive covid and hospitalized on the same day. She received steroids, Azithromycin, and Rocephin. She was discharged home with stable condition on 5/22/22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Nausea
- Hospital-Tage
- 3,0
- Labordaten
- SARS CoV PCR COVID 19 positive on 5/20/22
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- AVR, Pacemaker, DVT, Arthritis, MIgraine, HTN, HLD, OSA
- Andere Medikamente
- -
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 47,0
- Geschlecht
- F
- Eingang
- 22.05.2022
- Impfdatum
- 03.05.2022
- Beginn
- 10.05.2022
- Tage bis Beginn
- 7,0
- Dosis
- 4
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Full blood count
Metabolic function test
Urticaria
Symptomtext
Hives urticaria over 12 days needing ER visit
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- CBC bmp May 16 2022
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Ulcerative colitis in remission
- Andere Medikamente
- Lialda, Canasa, Zyrtec singular
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 20.05.2022
- Impfdatum
- 02.05.2022
- Beginn
- 16.05.2022
- Tage bis Beginn
- 14,0
- Dosis
- 4
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Feeling abnormal
Malaise
Pyrexia
Respiratory tract congestion
Rhinorrhoea
SARS-CoV-2 test positive
Symptomtext
I took my first flight in 2 years and I always seem to get sick afterwards. When I got back Sunday night, I didn't feel great. By Monday, I felt sick. I took an at home test on Tuesday and it was negative. I made an appointment for the minute clinic for Thursday (05/19/2022) and was tested and it was Positive for COVID. I have had congestion and a constant runny nose for 2 days. On Wednesday, I started taking Mucinex FastMax. I have taken Mucinex night time and Advil PM at bedtime. I feel a little out of it from the congestion today but that's it. I no longer have a fever and, I contacted my PCP, who recommended Paxlovid. However, she requested a video visit to discuss it but her only availability was a week out which is outside the recommended time to use Paxlovid. So I messaged her and am waiting for a response. I did not have a fever Monday but I had one Tuesday for about 2 hours and haven't had one since.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Malaise
- Hospital-Tage
- -
- Labordaten
- COVID test on 05/17/2022: negative, COVID test on 05/19/2022: Positive
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- High blood pressure and Gastric issues (ulcers, gastric reflux and "you name it")
- Andere Medikamente
- Valsartan 160mg, Hydrochlorothiazide 12.5mg, Esomeprazole 40mg, Rosuvastatin 10mg, Florastor, Multivitamin, Fish oil and Vitamin D.
- Allergien
- Morphine and Vicodin
- Vorherige Impfungen
- I have had a sore arm after each COVID vaccine and symptoms such as light headedness and nausea. Also, after the 4th dose I had
- Staat
- CA
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 17.05.2022
- Impfdatum
- 04.04.2022
- Beginn
- 11.04.2022
- Tage bis Beginn
- 7,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Gait disturbance
Pain
Tendon disorder
X-ray limb normal
Symptomtext
A week or so after the vaccine the back of knee began hurting. It hurts a lot when I walk. My doctor referred me to physical therapy and an orthopedic doctor. He says my bones are fine but it is my tendons that are suffering. However, he has no explanation as to why I'm having issues with my tendons. My physical therapy will start in the first week of June and I have been doing the advised stretches from home twice daily until I begin physical therapy.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- X-ray, nothing found 05/2022.
- Aktuelle Erkrankungen
- None.
- Vorgeschichte
- Diabetes (controlled)
- Andere Medikamente
- Metformin; Lipitor 10mg; vitamin D; magnesium; vitamin C; probiotic; fish oil
- Allergien
- Lactose
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 16.05.2022
- Impfdatum
- 21.04.2022
- Beginn
- 03.05.2022
- Tage bis Beginn
- 12,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Exposure to SARS-CoV-2
Oropharyngeal pain
Pyrexia
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
COVID BREAKTHROUGH CASE. On May 3rd I developed sore throat and fever and I was told that I had been exposes to COVID a few days prior. I did a rapid it was negative. Symptoms persisted fever and cough took another test on the 5th it was positive called my dr. she prescribed Paxlovid. Took for 5 days as prescribed symptoms subsided. Tested negative Sunday May 8th. I completed the medication on 9. On the 13 of May I had a fever sore throat took a rapid and it was positive. Called my dr. and she felt I rebounded from the medication.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Oropharyngeal pain
- Hospital-Tage
- -
- Labordaten
- Covid test.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Breast Cancer; High Blood Pressure
- Andere Medikamente
- Nebivolol 5mg; Actonel 35mg weekly; tamoxifen 10mg daily; vitamin B12 1000 daily; D3 1000 daily; aloe vera 5000 MG; krill
- Allergien
- Penicillin; sulfa
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 10.05.2022
- Impfdatum
- 14.04.2022
- Beginn
- 16.04.2022
- Tage bis Beginn
- 2,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Asthenia
COVID-19
Cough
Fatigue
Neck pain
Pain
Pyrexia
Rhinorrhoea
SARS-CoV-2 test positive
Symptomtext
Hurting every metal piece in my body, ankle, knees, and neck. Everything has gone away except my neck. This started two days after I received my third vaccine. Very low energy, fatigued to the point that I did do a COVID-19 test and it was positive just to check and it was negative. I have to see a doctor on 05/11/2022 for the continued pain in my neck. I found out I had COVID-19 about 01/01/2022, I could not get a doctor appointment until 01/11/2022. They said at that time I still had it, so I had to quarantine another 10 days. Achy, coughing, sniffling nose, and fever of about 101-102. My symptoms were pretty much gone when I went to the doctor, and the test was positive, so I had to quarantine again. I feel it would have been a whole lot worse if I had not gotten it.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- PCR COVID-19 test - Positive result
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- HBP High Cholesterol Heart Disease Metal in my Neck Arthritis Extra Bone in my Foot Sinus and Ear Issues Postnasal Drip Diverticulitis Ulcers
- Andere Medikamente
- Ropinirole Zoloft Metoprolol Atorvastatin Zetia Gabapentin Baby Aspirin 81mg Famotidine Multivitamin Vitamin B12 Fish Oil
- Allergien
- Voltaren Hay Fever
- Vorherige Impfungen
- 03/13/2021 - Moderna Vaccine Dose 1 - Swelling in the arms, hotness that started at injection site and continued around my arm.
- Staat
- NJ
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 09.05.2022
- Impfdatum
- 30.04.2022
- Beginn
- 01.05.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Herpes zoster
Pain in extremity
Symptomtext
sore arm, shingles
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 07.05.2022
- Impfdatum
- 29.04.2022
- Beginn
- 30.04.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Fatigue
Headache
Pain
Symptomtext
Severe chills, body aches, headache, fatigue.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 03.05.2022
- Impfdatum
- 04.04.2022
- Beginn
- 24.04.2022
- Tage bis Beginn
- 20,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
COVID-19
Chest discomfort
Cough
Headache
Nausea
Pain
SARS-CoV-2 test positive
Sinus congestion
Sneezing
Urinary tract infection
Urine analysis
Vaccine breakthrough infection
Vomiting
X-ray
Symptomtext
Breakthrough COVID case: Around 5PM I started sneezing and I felt congestion in my sinus'. I did not take anything because I thought it was allergies. The symptoms got worse and started a hollow cough and a headache. On 04/25/2022 I took some Nyquil because I thought I was having a cold. The next morning I took a rapid test and it came back positive. I went to the pharmacy to do a PCR test on 04/27/2022 the results came back positive. I contacted my doctor and I asked for Paxlovid and they denied because she stated I was vaccinated. Instead they prescribed some antibiotics and steroids. On 04/28/2022 my chest felt heavier and I went to the ER and they treated me with some anti-inflammatory and they gave Paxlovid. I took the medication and got very nauseous and couldn't keep anything down. On 05/01/2022 I went back to the ER and they gave IV fluids and nausea meds and antibiotics because it appeared I was getting a UTI. I'm taking naproxen for the aches and Zyrtec for my sinus'.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- 04/25/2022: PCR Test: positive. X-rays: waiting results. Uranalysis: waiting results. Emergency room.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- High Cholesterol; Anxiety; Arthritis
- Andere Medikamente
- Crestor 40mg once daily; Celexa 10mg once daily; Zyrtec 10mg once daily; naproxen 550mg twice daily.
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 03.05.2022
- Impfdatum
- 27.04.2022
- Beginn
- 28.04.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Diarrhoea
Headache
Illness
Myalgia
Nausea
Pyrexia
SARS-CoV-2 test positive
Symptomtext
COVID positive on rapid test, muscle aches, fever, nausea, headache, diarrhea. Treatment, Paxlovid, course of illness 6+ days
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- 4/28/22 iHealth antigen Rapid test, positive 05/02/22 iHealth antigen Rapid test, positive
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 30.04.2022
- Impfdatum
- 29.04.2022
- Beginn
- 29.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pruritus
Symptomtext
Patient experienced itching all over the evening of vaccination (approximately 6-10 hours post-vaccination. Patient took 25mg diphenhydramine and itching resolved until following morning. Patient then called pharmacy and was advised to take additional antihistamine as needed and to follow up with urgent care if symptoms worsened over the weekend.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- diabetes, hypertension, reflux
- Andere Medikamente
- amlodipine, metformin, pantoprazole, solifenacin, warfarin, ezetimibe
- Allergien
- sulfa allergy, tetracycline, statin
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 29.04.2022
- Impfdatum
- 23.04.2022
- Beginn
- 24.04.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Fatigue
Induration
Injection site pain
Injection site swelling
Lymphadenitis
Pain
Pain in extremity
Symptomtext
The morning after vaccine, my arm was sore. Pain at the injection site with swelling and a hard area underneath arm on the armpit. I did get chills, tiredness, achiness as well. I went to my doctor and the size has lessened some on 4/27/2022 and the pain is not as severe. The doctor did state it could take about 2 weeks to go away. My doctor told me that it was an inflamed lymph node. The injection did feel like it could have been off center. This definitely felt different than my other injections.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- HTN; Chronic Kidney Disease Stage 3A
- Andere Medikamente
- Losartan; Amlodipine
- Allergien
- Penicillin; Codeine; Sulfa
- Vorherige Impfungen
- Flu 2018, day after vaccine was sick then got pneumonia.
- Staat
- MO
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 29.04.2022
- Impfdatum
- 25.04.2022
- Beginn
- 27.04.2022
- Tage bis Beginn
- 2,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pain in extremity
Peripheral swelling
Symptomtext
Patient feels hands really swollen after receiving the Moderna booster; Patient feels hands really achy after receiving the Moderna booster; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Patient feels hands really swollen after receiving the Moderna booster) and PAIN IN EXTREMITY (Patient feels hands really achy after receiving the Moderna booster) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 vaccination. The patient never had any COVID-19 test or diagnosis previously. Previously administered products included for Product used for unknown indication: Pfizer (Dose 2) and Pfizer (Dose 1). Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer. Concurrent medical conditions included Penicillin allergy, Drug allergy (Morphine allergy), Drug allergy (Fentanyl allergy), Drug allergy (Bactrim allergy) and Arthritis (many years ago, before vaccines). Concomitant products included LOSARTAN for Blood pressure, OMEPRAZOLE for Prophylaxis, METOPROLOL, METAXALONE and HYDROCODONE for an unknown indication. On 25-Apr-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2022, the patient experienced PERIPHERAL SWELLING (Patient feels hands really swollen after receiving the Moderna booster) and PAIN IN EXTREMITY (Patient feels hands really achy after receiving the Moderna booster). At the time of the report, PERIPHERAL SWELLING (Patient feels hands really swollen after receiving the Moderna booster) and PAIN IN EXTREMITY (Patient feels hands really achy after receiving the Moderna booster) outcome was unknown. It was reported that patient received Pfizer for the primary series and Moderna COVID-19 vaccine for the booster dose. Concomitant drug Omeprazole was used for protect stomach and Losartan for maintained blood pressure. After two days of Moderna vaccine patient experienced hands really achy and swollen. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Drug allergy (Morphine allergy); Drug allergy (Fentanyl allergy); Drug allergy (Bactrim allergy); Penicillin allergy
- Vorgeschichte
- Medical History/Concurrent Conditions: Arthritis (many years ago, before vaccines); Comments: The patient never had any COVID-19 test or diagnosis previously.
- Andere Medikamente
- LOSARTAN; OMEPRAZOLE; METOPROLOL; METAXALONE; HYDROCODONE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 27.04.2022
- Impfdatum
- 25.04.2022
- Beginn
- 25.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Bone disorder
Chills
Dyspepsia
Headache
Spinal disorder
Symptomtext
spine. bones, headache issues: indigestion, chills
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- gi issues, bone issues, spine issues, degenerative disc, osteoporosis
- Andere Medikamente
- lisinopril, nexium, fluoxetine,xopenex, align, aspirin, vitamin d3, metamucil, magnesium citrate, biotin
- Allergien
- cymbalta, darvocet n, diludad, diltilazem, erythromycin, hydrocodone, lortab, medrol, pantoprozole, prednisone, topamax, tramadol
- Vorherige Impfungen
- Moderna, 55 years old, 2/9/2021
- Staat
- NY
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 26.04.2022
- Impfdatum
- 24.02.2022
- Beginn
- 25.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Axillary pain
Dizziness
Hypoaesthesia
Malaise
Muscle tightness
Nausea
Neck pain
Neuropathy peripheral
Pain
Pain in extremity
Skin discolouration
Vaccination site pain
Symptomtext
She got her vaccine, she was not told to wait 15 minutes so she left and had not eaten and thinks her blood sugar bottomed out and felt nauseous like she was going to pass out, but is normal for her. Did not feel well, and knew she needed to have something to boost it and she did not do that. She got a candy bar and some water which she was told to drink, and that feeling went away. She then noticed pain about a day later around her arm and under her arm, and took some Tylenol which the under arm pain went away. The pain in her arm at vaccine site did not go away and weeks have passed and months and still has the pain in her arm today, feels like she had the vaccine yesterday. She also has neuropathy which makes her hands go numb, not related to the vaccine. She has shooting pain in her arm. She woke up with the pain this morning, has a little dot which she had pain after the 2nd vaccine, but not like this. The pain is so sore today, no redness, a little dark mark, hurts a little under the arm, but no swelling. Says it's annoying, and doesn't know what is going on, and states she will not get another one. She thinks that who injected her hit the muscle itself, and it's crazy. The pain goes to her neck. She has notified her doctor of the issue and they told her to come in and see them. She also hurts in her arm, shoulder and all on the left side and she has tense muscles in her neck, which is making things worse. She has a herniated disc in her upper neck and lower back, sciatica as well.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None.
- Vorgeschichte
- Anxiety, panic disorder, PTSD, hypothyroidism, high cholesterol, high blood pressure, ADHD, benign central tremors.
- Andere Medikamente
- Klonopin 0.5 mg, Levothyroxine .75 mcg., Lipitor, Amlodipine, Metoprolol, baby aspirin, Vitamin D.
- Allergien
- Epinephrine and it's products, Cipro.
- Vorherige Impfungen
- Tetanus with fever, sore arm, and just felt miserable. Nothing life threatening when she cut herself on a can.
- Staat
- PA
- Alter
- 56,0
- Geschlecht
- M
- Eingang
- 26.04.2022
- Impfdatum
- 23.02.2022
- Beginn
- 24.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Antinuclear antibody positive
Blood test abnormal
Pain
Symptomtext
after getting the booster shot, the next morning I had excruciating pain all over my body. I talk to Internal Medicine Doctor at work and they recommended that I have blood work done for a possible ANA, so I did and it came back positive.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- blood work for ANA ?. came back positive
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 51,0
- Geschlecht
- M
- Eingang
- 24.04.2022
- Impfdatum
- 15.04.2022
- Beginn
- 16.04.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Ejaculation failure
Fatigue
Headache
Tinnitus
Symptomtext
fatigue, headache, tinnitus and inability to ejaculate
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Hyperlipidemia, depression, GERD, chronic pain, insomnia
- Andere Medikamente
- none
- Allergien
- PCN, Amoxicillin
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 22.04.2022
- Impfdatum
- 01.01.2022
- Beginn
- 01.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- SYR / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: ja
Erholt: nein
Arthralgia
Asthenia
Blood test
Chest X-ray
Decreased appetite
Dizziness
Fatigue
Lip swelling
Myalgia
Pain
Pyrexia
Swelling face
Symptomtext
recurring swollen face and lips, high fever, body aches , joint pain , myalgias, fatigue, weakness, loss of appetite, dizziness, lightheaded,
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- full blood panel chest xray
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 21.04.2022
- Impfdatum
- 30.03.2022
- Beginn
- 01.04.2022
- Tage bis Beginn
- 2,0
- Dosis
- 4
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Diarrhoea
Fatigue
Nausea
Vomiting
Symptomtext
I was severe fatigue, diarrhea, nausea and vomiting of about a week after the shot. I contacted my doctor. He gave me a nausea medicine and then I felt better.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- Allergies
- Vorgeschichte
- Hyperthyroidism; Depression; Osteoporosis
- Andere Medikamente
- Synthroid; Prozac
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 18.04.2022
- Impfdatum
- 14.04.2022
- Beginn
- 15.04.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Rash
Vomiting
Symptomtext
Body rash which started at chin and spread down body, per client started 4/15/22 and resolved on 04/18/22. Also had vomiting on 04/15/22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Fibromyalgia
- Andere Medikamente
- Vitamin D, cymbalta and inulin
- Allergien
- Erythromycin
- Vorherige Impfungen
- -
- Staat
- UT
- Alter
- 44,0
- Geschlecht
- F
- Eingang
- 14.04.2022
- Impfdatum
- 02.02.2022
- Beginn
- 02.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Blood pressure increased
Dizziness
Headache
Inappropriate schedule of product administration
Symptomtext
Elevated blood pressure, headache and dizziness. from about 4 pm until 11 pm. No treatment was not seen by provider
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- COVID
- Vorgeschichte
- HPTN, Chiari
- Andere Medikamente
- Metoprolol 50 mg daily, Tylenol 500 mg, Benadryl 25 mg
- Allergien
- Percocet, Ibuprofen
- Vorherige Impfungen
- COVID Moderna, 11/2021, stomach issues
- Staat
- CT
- Alter
- 25,0
- Geschlecht
- F
- Eingang
- 06.04.2022
- Impfdatum
- 24.02.2022
- Beginn
- 22.03.2022
- Tage bis Beginn
- 26,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Rash
Urticaria
Symptomtext
Hives rash reoccurring
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Reynauds disease, lactose intolerance, depression.
- Andere Medikamente
- Quetiapine, aurovela fe
- Allergien
- -
- Vorherige Impfungen
- Same vacine(COVID Moderna) bumps on fingers same day of vaccination
- Staat
- VA
- Alter
- 41,0
- Geschlecht
- M
- Eingang
- 28.03.2022
- Impfdatum
- 28.02.2022
- Beginn
- 02.03.2022
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Contusion
Gingival bleeding
Haematochezia
Myalgia
Pyrexia
Rash
Rash macular
Symptomtext
Fever to 102.5 despite tylenol myalgias spontaneous bleeding from gums and in stool easy bruising/spontaneous bruising red spots[2-4mm] rash on face/neck/torso/arms/legs
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myalgia
- Hospital-Tage
- -
- Labordaten
- bleeding/bruising/rash resolved in 48 hours before my PCP appointment.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- obese seasonal/environmental allergies
- Andere Medikamente
- claritin PRN
- Allergien
- historical allergy to pertussis vaccination pain in muscles/difficulty to stand for months after Johnson&Johnson COVID19 vaccine dust/pollen/cats
- Vorherige Impfungen
- muscle pain for months after J&J COVID19 vaccine received 9/12/21. historical pertussis intolerance as a child in 1980s -- swel
- Staat
- CO
- Alter
- 47,0
- Geschlecht
- M
- Eingang
- 20.03.2022
- Impfdatum
- 28.01.2022
- Beginn
- 29.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Influenza
Muscle spasms
Pain
Symptomtext
Flu symptoms, body cramps, body aches,
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- diabetes, high blood pressure
- Andere Medikamente
- adderall, acyclovir, Wellbutrin, atenolol, lisinopril, gabapentin, duloxetine, ambient, tenex , farxiga, amlodipine, risperidone, rosuvastatin, oxycodone, anastrozole
- Allergien
- nkda
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 44,0
- Geschlecht
- M
- Eingang
- 15.03.2022
- Impfdatum
- 22.01.2022
- Beginn
- 18.02.2022
- Tage bis Beginn
- 27,0
- Dosis
- 3
- Route/Site
- UN / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood glucose increased
Blood pressure increased
COVID-19
Hyperglycaemia
Influenza A virus test negative
Influenza B virus test
Malaise
Nervousness
Respiratory syncytial virus test negative
SARS-CoV-2 test positive
Symptomtext
BLOOD PRESSURE Pt reports "SBP was 235 at dialysis this morning and my blood sugar was so high they couldnt get a reading they told me to come here instead." Patient is a 44y.o. male with past medical history of CVA, hypertension, diabetes mellitus, ESRD on HD who presents to the emergency department for evaluation of hyperglycemia and elevated blood pressure.. Patient typically receives dialysis Monday, Wednesday, Friday. He presented to dialysis this morning and was told that his pressure was too high, 235/100s and was sent to the emergency department. He was also told that his blood sugar was high. He reports he has been compliant with his insulin. He states he feels somewhat shaky this morning, denies other symptoms. Denies any headaches or vision changes. Denies any weakness or numbness. No chest pain or difficulty breathing. No abdominal pain, vomiting, diarrhea. No urinary complaints. He does report a history of COVID-19 infection approximately 5 weeks ago for which he did test positive and was symptomatic at that time. He has no COVID-19 symptoms today. Review of Systems Constitutional: Negative for chills and fever. HENT: Negative for sore throat. Eyes: Negative for visual disturbance. Respiratory: Negative for cough and shortness of breath. Cardiovascular: Negative for chest pain and palpitations. Gastrointestinal: Negative for abdominal pain, nausea and vomiting. Genitourinary: Negative for difficulty urinating and dysuria. Musculoskeletal: Negative for arthralgias and myalgias. Skin: Negative for rash. Neurological: Negative for weakness and numbness. Psychiatric/Behavioral: Negative for confusion.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Malaise
- Hospital-Tage
- 1,0
- Labordaten
- LABORATORY Chart Review Copy HAR: Withheld DOB: Withheld (44 yrs) PT CLASS: Inpatient CSN: Withheld DEPT: Withheld PATIENT STATUS: Discharged GENDER: male BED: Withheld ORD DR: Withheld AUTH DR: Withheld Results Covid-19, Flu, RSV by NAA Contains abnormal data Covid-19, Flu, RSV by NAA Order: Status: Final result Visible to patient: Yes (not seen) Next appt: None Specimen Information: Nasopharyngeal; Swab 0 Result Notes Component Ref Range & Units Influenza A Not Detected Not Detected Influenza B Not Detected Not Detected RSV Not Detected Not Detected SARS-CoV-2 (COVID-19) by NAA, Micro Not Detected Detected Abnormal Narrative Methodology: Nucleic Acid Amplification(NAA)/Polymerase Chain Reaction(PCR) The SARS-CoV-2 (COVID-19) test is for in vitro diagnostic use under withheld for laboratories certified under withheld to perform high complexity testing. This test has not been cleared or approved. Specimen Collected: 02/18/22 10:53 AM Last Resulted: 02/18/22 11:55 AM Order Details View Encounter Lab and Collection Details Routing Result History Result Care Coordination Patient Communication Released Not seen Back to Top Comments Released Not seen View Info Covid-19, Flu, RSV by NAA (Order) on 2/18/22 Order Covid-19, Flu, RSV by NAA Reports Transmitted at Order Entry Transmitted to: Device ID:
- Aktuelle Erkrankungen
- ? Arthritis ? CVA (cerebral vascular accident) 11/2020 residual left leg weakness ? Diabetes mellitus ? Dialysis patient dx 11-2021 ? DM2 (diabetes mellitus, type 2) dx 2000 ? Dyslipidemia ? Eczema ? End stage renal disease ? Hypertension ? Migraine ? Postoperative nausea and vomiting
- Vorgeschichte
- ? Arthritis ? CVA (cerebral vascular accident) 11/2020 residual left leg weakness ? Diabetes mellitus ? Dialysis patient dx 11-2021 ? DM2 (diabetes mellitus, type 2) dx 2000 ? Dyslipidemia ? Eczema ? End stage renal disease ? Hypertension ? Migraine ? Postoperative nausea and vomiting
- Andere Medikamente
- CLONIDINE (CATAPRES) 0.3 MG PO TAB TAKE 1 TABLET BY MOUTH THREE TIMES DAILY ERGOCALCIFEROL (DRISDOL) 1.25 MG (50000 UT) PO CAP take 1 Capsule by mouth once weekly. FERROUS SULFATE 325 (65 FE) MG PO TAB take 1 Tablet by mouth t
- Allergien
- Pcn [Penicillins
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 24,0
- Geschlecht
- M
- Eingang
- 15.03.2022
- Impfdatum
- 01.03.2022
- Beginn
- 01.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Urticaria
Symptomtext
Hives across entire body beginning 12 days after injection.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 47,0
- Geschlecht
- F
- Eingang
- 05.03.2022
- Impfdatum
- 22.09.2021
- Beginn
- 01.02.2022
- Tage bis Beginn
- 132,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Arthralgia
Back pain
Blood test
Body temperature
Breath sounds abnormal
Chest X-ray abnormal
Electrocardiogram
Pulmonary congestion
Chest X-ray
Chest discomfort
Cough
Dysphonia
Headache
Inappropriate schedule of product administration
Muscle spasms
Myalgia
Productive cough
SARS-CoV-1 test
Symptomtext
pulmonary vascular congestion; really bad cough, cough was persistent; Her first dose was on 22sep2021 lot number 021C21A. Her second dose was on 25feb2022 lot number 084J21A.; headache; body aches; back and hips hurt like cramps; back and hips hurt like cramps; voice became scratchy; could feel and hear rattling and crackling in her chest; cough was waking her up at night; producing clear phlegm; could feel and hear rattling and crackling in her chest; back and hips hurt like cramps; This spontaneous case was reported by a consumer and describes the occurrence of PULMONARY CONGESTION (pulmonary vascular congestion), COUGH (really bad cough, cough was persistent), HEADACHE (headache), MYALGIA (body aches), MUSCLE SPASMS (back and hips hurt like cramps), BACK PAIN (back and hips hurt like cramps), DYSPHONIA (voice became scratchy), BREATH SOUNDS ABNORMAL (could feel and hear rattling and crackling in her chest), SLEEP DISORDER (cough was waking her up at night), PRODUCTIVE COUGH (producing clear phlegm), CHEST DISCOMFORT (could feel and hear rattling and crackling in her chest) and ARTHRALGIA (back and hips hurt like cramps) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 084J21A and 021C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included LISINOPRIL DIHYDRATE (LISINOPRIL [LISINOPRIL DIHYDRATE]) for Blood pressure high. On 22-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2022, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2022, the patient experienced HEADACHE (headache) (seriousness criterion medically significant), MYALGIA (body aches) (seriousness criterion medically significant), MUSCLE SPASMS (back and hips hurt like cramps) (seriousness criterion medically significant), BACK PAIN (back and hips hurt like cramps) (seriousness criterion medically significant), DYSPHONIA (voice became scratchy) (seriousness criterion medically significant), BREATH SOUNDS ABNORMAL (could feel and hear rattling and crackling in her chest) (seriousness criterion medically significant), SLEEP DISORDER (cough was waking her up at night) (seriousness criterion medically significant), PRODUCTIVE COUGH (producing clear phlegm) (seriousness criterion medically significant), CHEST DISCOMFORT (could feel and hear rattling and crackling in her chest) (seriousness criterion medically significant) and ARTHRALGIA (back and hips hurt like cramps) (seriousness criterion medically significant). On 25-Feb-2022, the patient experienced COUGH (really bad cough, cough was persistent) (seriousness criterion medically significant) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Her first dose was on 22sep2021 lot number 021C21A. Her second dose was on 25feb2022 lot number 084J21A.). On 27-Feb-2022, the patient experienced PULMONARY CONGESTION (pulmonary vascular congestion) (seriousness criterion medically significant). At the time of the report, PULMONARY CONGESTION (pulmonary vascular congestion) had not resolved and COUGH (really bad cough, cough was persistent), HEADACHE (headache), MYALGIA (body aches), MUSCLE SPASMS (back and hips hurt like cramps), BACK PAIN (back and hips hurt like cramps), DYSPHONIA (voice became scratchy), BREATH SOUNDS ABNORMAL (could feel and hear rattling and crackling in her chest), SLEEP DISORDER (cough was waking her up at night), PRODUCTIVE COUGH (producing clear phlegm), CHEST DISCOMFORT (could feel and hear rattling and crackling in her chest), ARTHRALGIA (back and hips hurt like cramps) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Her first dose was on 22sep2021 lot number 021C21A. Her second dose was on 25feb2022 lot number 084J21A.) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: normal (normal) normal. On an unknown date, Body temperature: normal (normal) normal. On an unknown date, Chest X-ray: abnormal (abnormal) pulmonary vascular congestion. On an unknown date, Electrocardiogram: normal (normal) normal. On an unknown date, SARS-CoV-1 test: negative (Negative) negative. On an unknown date, SARS-CoV-2 antibody test: negative (Negative) negative. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No treatment medication has been provided. On 25feb2022 she received her second Moderna shot and within 2 hours she developed a really bad cough. She went to the ER on 27feb2022 at 23:00 and was diagnosed with pulmonary vascular congestion. She was not treated, and was referred to a cardiologist to get images of her heart, She will have to see a PCP first though due to insurance and that appointment has been scheduled for 3mar2022 with her PCP. She said that she had a headache, body aches, her back and hips hurt like cramps, her cough was persistent and her voice became scratchy. About 24 hours after receiving the vaccine she could feel and hear rattling and crackling in her chest. The cough was waking her up at night and she was producing clear phlegm. In the ER she had an EKG and full bloodwork done which that all came back normal. She had a chest xray that showed the pulmonary vascular congestion. Both flu and Covid tests in the ER came back negative. Her first dose was on 22sep2021 lot number 021C21A. Her second dose was on 25feb2022 lot number 084J21A. Concomitant medication: lisinopril 40 mg daily or high blood pressure. She consents for safety to follow up. COMPANY COMMENT: This is an Spontaneous case concerning a 47-years-old female patient with no reported clinical history who experienced the unexpected events of PULMONARY CONGESTION, HEADACHE, MYALGIA, MUSCLE SPASMS, BACK PAIN, DYSPHONIA, BREATH SOUNDS ABNORMAL, SLEEP DISORDER, COUGH, PRODUCTIVE COUGH, CHEST DISCOMFORT, ARTHRALGIA and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION occurred unknown days after 2nd dose of RNA-1273. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. The medical history of LISINOPRIL remains a confounder for events "chest discomfort, sleep disorder, cough, productive cough". The case was assessed as serious due to IME; Sender's Comments: COMPANY COMMENT: This is an Spontaneous case concerning a 47-years-old female patient with no reported clinical history who experienced the unexpected events of PULMONARY CONGESTION, HEADACHE, MYALGIA, MUSCLE SPASMS, BACK PAIN, DYSPHONIA, BREATH SOUNDS ABNORMAL, SLEEP DISORDER, COUGH, PRODUCTIVE COUGH, CHEST DISCOMFORT, ARTHRALGIA and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION occurred unknown days after 2nd dose of RNA-1273. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. The medical history of LISINOPRIL remains a confounder for events "chest discomfort, sleep disorder, cough, productive cough". The case was assessed as serious due to IME
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- Test Name: blood test(bloodwork); Result Unstructured Data: normal; Test Name: Body temperature; Result Unstructured Data: normal; Test Name: Chest X-ray; Result Unstructured Data: pulmonary vascular congestion; Test Name: EKG; Result Unstructured Data: normal; Test Name: Covid test; Test Result: Negative ; Result Unstructured Data: negative; Test Name: SARS-CoV-2 antibody test; Test Result: Negative ; Result Unstructured Data: negative
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- LISINOPRIL [LISINOPRIL DIHYDRATE]
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PR
- Alter
- 26,0
- Geschlecht
- M
- Eingang
- 04.03.2022
- Impfdatum
- 28.02.2022
- Beginn
- 01.03.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Abdominal pain
Symptomtext
Pt. had aut abdominal pain that required a emergency department visit. Pt. came to the pharmacy a week after and said to be ok.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal pain
- Hospital-Tage
- -
- Labordaten
- Emergency department visit.
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Asthma.
- Andere Medikamente
- Unknown
- Allergien
- Iodine
- Vorherige Impfungen
- dizziness after recieving first 2 doses of moderna vaccine
- Staat
- NY
- Alter
- 49,0
- Geschlecht
- M
- Eingang
- 03.03.2022
- Impfdatum
- 10.01.2022
- Beginn
- 10.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Blood test normal
Interchange of vaccine products
Musculoskeletal pain
Symptomtext
Throbbing pain in right elbow and right shoulder blade since booster shot was administered. Treatments: 2x/ week acupuncture from Sports Medicine Doctor; 2x/ week Physical Therapy. Primary Care Dr who prescribed Mobic, medrol, prednisone. None of the steroids relieved the pain. Neurologist prescribed gabapentin and administered a Kennelog injection in shoulder. Orthopedic Surgeon administered a Kennelog injection in forearm. Nothing has helped in 8 weeks since the booster shot
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- MRI to be performed Blood panels and autoimmune tests administered - all negative
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Propecia 1 mg, Vitamin D, Vitamin B12 Complex, Fish Oil, Multi VItamin
- Allergien
- Penicillian
- Vorherige Impfungen
- 2nd Covid shot (Pfizer) - sick and achy for six days - age 49, administered 4/28/22
- Staat
- TN
- Alter
- 20,0
- Geschlecht
- F
- Eingang
- 02.03.2022
- Impfdatum
- 28.02.2022
- Beginn
- 28.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site pain
Injection site swelling
Injection site warmth
Symptomtext
Right arm pain of site of injection followed with redness which has increased daily since vaccination. This is day 3. Redness has migrated down the arm approx. 1 inch and is the size of a golf ball or slightly larger. Hot to touch. No red streaks. Tender to touch but no swelling
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- PCN
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 24.02.2022
- Impfdatum
- 05.01.2022
- Beginn
- 24.02.2022
- Tage bis Beginn
- 50,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Alopecia
Injection site erythema
Symptomtext
Patient reports 2" diameter injection sight reaction that is erythematous. She is treating it with OTC hydrocortisone cream and seeing relief. She also reports diminished hair growth in a baseball-sized patch on the crown of her head.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Lupus
- Andere Medikamente
- Hydrocodone/APAP 10-325mg, gabapentin 300mg, ibuprofen 800mg, lactulose solution 10g/15mL
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 23.02.2022
- Impfdatum
- 24.01.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 8,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Blood thyroid stimulating hormone decreased
Constipation
Fatigue
Feeling cold
Sensitive skin
Thyroxine normal
Tri-iodothyronine normal
Symptomtext
Over subsequent two weeks, became increasingly fatigued, sensitive to cold, and mildly constipated (typical when my thyroid levels were low). At the end of two weeks, serum level of TSH had dropped to 0.406 from 10/21/2021 level of 0.643. T3 and T4 levels had increased (although remaining well within normal range, and had not triggered hyperthyroid symptoms). Since then, my symptoms have improved and my physician has recommended waiting until May to retest (unless symptoms worsen again).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- 02/08/2022: TSH - 0.406, T3 - 102, Free Direct T4 - 1.00
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- hypothyroidism
- Andere Medikamente
- Armour Thyroid
- Allergien
- vicodin corn, cumin, fenugreek
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 38,0
- Geschlecht
- F
- Eingang
- 22.02.2022
- Impfdatum
- 16.02.2022
- Beginn
- 17.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Headache
Lymphadenopathy
Mass
Nausea
Neck mass
Oedema peripheral
Rash
Swelling
Symptomtext
Patient Received vaccine on 2-16-22. Noticed red swollen bumps on neck 2-17-22. Developed 4 lumps on right side of body. Had 2 lumps on neck. 1 lumps on top of shoulder by clavicle. 1 bump in axilla (arm pit). Also experience headache and nausea. Saw physician on 2-18-22. Dr. stated lymph nodes were swollen and expected it to resolve in a few weeks and to follow-up if symptoms worsen.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Amphetamine/Dextroamphetamine salts 10mg fluoxetine 40mg
- Allergien
- No know allergies.
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 21.02.2022
- Impfdatum
- 07.02.2022
- Beginn
- 07.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 24,0
- Geschlecht
- F
- Eingang
- 18.02.2022
- Impfdatum
- 18.02.2022
- Beginn
- 18.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Nausea
Vomiting
Symptomtext
two minutes after receiving her vaccine she felt light headed, she had nausea and small amount of vomit
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none that we know of
- Vorgeschichte
- none that we know of
- Andere Medikamente
- none that we know of
- Allergien
- none that we are aware of
- Vorherige Impfungen
- pt fainted when she received the tdap in middle school
- Staat
- OH
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 18.02.2022
- Impfdatum
- 15.01.2022
- Beginn
- 15.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Arthralgia
Back pain
Feeling cold
Influenza like illness
Injection site pain
Myalgia
Pain
Pyrexia
Symptomtext
The injection was very painful. About 4 hrs later, I had intense pain in my back that spread all over my body. I had pain in my joints and muscles with a fever. I felt very cold though. My symptoms felt like the flu. These symptoms continues about 48 hours.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Rheumatoid arthritis
- Andere Medikamente
- Promethazine
- Allergien
- Latex
- Vorherige Impfungen
- Adverse event from 1 and 2 dose Moderna
- Staat
- NM
- Alter
- 34,0
- Geschlecht
- F
- Eingang
- 17.02.2022
- Impfdatum
- 17.02.2022
- Beginn
- 17.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pain in extremity
Symptomtext
Pt was administered Prevnar 20 simultaneously with Moderna Covid 19 vaccine. The patient has only reported sore arm.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Diabetes
- Andere Medikamente
- Prevnar 20 was simultaneously administered her booster Moderna Covid vaccine. The Prevnar 20 was administered in the right arm, and the Moderna vaccine was administered in the left arm. Pt stayed for the 15 minute observation period. No re
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 17.02.2022
- Impfdatum
- 02.02.2022
- Beginn
- 02.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site pruritus
Symptomtext
Client presented to receive Moderna Booster. Client informed RN that when he received Moderna dose 1 on 2/3/21 client experienced itching 3 hrs. after vaccine for one day, at injection site only. No other symptoms. No meds taken. Dose 2 same thing happened 3 hrs. after. No meds taken. Client has high blood pressure. Client received approval to receive Moderna Booster COVID vaccine by MD. Client received Moderna Booster Lot#084J21A. Client reported no symptoms while waiting in observation area for 30 mins. Client left vaccination area in steady gait.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pruritus
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- high blood pressure
- Andere Medikamente
- uknown
- Allergien
- no known allergies
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 17.02.2022
- Impfdatum
- 03.02.2022
- Beginn
- 03.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Pruritus
Rash
Symptomtext
Client received Moderna dose 1 on 3/17/21 everything went well. Dose 2 on 4/14 client developed a rash all over body 24 hrs after vaccine. Client denies having SOB, no other symptoms, only itching. Client took Benadryl and subsided after 3 days. Client didn?t go to ER or informed her primary care provider. Client has allergy to shellfish (anaphylaxis). Client has no medical conditions. A medical consult was submitted by RN to Clinical Project Coordinator. Client received approval to receive Moderna Booster COVID vaccine by MD. Client received Moderna Booster Lot#084J21A. Client reported no symptoms while waiting in observation area for 30 mins. Client left vaccination area in steady gait.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- None reported
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- none reported
- Andere Medikamente
- unknown
- Allergien
- shellfish
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 16.02.2022
- Impfdatum
- 21.01.2022
- Beginn
- 21.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Pyrexia
Symptomtext
Patient was given Moderna 0.5ML IM in error. The MA administered the vaccination without being seen by the provider. The MA was the patient's mother and was given in the car. Patient experienced a 103 F fever for 2 days. No other adverse effects noted. CDC contacted for guidance. Her second dose will need to be the age appropriate Pfizer dose given 28 days after the Moderna was given.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- NOne
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 38,0
- Geschlecht
- F
- Eingang
- 16.02.2022
- Impfdatum
- 28.01.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 4,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Burning sensation
Pruritus
Rash
Rash erythematous
Rash pruritic
Symptomtext
I started with itchy palms, then I had a red rash spread all over my body. Every day it got worse and started to burn and itch. The rash was not raised or blistered. It would start on parts of my body then disappear within seconds, then spread to another part.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- NKA
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- NA
- Andere Medikamente
- -
- Allergien
- NKA
- Vorherige Impfungen
- Moderna vaccine 12/28 and 1/25
- Staat
- NJ
- Alter
- 30,0
- Geschlecht
- F
- Eingang
- 16.02.2022
- Impfdatum
- 10.02.2022
- Beginn
- 11.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Peripheral swelling
Rash erythematous
Swelling face
Symptomtext
Started to swell; Face was red like a rash; Arm was swollen; Face was reddish; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm was swollen), ERYTHEMA (Face was reddish), SWELLING FACE (Started to swell) and RASH ERYTHEMATOUS (Face was red like a rash) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 vaccination. Concurrent medical conditions included Food allergy (apricot), Food allergy (dumplings), Food allergy (a type of tea) and Allergy to plants (aloe vera). On 10-Feb-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2022, the patient experienced PERIPHERAL SWELLING (Arm was swollen) and ERYTHEMA (Face was reddish). On an unknown date, the patient experienced SWELLING FACE (Started to swell) and RASH ERYTHEMATOUS (Face was red like a rash). At the time of the report, PERIPHERAL SWELLING (Arm was swollen), ERYTHEMA (Face was reddish), SWELLING FACE (Started to swell) and RASH ERYTHEMATOUS (Face was red like a rash) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were reported. Patient had no allergies to medicines or vaccines. Reporter stated that patient had not had a previous diagnosis of covid-19. She was currently at a clinic awaiting treatment at the time of this call. No tests or medications have been administered at this time.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash erythematous
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Food allergy (dumplings); Food allergy (apricot); Food allergy (a type of tea)
- Vorgeschichte
- Medical History/Concurrent Conditions: Allergy to plants (aloe vera)
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 14.02.2022
- Impfdatum
- 10.02.2022
- Beginn
- 11.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Fall
Headache
Influenza like illness
Muscular weakness
Nausea
Pain
Urinary incontinence
Symptomtext
Patient stated that she noticed symptoms the night after getting a vaccine. She could not hold her bladder. She had 5 accidents. Weakness in legs and fell. Couldn't get up. Nausea/flulike symptoms. Headache. body aches. No injury. She said all her symptoms resolved by the time she called the pharmacy.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 21,0
- Geschlecht
- F
- Eingang
- 13.02.2022
- Impfdatum
- 09.01.2022
- Beginn
- 23.01.2022
- Tage bis Beginn
- 14,0
- Dosis
- 3
- Route/Site
- SYR / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Urticaria
Symptomtext
Spontaneous Urticaria 2+ weeks
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- Bupropion, birth control
- Allergien
- poultry, dust, mold
- Vorherige Impfungen
- -
- Staat
- PR
- Alter
- 37,0
- Geschlecht
- M
- Eingang
- 12.02.2022
- Impfdatum
- 14.01.2022
- Beginn
- 17.01.2022
- Tage bis Beginn
- 3,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenia
Axillary pain
Chills
Inflammation
Nodule
Pyrexia
Symptomtext
A 37-year-old male patient receives a booster dose of Moderna on 01/14/2022. The patient reports that on the third day after its administration, he presented inflammation of the nodules in the area of ??the left armpit. He reports presenting secondary symptoms such as fever, chills, weakness and pain in the left armpit area due to the presence of the nodule. He reports that the measurement of the nodule was the size of his fist. The patient is considered afebrile, with no redness in the area and no pain to the touch.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Axillary pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 37,0
- Geschlecht
- F
- Eingang
- 12.02.2022
- Impfdatum
- 27.01.2022
- Beginn
- 27.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Fatigue
Headache
Nausea
Somnolence
Symptomtext
This was much milder and easier to handle than previous Pfizer vaccine 1&2. Mild dull headache within one hour of vaccine, mild nausea started 2 hours in manageable with ginger chews and ginger ale. Nausea increased and Intense nausea that night about 3-4 hours later crackers and ginger only helped for a few minutes then intense nausea wave back. Felt like I needed to vomit but never did. I took 12.5 mg phenergan about 5-6 hours in and then bed shortly after. Slept 12 hours, woke up, nausea was mild to moderate and still felt tired and slept another 4 hours. Up for about 2 hours, felt fatigued, body drained and sleepy, back to bed for 2 additional hours and would have probably kept sleeping but woken up by a phone call. Felt very fatigued and drained the rest of the day and the next day. Slept another 10hours that night, then mostly ok. Took a few days to shake off the fatigued drained feeling
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Right sided migraines menstrual cycle related, well controlled.
- Andere Medikamente
- Inderal 120 mg daily
- Allergien
- None
- Vorherige Impfungen
- Pfizer x2 07/23/2021 and 08/30/2022
- Staat
- AK
- Alter
- 47,0
- Geschlecht
- F
- Eingang
- 11.02.2022
- Impfdatum
- 10.02.2022
- Beginn
- 10.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Erythema
Fatigue
Flushing
Rash erythematous
Rash papular
Throat irritation
Symptomtext
Pt evaluated at approximately 16:50 hrs. Noted Itchy throat, red raised rashes of anterior neck, red flushed appearing skin of upper chest, red raised rashes of Lt distal arm and palm of hand and Rt palm of hand. Also noted fatigue. Pt was given Diphenhydramine 25mg capsule, 2 capsules PO once at 16:55 hrs. Monitored in clinic for 35 minutes post Diphenhydramine administration. Rash of neck and upper chest and itchy throat subsided and resolved. Rash of Lt distal arm and palm of hand remained present but not any different in size or color. Rt palm rash resolved.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- Right sided lower quadrant pain with known follicle on Rt ovary and subserosal fibroid on Rt cornuate. Eczema of posterior neck along hairline.
- Vorgeschichte
- Anxiety, BPPV, Benign Essential HTN, Chronic Constipation, Hand Tingling, Joint Pain, PCOS, Obesity, Hyperlipidemia
- Andere Medikamente
- Amlodipine 5mg, Loratadine 10mg, Hydroxyzine 25mg.
- Allergien
- Amino acridine derivative, atorvastatin, hydrochlorothiazide, pantoprazole, penicillins, sulfamethoxazole.
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 52,0
- Geschlecht
- M
- Eingang
- 10.02.2022
- Impfdatum
- 25.01.2022
- Beginn
- 26.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blister rupture
Injection site erythema
Injection site induration
Injection site reaction
Injection site scab
Injection site vesicles
Local reaction
Skin exfoliation
Symptomtext
The day after the vaccine, patient experienced a local site reaction that eventually turned looking like a severe burn, patient stated that the skin blstered and the spot lost the first layer of skin and was draining a clear liquid. The spot scabbed over and is currently healing and pink. It has a hard spot the size of a nickel still. Patient has been cleaning with soap and water and using Neosporin to help heal. Patient did not want to visit a doctor regarding the reaction.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PR
- Alter
- 19,0
- Geschlecht
- M
- Eingang
- 10.02.2022
- Impfdatum
- 12.01.2022
- Beginn
- 12.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenia
Asthenopia
Fatigue
Symptomtext
Patient reports weakness, tiredness and heaviness in the eyes. Doctor is notified, who orders hydration by mouth until he is evaluated again.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- PNC, Anaphylaxis.
- Vorherige Impfungen
- -
- Staat
- PR
- Alter
- 30,0
- Geschlecht
- F
- Eingang
- 10.02.2022
- Impfdatum
- 15.01.2022
- Beginn
- 15.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dizziness
Symptomtext
A 30-year-old female patient refers, at the end of her post-vaccination waiting time, feeling dizzy. The patient is guided on the importance of not abandoning treatment and maintaining its consistency to avoid incidents caused by not adhering to the indication of daily medications.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- Hypoglycemia, Chronic Anemia.
- Vorgeschichte
- N/A
- Andere Medikamente
- Ferplex/No
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- PR
- Alter
- 35,0
- Geschlecht
- F
- Eingang
- 09.02.2022
- Impfdatum
- 19.01.2022
- Beginn
- 19.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site pruritus
Symptomtext
The patient reports that after the vaccine was administered, her right arm itched a lot, which was the one that administered the vaccine. She was evaluated and the medical control was called, who indicated that 50mg of intramuscular BENADRYL be administered. The patient begins to respond beneficially to it and is evaluated every 15 minutes. The patient reports feeling well and leaves the place.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pruritus
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- Dermatitis
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 41,0
- Geschlecht
- F
- Eingang
- 09.02.2022
- Impfdatum
- 13.01.2022
- Beginn
- 04.02.2022
- Tage bis Beginn
- 22,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dizziness
Vertigo
Symptomtext
Patient is experiencing dizziness/vertigo randomly throughout the day resulting in a need to lay down and wait for symptoms to pass. No history of this issue prior to vaccine. Similar symptoms have been experienced by myself as well as my mother all following our booster shot.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- We will be scheduling medical visit as this is recent and becoming more concerning due to increasing frequency.
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- No
- Andere Medikamente
- None
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 44,0
- Geschlecht
- M
- Eingang
- 09.02.2022
- Impfdatum
- 02.01.2022
- Beginn
- 18.01.2022
- Tage bis Beginn
- 16,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pruritus
Symptomtext
On January 18th in the afternoon my head started itching. The following day on January 19th my entire body started itching. I took Benadryl and it caused the itching to stop. The next day on January 20th the same thing happened so I took another Benadryl. I went to see a doctor on January 21st. The doctor attributed my itching to the vaccine. I have been taking an antihistamine since then called Allegra.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- I had covid in the middle of December 2021.
- Vorgeschichte
- Asthma
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 08.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 03.02.2022
- Tage bis Beginn
- 2,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Ear pain
Eye swelling
Fatigue
Injection site pain
Lacrimation increased
Myalgia
Pruritus
Rash
Respiratory tract congestion
Restless arm syndrome
Restless legs syndrome
Swelling
Urticaria
Symptomtext
severe, itchy, swollen hives and rash on right side of face; severe earache and swelling in right ear; sore right shoulder at shot location; general muscle aches, fatigue and congestion; restless limbs; some swelling around right eye and "watery" vision;
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Ear pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- hiatic hernia
- Andere Medikamente
- esomeprazole (nexium) numerous supplements and herbal remedies
- Allergien
- penicillin
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 36,0
- Geschlecht
- F
- Eingang
- 08.02.2022
- Impfdatum
- 28.01.2022
- Beginn
- 06.02.2022
- Tage bis Beginn
- 9,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Urticaria
Symptomtext
PATIENT REPORTED HIVES ABLE TO BE MANAGED WITH BENADRYL
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 07.02.2022
- Impfdatum
- 04.02.2022
- Beginn
- 06.02.2022
- Tage bis Beginn
- 2,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Axillary pain
Lymphadenopathy
Symptomtext
Patient reported axillary swelling and pain about the size of her palm beginning two days after vaccination. This is on the same side as the vaccination. Explained to the patient that this is a known adverse effect of the vaccine and if it does not start to improve as the week progresses that she should be seen by a doctor. Also supplied her with the fact sheets for recipients and providers updated on 1/31/22. Patient reported this on 2/7/22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Axillary pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None Reported
- Vorgeschichte
- None Reported
- Andere Medikamente
- None Reported
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 07.02.2022
- Impfdatum
- 07.02.2022
- Beginn
- 07.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Malaise
Unresponsive to stimuli
Symptomtext
Patient was not feeling well after vaccine administration, and nearly passed out. She was caught by staff before falling, and placed on the floor with legs elevated. 911 was called. She became responsive and stated she felt better. We gave her water, and used ice packs on the back of her head and chest. EMS arrived, and evaluated her. She did not receive additional medical attention.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- N/A.
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- Unknown
- Allergien
- None known
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 44,0
- Geschlecht
- F
- Eingang
- 05.02.2022
- Impfdatum
- 04.02.2022
- Beginn
- 04.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Hypoaesthesia
Induration
Injection site mass
Lymph node pain
Lymphadenopathy
Pruritus
Vision blurred
Symptomtext
Itching. numbness on left side of face and next, this did go away. Lump the size of my palm at injection site and in my armpit at lymph nodes area, very hard and painful. Vision a little blurred, not so crisp.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site mass
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None. I have had Guillain-Barr? as a child.
- Andere Medikamente
- IBU and APAP
- Allergien
- Allergic to shellfish
- Vorherige Impfungen
- guillian barre age 7
- Staat
- NJ
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 05.02.2022
- Impfdatum
- 03.02.2022
- Beginn
- 03.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Fatigue
Headache
Myalgia
Pain in extremity
Symptomtext
Headache, fatigue, very sore arm, muscle aches.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- HBP, cholesterol
- Andere Medikamente
- Simvastin, hydrochlorothiazide, irbesatan, B12, D3, magnesium, zinc, Vit C, COQ10,
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 30,0
- Geschlecht
- F
- Eingang
- 05.02.2022
- Impfdatum
- 28.01.2022
- Beginn
- 05.02.2022
- Tage bis Beginn
- 8,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site swelling
Injection site warmth
Urticaria
Symptomtext
Swelling and raised welt about 5 X 4 inches in diameter on location of shot. Warm-to-touch.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site swelling
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Spironolactone
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 39,0
- Geschlecht
- F
- Eingang
- 05.02.2022
- Impfdatum
- 21.01.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 11,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Mechanical urticaria
Pruritus
Swelling
Symptomtext
I have developed dermatograpghia 11 days after getting the booster shot. It's been 5 days so far that I've had this condition. I did not have this with my first two shots. Symptoms include: skin (anywhere on whole body) that turns red with raised bumps after light touch, itchy skin after that happens. Goes away within 30 minutes if not touched. No other symptoms. Zyrtec taken daily does not help. No treatment has not helped so far.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mechanical urticaria
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Birth control pill, multivitamin, biotin
- Allergien
- Mango
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 50,0
- Geschlecht
- M
- Eingang
- 04.02.2022
- Impfdatum
- 25.01.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 7,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Erythema
Neck pain
Pain
Pain in extremity
Rash
Swelling
Symptomtext
Painful Rash on left forehead. Painful Swollen left neck side. Left 2nd toe has red circle on it and hurts. Body aches and Chills sometimes.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- None yet.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Gout (chronic)
- Andere Medikamente
- Benazepril, Amlodipine, Allopurinol, Atorvastatin
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 20,0
- Geschlecht
- F
- Eingang
- 04.02.2022
- Impfdatum
- 20.01.2022
- Beginn
- 31.01.2022
- Tage bis Beginn
- 11,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Urticaria
Symptomtext
Hives on extremities, scalp and trunk
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 03.02.2022
- Impfdatum
- 25.01.2022
- Beginn
- 25.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Myalgia
Neck pain
Pain
Symptomtext
The pain from left deltoid down to the toes and right hand middle fingers joins are so painful. Two days later the pain extended to the neck pain.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 02.02.2022
- Impfdatum
- 22.01.2022
- Beginn
- 23.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Back pain
Herpes zoster
Incorrect route of product administration
Pain in extremity
Symptomtext
After receiving the immunization the patient was experiencing pain under his left arm and middle of back. The patient returned to the pharmacy stating the immunization was given to high and possibly hit a nerve causing his pain. Patient was refurred to his provider but patient decided to go to emergency room instead. When the patient returned to the pharmacy with presciptions he was diagnosed with shingles.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Back pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- enlarged prostate
- Andere Medikamente
- Tamsulosin 0.4mg, and Finasteride 5.0mg
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 38,0
- Geschlecht
- F
- Eingang
- 02.02.2022
- Impfdatum
- 08.01.2022
- Beginn
- 15.01.2022
- Tage bis Beginn
- 7,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Rash
Symptomtext
Site: Redness at Injection Site-Mild, Systemic: Allergic: Rash Generalized-Medium
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 01.02.2022
- Impfdatum
- 31.01.2022
- Beginn
- 31.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Headache
Pain
Pyrexia
Symptomtext
Fever, chills, body aches, headache
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Long hauler with COVID
- Andere Medikamente
- vitamin D3, Zinc, probiotic
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 50,0
- Geschlecht
- M
- Eingang
- 01.02.2022
- Impfdatum
- 31.01.2022
- Beginn
- 31.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect dose administered
Pain in extremity
Symptomtext
Patient was expecting to receive a Moderna Booster (.25ml) but received a full dose (.5ml) of Moderna. Patient is NOT immunocompromised. Patient had completed pfizer series over 5 months prior. Followed up with patient and he only reported a sore arm.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 47,0
- Geschlecht
- F
- Eingang
- 01.02.2022
- Impfdatum
- 09.01.2022
- Beginn
- 10.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pain
Symptomtext
Site: Pain at Injection Site-Medium
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 34,0
- Geschlecht
- M
- Eingang
- 29.01.2022
- Impfdatum
- 16.01.2022
- Beginn
- 25.01.2022
- Tage bis Beginn
- 9,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Burning sensation
Hypersensitivity
Peripheral swelling
Respiratory viral panel
SARS-CoV-2 test negative
Urticaria
Symptomtext
Allergic reaction causing hives on feet, legs, chest, and neck. Left and right hand swelling. Both hands had severe burning pain.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- Respiratory Pathogen Panel - all came back negative Covid-19 PCR - came back negative
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 28,0
- Geschlecht
- M
- Eingang
- 28.01.2022
- Impfdatum
- 08.01.2022
- Beginn
- 24.01.2022
- Tage bis Beginn
- 16,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Laboratory test normal
Pain
Pruritus
Rash
Skin burning sensation
Urticaria
Vitamin D decreased
Symptomtext
Severe skin rash- red, itchy , welts , burning and pain . Antihistamine ( Claritin Zyrtec and Benadryl )
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- Lab results are normal. Low vitamin D
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- n/a
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 34,0
- Geschlecht
- F
- Eingang
- 28.01.2022
- Impfdatum
- 28.01.2022
- Beginn
- 28.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pruritus
Symptomtext
patient reported feeling itchy all over 15 minutes after receiving the vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- none at this time
- Aktuelle Erkrankungen
- none reported
- Vorgeschichte
- none reported
- Andere Medikamente
- none reported
- Allergien
- allergy to Benadryl, penicillin, nystatin, ampicillin, steotomycin
- Vorherige Impfungen
- patient's face started swelling up and had rashes on her back 40 minutes after the vaccination. First dose of COVID (moderna)
- Staat
- MO
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 28.01.2022
- Impfdatum
- 24.01.2022
- Beginn
- 24.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Immediate post-injection reaction
Injection site discolouration
Injection site erythema
Injection site haemorrhage
Injection site swelling
Symptomtext
Immediately after injection, the injection site started profusely bleeding. The area of the injection immediately swelled and became hard and turned a purplish color. The patient said they were not experiencing pain. It is assumed that a vein was hit when injecting the vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site discolouration
- Hospital-Tage
- -
- Labordaten
- Unknown
- Aktuelle Erkrankungen
- Back pain
- Vorgeschichte
- Unknown
- Andere Medikamente
- Unknown
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 28.01.2022
- Impfdatum
- 24.01.2022
- Beginn
- 01.01.2022
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Back pain
Chills
Cough
Sinusitis
Symptomtext
lower back and up to shoulder were killing me/hurting/Back pain; shoulder were killing me; Chills; Started coughing, coughed and cough and it wouldn't let up; Sinus were just draining; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Started coughing, coughed and cough and it wouldn't let up), SINUSITIS (Sinus were just draining), BACK PAIN (lower back and up to shoulder were killing me/hurting/Back pain), ARTHRALGIA (shoulder were killing me) and CHILLS (Chills) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 vaccination. The patient's past medical history included Hyperthyroidism (being treated in the past for hyperthyroidism). Concomitant products included METOPROLOL SUCCINATE (TOPROL XL) and CICLOPIROX for an unknown indication. On 24-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2022, the patient experienced COUGH (Started coughing, coughed and cough and it wouldn't let up), SINUSITIS (Sinus were just draining) and CHILLS (Chills). On 24-Jan-2022, the patient experienced BACK PAIN (lower back and up to shoulder were killing me/hurting/Back pain) and ARTHRALGIA (shoulder were killing me). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) for Adverse event, at a dose of Tylenol around 10pm. and Bed rest (Laid down got some relief) for Back pain. At the time of the report, COUGH (Started coughing, coughed and cough and it wouldn't let up) had not resolved, SINUSITIS (Sinus were just draining) and ARTHRALGIA (shoulder were killing me) outcome was unknown and BACK PAIN (lower back and up to shoulder were killing me/hurting/Back pain) and CHILLS (Chills) was resolving. Sinus were just draining went through a whole box of Kleenex. This case was linked to MOD-2022-461617, MOD-2022-461572 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Hyperthyroidism (being treated in the past for hyperthyroidism.)
- Andere Medikamente
- TOPROL XL; CICLOPIROX.
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 27.01.2022
- Impfdatum
- 13.01.2022
- Beginn
- 13.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood urine present
Chills
Dysmenorrhoea
Fatigue
Intermenstrual bleeding
Pyrexia
Symptomtext
Caller took the vaccine on January the 13th and 12:30 pm and within an hour she started to have symptoms. Symptoms: Spotting, chills, fever of 101, extreme fatigue, stayed in bed for 3 days, has not felt right since that day and has blood in her urine and is having period pains.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- No test have been made.
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Diabetes
- Andere Medikamente
- Medication for type 2 diabetes.
- Allergien
- N/A
- Vorherige Impfungen
- Caller took the Pfizer vaccine as her first dose on 02/15/2021, she was 56, her symptoms, fever of 102, difficulty breathing, ch
- Staat
- MI
- Alter
- 47,0
- Geschlecht
- F
- Eingang
- 27.01.2022
- Impfdatum
- 11.01.2022
- Beginn
- 14.01.2022
- Tage bis Beginn
- 3,0
- Dosis
- 3
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Ear pruritus
Nasal congestion
Nasal pruritus
Skin fissures
Symptomtext
A few days after I noticed my ears and nose were itching quite a bit. One day I noticed my left nostril was swollen. It felt really weird. Then the skin where my two nostrils and lip meet had split. So I started taking a antibiotic (Clarithromycin 500mg) I had at home and made an appointment with my Doctor. He told me to continue taking the antibiotic and prescribed me a cream (Mupirocin) for the split. The nose swelling has decreased but it is still a little swollen now. It doesn't hurt like it used to.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Ear pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- 1 a day vitamin 500mg Vitamin C Once a week Blood Builder Magnesium Vitamin D
- Allergien
- Sulfa Products
- Vorherige Impfungen
- The 1st Moderna Vaccination 03/21/2021 - The day after I threw up and was nauseated and couldn't hold anything down for three da
- Staat
- UT
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 27.01.2022
- Impfdatum
- 24.01.2022
- Beginn
- 25.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Feeling abnormal
Headache
Hyperhidrosis
Lymph node pain
Lymphadenopathy
Pain
Symptomtext
headache, chills, sweats, aches, generally felt horrible - this lasted two days lingering - swollen and sore gland in armpit
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- arthritis, peripheral neuropathy, cellulitis (hasn't reappeared in 3 years)
- Andere Medikamente
- estridiol, gabapenten, avorvastin, pantoprazolee Lenothyroxine, mutivitamin, vit D, calcium
- Allergien
- None
- Vorherige Impfungen
- headache, chills, sweats, aches
- Staat
- TX
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 26.01.2022
- Impfdatum
- 24.01.2022
- Beginn
- 25.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Back pain
Pain
Peripheral swelling
Pyrexia
Rash
Rash erythematous
Swelling
Symptomtext
Fever for 28 hours of 102+ entire time, next morning, woke up to left side of body swollen especially on the left arm down to mid back with red rash all over trunk area including behind ears and neck. Radiating pain from left shoulder down to lower back left side.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- VT
- Alter
- 19,0
- Geschlecht
- F
- Eingang
- 26.01.2022
- Impfdatum
- 24.01.2022
- Beginn
- 24.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- SYR / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Contusion
Feeling cold
Headache
Hot flush
Vomiting
Symptomtext
upon going to be had severe hot and cold flashes followed by head ache. Lasted all night long. Threw up in the early morning of the Jan. 25, 2022 and again that same afternoon. Arm has lots of bruising. Threw up again today Jan. 26, 2022 in the am, before 8:00 am
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- IUD
- Allergien
- none
- Vorherige Impfungen
- the first two doses of the Covid-19 vaccines
- Staat
- WA
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 25.01.2022
- Impfdatum
- 21.01.2022
- Beginn
- 21.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site bruising
Injection site erythema
Injection site swelling
Injection site warmth
Symptomtext
Patient called on 1/24/2022. She stated she had a bruised, swollen, raised and hot injection site. She also was concerned about the depth and location of the injection (too deep and too high) on the phone. She came in later the same day and the pharmacist looked at the site. The pharmacist stated that it was swollen, red, and bruised, but appeared to be in a normal position and a common response to a vaccination in their opinion. Patient also saw her doctor later that day about the reaction, and per the patient, the doctor said to watch it and see if it improves.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site bruising
- Hospital-Tage
- -
- Labordaten
- Unknown
- Aktuelle Erkrankungen
- None Reported
- Vorgeschichte
- None Reported
- Andere Medikamente
- Unknown
- Allergien
- None Reported
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 25.01.2022
- Impfdatum
- 18.01.2022
- Beginn
- 18.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Malaise
Neck pain
Symptomtext
pt said he had chills, not feeling well at all as well as neck pain for 7 days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 25.01.2022
- Impfdatum
- 23.01.2022
- Beginn
- 23.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Fatigue
Muscle swelling
Myalgia
Nausea
Oedema peripheral
Pyrexia
Tenderness
Symptomtext
Shot at 11:30am on 1/23/2022 Symptoms Began ~ 8:30pm - Slight Fever, Fatigue, Tiredness, slight nausea (never vomited) 3:00am more symptoms (chills) By morning ~9am (1/24/2022) I noticed tenderness and slight swelling of the armpit/pectoral area of the arm the shot was administered. Symptom of Fatigue has also continued on the day of 1/24/2022. 1/25/2022 ~12:30pm - still experiencing tenderness and swelling of armpit/pectoral area
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Asthma
- Andere Medikamente
- None
- Allergien
- Penicillin
- Vorherige Impfungen
- Fatigue, Chills, Nausea, fever, headache, arm soreness. Occurred following both 1st Dose & 2nd Dose of Moderna Covid-19 Vaccine
- Staat
- PA
- Alter
- 47,0
- Geschlecht
- F
- Eingang
- 24.01.2022
- Impfdatum
- 14.01.2022
- Beginn
- 15.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Axillary pain
Chills
Decreased appetite
Fatigue
Headache
Injection site erythema
Injection site pain
Injection site pruritus
Injection site rash
Injection site reaction
Injection site swelling
Injection site warmth
Limb discomfort
Lymphadenopathy
Nausea
Pain in extremity
Pyrexia
Symptomtext
01/15/2022: Injection site reaction - rash around injection developed and became increasingly larger each day through 01/21/2022. The area was about the surface size of an orange and was red, hot, painful, circular, swollen, itchy, and heavy feeling. I also developed swelling and pain in my armpit area to the level that it made it hard to rest my arm against my body. This all continued, and my whole arm began to feel painful down to the tips of my fingers with a great feeling of heaviness. As of today, 01/24/2022, the redness has somewhat faded, but it is still warm, swollen, itchy, and heavy feeling with a "fluttering" feeling in my arm. 01/15/2022: General health - developed a fever (102 at highest point), chills, fatigue, nausea, loss of appetite, headache with symptoms progressively getting better each day after.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Axillary pain
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Synthroid, Buproprion, Esomeprazole, multi-vitamin
- Allergien
- Pertussis vaccination
- Vorherige Impfungen
- Extreme spike in white blood cell count, around 10-11 yrs old, unknown date, Pertussis vaccination
- Staat
- CO
- Alter
- 20,0
- Geschlecht
- F
- Eingang
- 23.01.2022
- Impfdatum
- 17.01.2022
- Beginn
- 18.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Abdominal pain upper
Chills
Headache
Nausea
Pain
Pyrexia
Vomiting
Symptomtext
High fever, body aches, chills, stomach pain, headache, nausea/vomiting
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal pain upper
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- Urinary Tract Infection
- Vorgeschichte
- None
- Andere Medikamente
- Nitrofurantion 100mg bid
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 27,0
- Geschlecht
- F
- Eingang
- 22.01.2022
- Impfdatum
- 21.01.2022
- Beginn
- 21.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Erythema
Hypersensitivity
Pruritus
Urticaria
Symptomtext
27 Y.O female was received Moderna Booster vaccine lot# 084J21A on 1/21/2022 at 1720. Patient started having hives, redness on her neck and chest area. Patient complained of itching on her upper chest area and her left arm. Denied shortness of breath. Benadryl 50mg/1ml IM to right deltoid muscle was given. No adverse reaction noted. at 1740 patient's BP was 150/85 HR 77. 911 services was offered to the patient due having continued redness on her chest area. Patient refused the service. Educated regarding allergic reactions to seek emergency services if reaction persist. Patient released to a care of a family member.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 22.01.2022
- Impfdatum
- 13.01.2022
- Beginn
- 15.01.2022
- Tage bis Beginn
- 2,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Confusional state
Pruritus
Rash pruritic
Symptomtext
also experiencing itches on gluteus and elbows; patient feels confused; itchy rash appeared on her legs, on the outside of the thighs; slight itching in her legs and back; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (slight itching in her legs and back), RASH PRURITIC (itchy rash appeared on her legs, on the outside of the thighs), PRURITUS (also experiencing itches on gluteus and elbows) and CONFUSIONAL STATE (patient feels confused) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 vaccination. Concurrent medical conditions included Diabetes, Blood pressure high and Candida infection. Concomitant products included LISINOPRIL for Blood pressure high, METFORMIN for Diabetes. On 13-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2022, the patient experienced PRURITUS (slight itching in her legs and back). On 16-Jan-2022, the patient experienced RASH PRURITIC (itchy rash appeared on her legs, on the outside of the thighs). On an unknown date, the patient experienced PRURITUS (also experiencing itches on gluteus and elbows) and CONFUSIONAL STATE (patient feels confused). At the time of the report, PRURITUS (slight itching in her legs and back), RASH PRURITIC (itchy rash appeared on her legs, on the outside of the thighs), PRURITUS (also experiencing itches on gluteus and elbows) and CONFUSIONAL STATE (patient feels confused) had not resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient reported that she is not sure about what caused rash, because she explained started taking a naturopathic pills for Candida around the same time as the booster, but she stop medication when she noticed about rash. No treatment has been given. This case was linked to MOD-2022-456397 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Blood pressure high; Diabetes.
- Vorgeschichte
- Medical History/Concurrent Conditions: Candida infection.
- Andere Medikamente
- METFORMIN; LISINOPRIL.
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 20,0
- Geschlecht
- M
- Eingang
- 21.01.2022
- Impfdatum
- 18.01.2022
- Beginn
- 19.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Insomnia
Keratosis pilaris
Pain in extremity
Peripheral swelling
Pyrexia
Symptomtext
I received the J&J vaccine back in March of 2021 and actually went to the ER due to an extremely high fever. A few days ago, I received the Moderna booster and once again had an extremely high fever of 101+, accompanied by excruciating pain in my right arm upon waking up the day after. At the end of that day, the 19th, my fever had felt like it was mostly gone however I was still left with extreme pain in my arm. Now, at 5 AM on the 21st, unable to sleep due to the pain in my arm that is now particularly swollen with a large red area on it along with "chicken skin", I am not having the greatest time. I plan on going and getting it looked at later today.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Strep Throat, Asymptomatic COVID
- Vorgeschichte
- -
- Andere Medikamente
- Tylenol and Ibuprofen
- Allergien
- Amoxicillin/Penicillin
- Vorherige Impfungen
- J&J COVID Vaccine
- Staat
- CO
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 20.01.2022
- Impfdatum
- 24.06.2021
- Beginn
- 27.06.2021
- Tage bis Beginn
- 3,0
- Dosis
- 3
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site erythema
Injection site pruritus
Injection site swelling
Injection site warmth
Symptomtext
On the 3rd day 6/27/2021 my injection site was feverish, red, itchy and swollen and covered my whole upper arm. This lasted for 3 to 4 days. I took generic Benadryl, ice packs and hydrocortisone cream until it subsided. On January 19, 2022 the booster (3) vaccine (received on 9/17/2022) same reaction has done the same but not as severe.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- psoriases
- Andere Medikamente
- -
- Allergien
- adhesives/tapes
- Vorherige Impfungen
- -
- Staat
- NH
- Alter
- 50,0
- Geschlecht
- F
- Eingang
- 20.01.2022
- Impfdatum
- 16.01.2022
- Beginn
- 18.01.2022
- Tage bis Beginn
- 2,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pruritus
Injection site reaction
Injection site swelling
Injection site warmth
Limb discomfort
Rash macular
Symptomtext
On Monday, Jan 17, I had slight warmth and swelling at the injection site on my right arm. By evening, it was quite warm, and the skin felt very tight. It began to itch. On Tuesday, Jan 18, my arm was hot to the touch, visibly swollen, and had a splotchy redness unevenly around the injection site. It was itching a little more. On Wednesday, Jan 19, my arm continued to be hot to the touch and visibly swollen, though the redness had gone down slightly. The itching was more intense, and I used an off brand version of Benadryl Itch Relief Spray paired with ice packs on the injection site. This brought a lot of relief. Today, Jan. 20, it is still hot to the touch, but the swelling has gone down considerably, and only a small (quarter size) amount of red blotchiness remains. The itch is still intense, and I am continuing to use ice packs and the itch spray for relief. I had no fever throughout this event. I had normal (for me) aches and pains in my joints.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pruritus
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- None.
- Vorgeschichte
- Exercise-induced asthma, well controlled. Obese (BMI 31)
- Andere Medikamente
- Buspirone 15mg, 2 x a day Loratadine 10mg, 1 x a day Acidophilus 1 billion CFU 1x a day Fish Oil 1000mg 1 x a day One a Day 50+ 1 x a day Sertraline 50mg 1x a day
- Allergien
- Allergic to penicillin and derivatives (anaphylaxis) Sensitivity to tetracycline and erythromycin (stomach upset) Sensitivity to scallops
- Vorherige Impfungen
- Moderna 2nd shot (037C21A), 05/20/21, right arm. Same reaction, beginning a few days after injection and continuing for a full w
- Staat
- -
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 20.01.2022
- Impfdatum
- 19.01.2022
- Beginn
- 20.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Dizziness
Dysarthria
Hyperventilation
Somnolence
Symptomtext
Patient felt light headed when she sat down in observation after receiving her Moderna Booster. BP elevated 173/115, continued to be elevated on repeat. HR 92 O2sat 99%. Pt hyperventilating at times, trouble keeping eyes open, slurred speech. EMS called, EMS brought pt to Hospital. Staff called patient 1/20/22 she reported she is feeling much better, no interventions in ED, they just monitored her and discharged her after 4 hours.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none per pt
- Vorgeschichte
- HTN
- Andere Medikamente
- Blood pressure pills, name unknown
- Allergien
- none per pt.
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 19.01.2022
- Impfdatum
- 15.01.2022
- Beginn
- 16.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Burning sensation
Lymphadenopathy
Mass
Rash
Symptomtext
Patient had Rash and LUMP ON LEFT CLAVICAL AREA, She was diagnosed with LYMPHADENOPATHY. She noted the next morning of vaccine, had some burning sensation. She has to follow up the doctor in 3 to 4 days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Taking medicines for high blood pressure, cholesterol, and depression.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 35,0
- Geschlecht
- F
- Eingang
- 19.01.2022
- Impfdatum
- 18.01.2022
- Beginn
- 18.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Anxiety
Chills
Dizziness
Fatigue
Flushing
Headache
Hyperhidrosis
Symptomtext
CLIENT BECAME LIGHTHEADED 15' POST VACCINATION. 12:00PM PRESENTED WITH MILD DIAPHORESIS AND FEELING LIGHTHEADED AND FAINT. SHE BECAME FLUSHED AND REPORTED CHILLS AND FATIGUE. HR54, R99% SAT, BP 130/70. 12:10 HR 57, R 96%, BP 108/72. 12:30 HR 64, R 96%, BP 122/70. SHE RESTED ON A COT FOR 45-50 MINUTES. NO MEDICATION GIVEN. SHE REPORTED A HEADACHE AT 12:15 BUT STATED THATS TYPICAL FOR HER. ABLE TO STAND AND WALK TO RR @ 12:50 WITHOUT DIFFICULTY. RECEIVED SNACKS @1:15 AND REPORTED FEELING BETTER WITH FOOD AND STATED SHE THINKS HER BS WAS LOW AND CAUSING INCREASED ANXIETY. RETURNED TO REST ON COT FROM 1-1:30PM. SHE WAS ABLE TO LEAVE AFTER FEELING MUCH BETTER AND REPORTED OK TO LEAVE.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- STATED ANXIETY
- Vorgeschichte
- ANXIETY
- Andere Medikamente
- PROPRANALOL, WELLBUTRIN, VALIUM, PRESTIQ, AMANTIDINE, THYROXINE, PROVIGIL, SUNOSI.
- Allergien
- NO
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 19.01.2022
- Impfdatum
- 16.01.2022
- Beginn
- 17.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Discomfort
Injection site erythema
Injection site pain
Injection site warmth
Symptomtext
injection site red, burning, hot to touch, growing area starting 1 day after immunization
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 34,0
- Geschlecht
- M
- Eingang
- 19.01.2022
- Impfdatum
- 19.01.2022
- Beginn
- 19.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Peripheral swelling
Rash
Rash erythematous
Rash pruritic
Symptomtext
Swelling of left forefingers, itchy red rash on back of hand. Took oral benedryl on onset of symptoms. Symptoms resolving
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- N/a
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Fibromyalgia, arthritis, arthritis-mediated gout, asthma
- Andere Medikamente
- Qvar, testosterone 1% gel, albuterol as needed
- Allergien
- Tramadol, flu/pneumonia dual vaccine
- Vorherige Impfungen
- Flu/pneumonia combined vaccine
- Staat
- AL
- Alter
- 48,0
- Geschlecht
- F
- Eingang
- 19.01.2022
- Impfdatum
- 18.01.2022
- Beginn
- 19.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Injection site pain
Lymphadenopathy
Pain
Symptomtext
In addition to pain at the injection site, the gland on the left side of my body by my collarbone has swollen considerably (size of an egg) and is very painful.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- birth control, multi-vitamin, tylenol
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 50,0
- Geschlecht
- M
- Eingang
- 19.01.2022
- Impfdatum
- 06.01.2022
- Beginn
- 06.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Headache
Symptomtext
Systemic: Dizziness / Lightheadness-Medium, Systemic: Headache-Mild
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 34,0
- Geschlecht
- M
- Eingang
- 18.01.2022
- Impfdatum
- 04.01.2022
- Beginn
- 05.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Myalgia
Pyrexia
Sleep disorder
Symptomtext
Fever, chills, muscle aches. Severe enough to keep me up all night. Unsure of temperature. Lasted for about 16 hours
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Smoker
- Andere Medikamente
- Adderall IR 15mg 3-4 times daily Vitamin D and vitamin K supplements
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- HI
- Alter
- 26,0
- Geschlecht
- M
- Eingang
- 18.01.2022
- Impfdatum
- 17.01.2022
- Beginn
- 18.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Headache
Lethargy
Pain
Photophobia
Pyrexia
Symptomtext
Fever, aches, pains, lethargic, headache and light sensitivity.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Allegra
- Allergien
- Allergies
- Vorherige Impfungen
- Similar problems, but with nausea added; 25; May 26, 2021; Moderna second shot.
- Staat
- WA
- Alter
- 42,0
- Geschlecht
- M
- Eingang
- 18.01.2022
- Impfdatum
- 03.01.2022
- Beginn
- 05.01.2022
- Tage bis Beginn
- 2,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Back pain
Tenderness
Symptomtext
Constant tenderness and achiness in back (left-side) below the ribs.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Back pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None.
- Vorgeschichte
- None.
- Andere Medikamente
- None.
- Allergien
- None.
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 18.01.2022
- Impfdatum
- 14.01.2022
- Beginn
- 15.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Diarrhoea
Dizziness
Feeling abnormal
Injection site induration
Injection site swelling
Injection site warmth
Insomnia
Nausea
Pain
Pruritus
Symptomtext
I woke the next day and I could feel the injection site on my arm was swollen hard & hot. I also felt nauseous & achy. I felt worse that night & my arm was itchy. I begin to get nerve pings all over, I had trouble sleeping & I had to use the restroom numerous times that night. The next morning the swelling in my arm got larger but my arm was itching real bad. So Monday morning the spot was swollen even more & I felt lightheaded & foggy, so I called my Dr. & she advised me to put hydrocortisone cream on the swollen arm & take Tylenol & ice it down. Currently my arm is still a little swollen & I am starting to feel better
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- Gastroes0phogeal, Generalized Anxiety Disorder
- Andere Medikamente
- Prozac, Meloxicam, Omeprazole, Reglan, Buspar, Benadryl, Ziac
- Allergien
- NONE
- Vorherige Impfungen
- FLU SHOT
- Staat
- VA
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 17.01.2022
- Impfdatum
- 05.01.2022
- Beginn
- 08.01.2022
- Tage bis Beginn
- 3,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Pruritus
Symptomtext
patient complains of red hands and itchy leg. went to dr and received prescriptions for benadryl, triamcinolone cream and prednisone
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- transplant patient
- Andere Medikamente
- ibandronate, humulin, lumigan, pantoprazole, tacrolimus, mycophenolate, dicyclomine
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 17.01.2022
- Impfdatum
- 12.01.2022
- Beginn
- 12.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Pain
Symptomtext
Patient had only slight body ache for 2 days after vaccine was administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- scoliosis of thoracic spine, major depression, Dysmenorrhea
- Andere Medikamente
- Fluoxetine, 20mg Cryselle28 30mcg-0.3mg, topiramate 25mg,
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 29,0
- Geschlecht
- F
- Eingang
- 17.01.2022
- Impfdatum
- 05.01.2022
- Beginn
- 15.01.2022
- Tage bis Beginn
- 10,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Insomnia
Mechanical urticaria
Pain
Pruritus
Urticaria
Symptomtext
Extremely itchy all over body. Breaking out all over the body in hives. Experiencing dermatographia. Never had an allergic reaction to anything before, and no family history of anything like this. Difficulty sleeping because I am in so much pain. Took benadryl but symptoms are not going away. Hesitant to take prednisone because I am only a few weeks into my pregnancy.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mechanical urticaria
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 16.01.2022
- Impfdatum
- 14.01.2022
- Beginn
- 15.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Arthralgia
Symptomtext
Patient complains of severe joint pain to the point where the patient can't go up or down stairs or get dressed without assistance.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- Penicillins
- Vorherige Impfungen
- Patient had a similar reaction (joint pain) to the first dose of the Moderna COVID19 vaccine (12/13/2021) but not as severe.
- Staat
- IL
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 16.01.2022
- Impfdatum
- 08.01.2022
- Beginn
- 10.01.2022
- Tage bis Beginn
- 2,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Urticaria
Vaccine positive rechallenge
Symptomtext
2 Days after the shot I got hives on my arm. I have had chronic hives since my last Moderna vaccine in Feb. 2021. I am taking 2 Allegra, 2 Pepcid and 1 Claritan to control my hives. I was hive free for 2 weeks with these medicines, but have had hives again since getting my Booster shot. The hives aren't as widespread as before, I am assuming the antihistamines I am taking are helping keep them under control. I always get my hives at night after sitting or laying down so I think they are caused from heat and/or pressure. I have gotten hives after all 3 shots so I am assuming there is a connection to the vaccines.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- I did have a cold from Dec. 20 - Dec. 25 - I did get tested and was negative.
- Vorgeschichte
- I have had chronic (pretty much daily) hives since my 2nd Covid Vaccine on 02/27/2021. I started taking 2 Allegra per day in August, added in 2 Pepcid per day in early Nov. and then added 1 Claritan a day around Dec. 20. This combination finally helped and I was hive free for 2 weeks before getting my Moderna Booster Shot on Jan. 8, 2022. My hives came back on Mon. Jan. 10, but aren't as widespread as before. I am still taking the 2 antihistamine medications.
- Andere Medikamente
- Atorvastatin 20 mg, Escitalopram 10 mg, Hydrochlorothiazide 12.5, Bupropian HCL XL 300 mg, NP Thyroid 60 mg (2) Allegra 180 mg, (2) Famotidine 20 mg, and 1 Claritan 10 mg/ day to control the chronic hives that I have had since my 2nd Moder
- Allergien
- -
- Vorherige Impfungen
- I have had chronic hives since my 2nd Moderna Covid Vaccine. I was 51 when I got the vaccine on Feb. 27,2021
- Staat
- CA
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 14.01.2022
- Impfdatum
- 14.01.2022
- Beginn
- 14.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Diarrhoea
Vomiting
Symptomtext
Patient's daughter called the pharmacy back roughly 3 hours post-vaccination stating that the patient was experiencing diarrhea and vomiting. These could be possible side effects from vaccination, or they could be unrelated. Either way, I felt it was important to report this event. I counseled the patient's daughter on the importance of hydration while experiencing diarrhea/vomiting and recommended a trip to the ER if the patient cannot tolerate fluids or appears to be dehydrated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Renal abnormalities (1 kidney)
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 14.01.2022
- Impfdatum
- 08.01.2022
- Beginn
- 11.01.2022
- Tage bis Beginn
- 3,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pain
Injection site reaction
Injection site swelling
Injection site warmth
Pruritus
Skin swelling
Symptomtext
1/11 Woke up itch and a small puffy area that was warm to the touch at the injection site. Put ice and took Tylenol to help with swelling and pain. 1/12 Woke up with worsening situation. Put some hydrocortisone and ice to help. Called Dr. office and was advised to continue treatment and if it gets any worse, schedule an appt. 1/13 This time it looked mean and was six inches wide and four inches across. And at that time called doctor and tried to get a doctor to looked at it. Went to pharmacy where I got the shot and was advised the same. Wrapped in bandage to prevent scratching it and it helped. 1/14 Telehealth with doctor and she prescribed some antibiotics and steroid cream. Will see doctor again on the 1/20 for follow-up and check-up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- 1/14 Physical only. No Test or Labs as of yet.
- Aktuelle Erkrankungen
- Bronchitis
- Vorgeschichte
- Diabetes type 2; Seasonal Allergies; Arthritis; Psoriatic Arthritis
- Andere Medikamente
- Metformin; Atorvastatin; Glimepiride; Losartan; Pantoprazole; Aspirin; Elderberry chewable; One-a-Day women's 50+ gummy; Nutrition Essentials Probiotic; Chamomile
- Allergien
- Jardiance; crab
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- 31,0
- Geschlecht
- F
- Eingang
- 13.01.2022
- Impfdatum
- 10.01.2022
- Beginn
- 10.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pain in extremity
Symptomtext
Patient reported sharp pain from elbow down to wrist since 36-48 hours post vaccine. Pain unchanged by Motrin/Tylenol use. I suggested a topical lidocaine-containing OTC product with continued Motrin/Tylenol use. If still unchanged, I suggested to visit PCP.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 13.01.2022
- Impfdatum
- 10.01.2022
- Beginn
- 11.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Axillary pain
Cough
Oropharyngeal pain
Pain in extremity
Symptomtext
Soreness on arm seemed to wrap around under arm and armpit. Sore throat, cough
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Axillary pain
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- Had a cold or flu in December
- Vorgeschichte
- Fibromyalgia
- Andere Medikamente
- Hydroxychloroquine 200mg 1xday Methylphenidate 18mg 1xday Tizanidine 4mg 1xday Trazodone 150mg 1xday Wellbutrin 75mg 2x day Clonazepam 0.05mg 1/2 tab day Pioglitazone 15mg 1/2 tab day Folic Acid 1mg 1xday Levothyroxine 0.05mcg 1xday D3 5,0
- Allergien
- Sulfa Iodine as contrast Quetiapine
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 49,0
- Geschlecht
- M
- Eingang
- 13.01.2022
- Impfdatum
- 10.01.2022
- Beginn
- 12.01.2022
- Tage bis Beginn
- 2,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Immediate post-injection reaction
Injection site induration
Injection site pain
Injection site pruritus
Injection site rash
Injection site reaction
Injection site warmth
Musculoskeletal stiffness
Rash erythematous
Symptomtext
I received a standard injection for my booster shot in my upper right arm. The day after the booster shot the muscle region immediately underneath the injection site was very firm and sore. The soreness gradually went away after about 36 hours while the stiffness persisted. A large red rash also began to appear on the skin of the upper right arm under the injection site. Its dimensions are about 4 inches across and 3 inches in height in a roughly oval configuration. It is warm to the touch, slightly itchy, has some red bumps on the skin, and a large red patch with the dimensions mentioned. I did not have any such reaction - nor any other side effect - after my first two doses in March and April 2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site induration
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Epilepsy
- Andere Medikamente
- Various vitamins and amino acids, along with prescription pain killers and blood pressure medication
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- 45,0
- Geschlecht
- F
- Eingang
- 12.01.2022
- Impfdatum
- 08.01.2022
- Beginn
- 09.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Body temperature increased
Eye irritation
Feeling abnormal
Headache
Lymphadenopathy
Nausea
Pain
Vision blurred
Symptomtext
Temperature of 103, excruciating body pain, nausea, swollen lympnodes in neck and under armpit on left side, unbearable headache, burning eyes, blurry vision, mental fog
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Reflux
- Andere Medikamente
- Estradiol Omeprazole Zinc Vitamin C and D
- Allergien
- Fentanyl
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 41,0
- Geschlecht
- M
- Eingang
- 12.01.2022
- Impfdatum
- 11.01.2022
- Beginn
- 11.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Headache
Injection site pain
Nausea
Symptomtext
I had a bad headache, felt like throwing up so I went to bed. and then I had chills overnight in addition to the other 2 symptoms. My arm is tender at injection site but not bad.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Psoriasis
- Andere Medikamente
- Otezla
- Allergien
- -
- Vorherige Impfungen
- Headache and exhaustion 1st time, Headache and chills and exhaustion 2nd time, 41, 3/30/21 and 5/4/21, COVID-19,Moderna
- Staat
- OH
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 11.01.2022
- Impfdatum
- 04.01.2022
- Beginn
- 06.01.2022
- Tage bis Beginn
- 2,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blister
Pain
Pruritus
Rash
Symptomtext
Spreading rash with blistering, itching and pain to right inner forearm
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- High blood pressure
- Andere Medikamente
- HCTZ, Excedrin Migraine
- Allergien
- Latex, sulfa, folic acid,, Zyrtec, Potassium Clavulanate
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 09.01.2022
- Impfdatum
- 06.01.2022
- Beginn
- 07.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Dizziness
Dry mouth
Headache
Nausea
Pain
Symptomtext
I felt extremely dizzy, nauseous and had body aches especially in legs. I had chills but no fever. Mouth extremely dry. Slight headache but not as severe as first dose where I had a miserable migraine for an entire day. Arm extremely sore with large bump at site of vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Vennaflaxen 150mg
- Allergien
- None
- Vorherige Impfungen
- Moderna
- Staat
- IL
- Alter
- 24,0
- Geschlecht
- F
- Eingang
- 05.01.2022
- Impfdatum
- 05.01.2022
- Beginn
- 05.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Anxiety
Blood pressure decreased
Feeling hot
Malaise
Symptomtext
Patient got Moderna COVID-19 vaccine dose #1. Few minutes later, she was not feeling well. She indicated she was feeling uneasy and hot. I advised her to lay down on the bench and put her feet up. At that point, we checked her BP. It was 77/47. Then we gave her ice packs to put on her cheek and feet. She said that ice packs are helping her. We took second BP reading and it was 99/60. We also took a 3rd BP reading 5 minutes later and it was 108/79. At this point, she was feeling lot better. We asked her to stay under our observation for additional 30 minutes, which she did. She indicated she does not have PCP.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Malaise
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 50,0
- Geschlecht
- F
- Eingang
- 10.08.2023
- Impfdatum
- 08.01.2022
- Beginn
- 13.01.2023
- Tage bis Beginn
- 370,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Hypersensitivity
Symptomtext
ALLERGIC REACTION, INIT
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypersensitivity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 50,0
- Geschlecht
- F
- Eingang
- 10.08.2023
- Impfdatum
- 09.01.2022
- Beginn
- 26.02.2023
- Tage bis Beginn
- 413,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Insomnia
Obstructive sleep apnoea syndrome
Sleep apnoea syndrome
Symptomtext
INSOMNIA W SLEEP APNEA ADULT OBSTRUCTIVE SLEEP APNEA, MILD
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Insomnia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 82,0
- Geschlecht
- M
- Eingang
- 29.06.2023
- Impfdatum
- 10.01.2022
- Beginn
- 04.12.2022
- Tage bis Beginn
- 328,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Breakthrough case admission after 3 vaccines Moderna 2/9/21 Lot# 007M20A; Moderna 3/9/21 no lot#; MOderna 1/10/22 lot# 084J21A
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- COVID +
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 30.03.2023
- Impfdatum
- 17.01.2022
- Beginn
- 25.10.2022
- Tage bis Beginn
- 281,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Breakthrough case admission after 3 vaccines ; Moderna 3/1/21 Lot# 010A21A; Moderna 3/29/21 Lot# 018B21A; Moderna 1/17/22 Lot# 084J21A
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- COVID+
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 28.02.2023
- Impfdatum
- 08.01.2022
- Beginn
- 05.08.2022
- Tage bis Beginn
- 209,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Breakthrough case admission after three vaccines Moderna 3/18/21 Lot# 006B21A; Moderna 4/15/21 Lot# 043B21A; Moderna 1/8/22 Lot# 084J21A
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- COVID +
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- HI
- Alter
- 42,0
- Geschlecht
- F
- Eingang
- 24.02.2023
- Impfdatum
- 18.02.2022
- Beginn
- 01.05.2022
- Tage bis Beginn
- 72,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Proctalgia
Rectal spasm
Symptomtext
After my 3rd vaccine I started experiencing severe rectal pain. I was diagnosed with rectal spasms and prescribed nitroglycerin cream. I feel that I have recovered at this time.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Proctalgia
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Aceclidine; chronic asthma; acne; restless leg syndrome; rhinitis
- Andere Medikamente
- Ropinirole; magnesium; melatonin; ALERTEC; HUMIRA; omeprazole; albuterol; valacyclovir; tretinoin; clindamycin solution
- Allergien
- Sulfa; shrimp; shellfish
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 28,0
- Geschlecht
- F
- Eingang
- 14.02.2023
- Impfdatum
- 09.02.2022
- Beginn
- 09.11.2022
- Tage bis Beginn
- 273,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
COVID-19
Ultrasound scan
Vaccination failure
Symptomtext
I was diagnosed with Covid on 09Nov2022; I was diagnosed with Covid on 09Nov2022; This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient. A 29-year-old female patient received BNT162b2 (BNT162B2), on 30Jun2021 as dose 1, single (Lot number: EW0187), on 22Jul2021 as dose 2, single (Lot number: EW0187) and on 09Feb2022 as dose 3 (booster), single (Lot number: 084J21A) at the age of 28 years for covid-19 immunisation. The patient's relevant medical history included: "Bipolar II disorder" (unspecified if ongoing); "Generalized Anxiety Disorder" (unspecified if ongoing); "Known allergies: Penicillin" (unspecified if ongoing). Concomitant medication(s) included: SEROQUEL, start date: 27Sep2021; LAMOTRIGINE, start date: 12Apr2021; LEVOTHYROXINE, start date: 12Jul2021. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 09Nov2022, outcome "unknown" and all described as "I was diagnosed with Covid on 09Nov2022". The event "i was diagnosed with covid on 09nov2022" required emergency room visit. The patient underwent the following laboratory tests and procedures: Ultrasound scan: (14Sep2022) Unknown results. Therapeutic measures were taken as a result of vaccination failure, covid-19 which included Paxlovid.; Sender's Comments: Based on the available information in the case, the causal association between the events vaccination failure, COVID-19 and the suspect drug cannot be excluded.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- Test Date: 20220914; Test Name: ultrasound; Result Unstructured Data: Test Result:Unknown results
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Bipolar II disorder; Generalized anxiety disorder; Penicillin allergy
- Andere Medikamente
- SEROQUEL; LAMOTRIGINE; LEVOTHYROXINE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 17.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event, patient was vaccinated with a BUD vaccine as per moderna no need for re-vaccination.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 17.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event. Patient got vaccinated with a BUD vaccine, as per manufacturer moderna no need for re-vaccination since vaccine maintained its stability.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 17.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event. Patient got vaccinated with a BUD vaccine, as per manufacturer moderna no need for re-vaccination since vaccine maintained its stability.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 17.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event, patient got vaccinated with a BUD vaccine as per manufacturer moderna no need for re-vaccination since vaccine it maintained its stability.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 17.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event, patient got vaccinated with a BUD vaccine as per manufacturer moderna no need for re-vaccination since vaccine it maintained its stability.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 62,0
- Geschlecht
- M
- Eingang
- 17.01.2023
- Impfdatum
- 26.04.2022
- Beginn
- 26.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event patient was vaccinated with a BUD vaccine as per moderna no need to re-vaccinate
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 62,0
- Geschlecht
- M
- Eingang
- 17.01.2023
- Impfdatum
- 26.04.2022
- Beginn
- 26.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event patient was vaccinated with a BUD vaccine as per moderna no need to re-vaccinate
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 17.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event, patient was vaccinated with a BUD vaccine. As per moderna no need for re-vaccination since vaccine it maintained its stability.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 17.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event, patient was vaccinated with a BUD vaccine. As per moderna no need for re-vaccination since vaccine it maintained its stability.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 17.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event. Patient was vaccinated with a BUD vaccine, as per moderna no need for re-vaccination since vaccine still maintained its stability.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 17.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event. Patient was vaccinated with a BUD vaccine, as per moderna no need for re-vaccination since vaccine still maintained its stability.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 17.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event, patient was vaccinated with a vaccine and as per Moderna no need for re-vaccination since vaccine it maintained its stability.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 17.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event, patient was vaccinated with a vaccine and as per Moderna no need for re-vaccination since vaccine it maintained its stability.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 16.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event. Patient got vaccinated with a BUD vaccine on 04/19/2022. As per manufacturer Moderna no need to re-vaccinate since vaccine it maintained its stability.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 16.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event. Patient got vaccinated with a BUD vaccine on 04/19/2022. As per manufacturer Moderna no need to re-vaccinate since vaccine it maintained its stability.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 16.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event patient got vaccinated with a BUD vaccine on 04/19/2022. Patient had no problems or issues. Called Moderna the Manufacturer and as per them vaccine maintained its stability during that time, no need to get re-vaccinated. Patient is aware.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 16.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event patient got vaccinated with a BUD vaccine on 04/19/2022. Patient had no problems or issues. Called Moderna the Manufacturer and as per them vaccine maintained its stability during that time, no need to get re-vaccinated. Patient is aware.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 56,0
- Geschlecht
- M
- Eingang
- 16.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event. Patient got vaccinated with a BUD vaccine on 04/19/2022. I called the manufacturer and as per Moderna vaccine it maintained its stability no need for re-vaccination. Patient is aware.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 56,0
- Geschlecht
- M
- Eingang
- 16.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event. Patient got vaccinated with a BUD vaccine on 04/19/2022. I called the manufacturer and as per Moderna vaccine it maintained its stability no need for re-vaccination. Patient is aware.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 16.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event, patient got vaccinated with a BUD vaccine. As per manufacturer moderna no need for re-vaccination since it maintained its stability.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 16.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event, patient got vaccinated with a BUD vaccine. As per manufacturer moderna no need for re-vaccination since it maintained its stability.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 16.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event, patient got vaccinated with a BUD vaccine on 04/19/2022. As per manufacturer Moderna, no need for re-vaccination since vaccine it maintained its stability. Patient is aware.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 16.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event, patient got vaccinated with a BUD vaccine on 04/19/2022. As per manufacturer Moderna, no need for re-vaccination since vaccine it maintained its stability. Patient is aware.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 16.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event. Patient got vaccinated with a BUD vaccine on 04-19-22. As per manufacturer Moderna no need for re-vaccination.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 16.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event. Patient got vaccinated with a BUD vaccine on 04-19-22. As per manufacturer Moderna no need for re-vaccination.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 16.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event. Patient got vaccinated with a BUD vaccine on 04/19/22. As per manufacturer Moderna no need for re-vaccination since vaccine it maintain its stability. Patient is aware.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 16.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event. Patient got vaccinated with a BUD vaccine on 04/19/22. As per manufacturer Moderna no need for re-vaccination since vaccine it maintain its stability. Patient is aware.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 16.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was not adverse event. Patient got vaccinated with a BUD vaccine on 04/19/22. As per the manufacturer no need for re-vaccination since vaccine it maintained its stability. Patient is aware.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 16.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was not adverse event. Patient got vaccinated with a BUD vaccine on 04/19/22. As per the manufacturer no need for re-vaccination since vaccine it maintained its stability. Patient is aware.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 16.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event Patient got vaccinated with a BUD vaccine. As per manufacturer Moderna no need for re-vaccination since it maintained its stability.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 16.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event Patient got vaccinated with a BUD vaccine. As per manufacturer Moderna no need for re-vaccination since it maintained its stability.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 16.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event. Patient got vaccinated with a BUD vaccine on 04/19/22. As per manufacturer Moderna no need for re-vaccination.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 16.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event. Patient got vaccinated with a BUD vaccine on 04/19/22. As per manufacturer Moderna no need for re-vaccination.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 16.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event. Patient got vaccinated with a BUD vaccine. As per moderna no need for re-vaccination since it maintained its stability.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 16.01.2023
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
There was no adverse event. Patient got vaccinated with a BUD vaccine. As per moderna no need for re-vaccination since it maintained its stability.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- -
- Geschlecht
- U
- Eingang
- 12.01.2023
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
4 adult patients received expired original booster Moderna COVID-19 beyond 30 days after thawing; the vaccine may have been refrozen; No Adverse Event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (4 adult patients received expired original booster Moderna COVID-19 beyond 30 days after thawing), PRODUCT STORAGE ERROR (the vaccine may have been refrozen) and NO ADVERSE EVENT (No Adverse Event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (4 adult patients received expired original booster Moderna COVID-19 beyond 30 days after thawing), PRODUCT STORAGE ERROR (the vaccine may have been refrozen) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (4 adult patients received expired original booster Moderna COVID-19 beyond 30 days after thawing), PRODUCT STORAGE ERROR (the vaccine may have been refrozen) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (4 adult patients received expired original booster Moderna COVID-19 beyond 30 days after thawing) and PRODUCT STORAGE ERROR (the vaccine may have been refrozen). Concomitant products were not reported. The vial was initially stored in the refrigerator on 29-Mar-2022, and the vial was administered to patients on 13-Apr-2022, 15-Apr-2022, 22-Apr-2022. The vial did not undergo temperature excursion. The patient received expired original booster Moderna COVID-19 beyond 30 days after thawing and the vaccine may have been refrozen. Treatment medications were not reported. This case was linked to US-MODERNATX, INC.-MOD-2023-694650 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-694650:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- -
- Geschlecht
- U
- Eingang
- 11.01.2023
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
Adult patient received expired original booster Moderna COVID-19 beyond 30 days after thawing; the vaccine may have been refrozen; No Adverse Event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Adult patient received expired original booster Moderna COVID-19 beyond 30 days after thawing), PRODUCT STORAGE ERROR (the vaccine may have been refrozen) and NO ADVERSE EVENT (No Adverse Event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Adult patient received expired original booster Moderna COVID-19 beyond 30 days after thawing), PRODUCT STORAGE ERROR (the vaccine may have been refrozen) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Adult patient received expired original booster Moderna COVID-19 beyond 30 days after thawing), PRODUCT STORAGE ERROR (the vaccine may have been refrozen) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Adult patient received expired original booster Moderna COVID-19 beyond 30 days after thawing) and PRODUCT STORAGE ERROR (the vaccine may have been refrozen). This case included information of patient 3rd out of 4 specified patients. None of the patient were pregnant. Concomitant products were not reported. The vial was initially stored in the refrigerator on 29-Mar-2022, and the vial was administered to patients on 13-Apr-2022, 15-Apr-2022, 22-Apr-2022. The vial did not undergo temperature excursion. The patient received expired original booster Moderna COVID-19 beyond 30 days after thawing and the vaccine may have been refrozen. Patient had no adverse event. Treatment medications were not reported. This case was linked to MODERNATX, INC.-MOD-2023-694650 (E2B Linked Report). Sender's Comments: MODERNATX, INC.-MOD-2023-694650:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- -
- Geschlecht
- U
- Eingang
- 11.01.2023
- Impfdatum
- 01.04.2022
- Beginn
- 01.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
the vaccine may have been refrozen; No adverse event; 4 adult patients received expired original booster Moderna COVID-19 beyond 30 days after thawing; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (4 adult patients received expired original booster Moderna COVID-19 beyond 30 days after thawing), PRODUCT STORAGE ERROR (the vaccine may have been refrozen) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 prophylaxis. No Medical History information was reported. In April 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (4 adult patients received expired original booster Moderna COVID-19 beyond 30 days after thawing). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (the vaccine may have been refrozen) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (4 adult patients received expired original booster Moderna COVID-19 beyond 30 days after thawing), PRODUCT STORAGE ERROR (the vaccine may have been refrozen) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (4 adult patients received expired original booster Moderna COVID-19 beyond 30 days after thawing) and PRODUCT STORAGE ERROR (the vaccine may have been refrozen). No concomitant medication was reported. The patient received expired original booster Moderna COVID-19 beyond 30 days after thawing and the vaccine may have been refrozen. Pharmacist stated that it was placed in the refrigerator and it was used about 1 week after arriving at the facility. The vial was initially stored in the refrigerator on 29-Mar-2022, and the vial was administered to patients on 13-Apr-2022, 15-Apr-2022, 22-Apr-2022. The vial did not undergo temperature excursion. Patient had no adverse events and was not pregnant at the time of vaccination. No treatment information was provided. This case contains information for the 2 of 4 adult patients described by the reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- -
- Geschlecht
- U
- Eingang
- 11.01.2023
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
4 adult patients received expired original booster Moderna COVID-19 beyond 30 days after thawing; the vaccine may have been refrozen; No Adverse Event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (4 adult patients received expired original booster Moderna COVID-19 beyond 30 days after thawing), PRODUCT STORAGE ERROR (the vaccine may have been refrozen) and NO ADVERSE EVENT (No Adverse Event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (4 adult patients received expired original booster Moderna COVID-19 beyond 30 days after thawing), PRODUCT STORAGE ERROR (the vaccine may have been refrozen) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (4 adult patients received expired original booster Moderna COVID-19 beyond 30 days after thawing), PRODUCT STORAGE ERROR (the vaccine may have been refrozen) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (4 adult patients received expired original booster Moderna COVID-19 beyond 30 days after thawing) and PRODUCT STORAGE ERROR (the vaccine may have been refrozen). This case included information of patient 1st out of 4 specified patients. None of the patient were pregnant. Concomitant products were not reported. The vial was initially stored in the refrigerator on 29-Mar-2022, and the vial was administered to patients on 13-Apr-2022, 15-Apr-2022, 22-Apr-2022. The vial did not undergo temperature excursion. The patient received expired original booster Moderna COVID-19 beyond 30 days after thawing and the vaccine may have been refrozen. Patient had no adverse event. Treatment medications were not reported. This case was linked to US-MODERNATX, INC.-MOD-2023-695198, US-MODERNATX, INC.-MOD-2023-695263, US-MODERNATX, INC.-MOD-2023-695333 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-695263:3 of 4 patient US-MODERNATX, INC.-MOD-2023-695333:4 of 4 patient US-MODERNATX, INC.-MOD-2023-695198:2 of 4 patient
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 10.01.2023
- Impfdatum
- 15.01.2022
- Beginn
- 01.10.2022
- Tage bis Beginn
- 259,0
- Dosis
- UNK
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Hypoaesthesia
Symptomtext
Numbness in my hands and feet.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypoaesthesia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Asthma
- Vorgeschichte
- Asthma
- Andere Medikamente
- Advair 250/50, Levothyroxine
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 04.01.2023
- Impfdatum
- 15.04.2022
- Beginn
- 22.12.2022
- Tage bis Beginn
- 251,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Symptomtext
Verified with patient on 1/3/2023. No adverse event noted.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 64,0
- Geschlecht
- M
- Eingang
- 04.01.2023
- Impfdatum
- 13.04.2022
- Beginn
- 22.12.2022
- Tage bis Beginn
- 253,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
No adverse event
Symptomtext
Confirmed with patient on 1/3/2023. No adverse events noted.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 14,0
- Geschlecht
- M
- Eingang
- 04.01.2023
- Impfdatum
- 22.04.2022
- Beginn
- 22.12.2022
- Tage bis Beginn
- 244,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Symptomtext
Communicated his mom on 1/3/23. No adverse event noted.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 45,0
- Geschlecht
- F
- Eingang
- 04.01.2023
- Impfdatum
- 22.04.2022
- Beginn
- 22.12.2022
- Tage bis Beginn
- 244,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Symptomtext
Verified with patient on 1/3/2023. No adverse event noted.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 52,0
- Geschlecht
- U
- Eingang
- 31.12.2022
- Impfdatum
- 26.04.2022
- Beginn
- 26.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Patient got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) in a 52-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 26-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 26-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD). Patient registry ID was reported. No concomitant medication information was reported. No treatment information was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 71,0
- Geschlecht
- U
- Eingang
- 31.12.2022
- Impfdatum
- 26.04.2022
- Beginn
- 26.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; The patient was vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patient was vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) in a 71-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 26-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 26-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient was vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The patient was vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (The patient was vaccinated after BUD). The patient registry ID was reported as Unknown. Concomitant medication of the patient was not reported. No treatment information was provided by the reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 78,0
- Geschlecht
- U
- Eingang
- 31.12.2022
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse Event; Got vaccinated aft er BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Got vaccinated aft er BUD) and NO ADVERSE EVENT (No adverse Event) in a 78-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 19-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 19-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Got vaccinated aft er BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Got vaccinated aft er BUD) and NO ADVERSE EVENT (No adverse Event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse Event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Got vaccinated aft er BUD). No concomitant medications were reported. It was reported that, the patient received vaccine after the beyond use-by date. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 59,0
- Geschlecht
- U
- Eingang
- 31.12.2022
- Impfdatum
- 19.04.2022
- Beginn
- 19.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse Event; patients information that got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patients information that got vaccinated after BUD) and NO ADVERSE EVENT (No adverse Event) in a 59-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 19-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 19-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patients information that got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patients information that got vaccinated after BUD) and NO ADVERSE EVENT (No adverse Event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse Event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (patients information that got vaccinated after BUD). No concomitant medications were reported. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 59,0
- Geschlecht
- U
- Eingang
- 31.12.2022
- Impfdatum
- 03.05.2022
- Beginn
- 03.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse reaction; got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse reaction) in a 59-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 03-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse reaction). At the time of the report, EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse reaction) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse reaction) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD). No concomitant medications were reported. It was reported that, the patient received vaccine after the beyond use-by date. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 93,0
- Geschlecht
- U
- Eingang
- 31.12.2022
- Impfdatum
- 03.05.2022
- Beginn
- 03.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse reaction; got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse reaction) in a 93-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 03-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse reaction). At the time of the report, EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse reaction) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse reaction) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD). No concomitant medications were reported. It was reported that, the patient received vaccine after the beyond use-by date. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 77,0
- Geschlecht
- U
- Eingang
- 31.12.2022
- Impfdatum
- 03.05.2022
- Beginn
- 03.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse reaction; Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse reaction) in a 77-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 03-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse reaction). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse reaction) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse reaction) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medications were reported. It was reported that, the patient received vaccine after the beyond use-by date. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 78,0
- Geschlecht
- U
- Eingang
- 31.12.2022
- Impfdatum
- 03.05.2022
- Beginn
- 03.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Patient got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) in a 78-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 03-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD). Patient registry ID was reported. No concomitant medication information was provided. It was reported that, the patient received vaccine after the beyond use-by date. No treatment medication was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 73,0
- Geschlecht
- U
- Eingang
- 31.12.2022
- Impfdatum
- 03.05.2022
- Beginn
- 03.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) in a 73-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 03-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD). Patient registry ID was reported as Unknown. No concomitant medications were reported. It was reported that, the patient received vaccine after the beyond use-by date. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 60,0
- Geschlecht
- U
- Eingang
- 31.12.2022
- Impfdatum
- 03.05.2022
- Beginn
- 03.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Patient got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) in a 60-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 03-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD). No concomitant medications were reported. It was reported that, the patient received vaccine after the beyond use-by date. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 57,0
- Geschlecht
- U
- Eingang
- 31.12.2022
- Impfdatum
- 03.05.2022
- Beginn
- 03.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) in a 57-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 03-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD). No concomitant medication were reported. No treatment information was provided by the reporter.The patient got vaccinated after BUD.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 27,0
- Geschlecht
- U
- Eingang
- 31.12.2022
- Impfdatum
- 03.05.2022
- Beginn
- 03.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse reaction; got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse reaction) in a 27-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 03-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse reaction). At the time of the report, EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse reaction) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse reaction) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD). No concomitant medications were reported. It was reported that, the patient received vaccine after the beyond use-by date. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 91,0
- Geschlecht
- U
- Eingang
- 31.12.2022
- Impfdatum
- 26.04.2022
- Beginn
- 26.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; patient got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) in a 91-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 26-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 26-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (patient got vaccinated after BUD). No relevant concomitant medications were reported. No treatment information was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 57,0
- Geschlecht
- U
- Eingang
- 31.12.2022
- Impfdatum
- 03.05.2022
- Beginn
- 03.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Patient got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) in a 57-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 03-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD). No concomitant medications were reported. It was reported that, the patient received vaccine after the beyond use-by date. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 59,0
- Geschlecht
- U
- Eingang
- 31.12.2022
- Impfdatum
- 03.05.2022
- Beginn
- 03.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) in a 59-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 03-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD). No concomitant drug was reported. No treatment drug was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 83,0
- Geschlecht
- U
- Eingang
- 31.12.2022
- Impfdatum
- 03.05.2022
- Beginn
- 03.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse reaction; Got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Got vaccinated after BUD) and NO ADVERSE EVENT (No adverse reaction) in an 83-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 03-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse reaction). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Got vaccinated after BUD) and NO ADVERSE EVENT (No adverse reaction) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse reaction) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Got vaccinated after BUD). No concomitant medications were reported. It was reported that, the patient received vaccine after the beyond use-by date. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 82,0
- Geschlecht
- U
- Eingang
- 31.12.2022
- Impfdatum
- 26.04.2022
- Beginn
- 26.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse Event; got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse Event) in an 82-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 26-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 26-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse Event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse Event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD). No concomitant medications were reported. It was reported that, the patient received vaccine after the beyond use-by date. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 76,0
- Geschlecht
- U
- Eingang
- 31.12.2022
- Impfdatum
- 26.04.2022
- Beginn
- 26.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse Event; Patient got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse Event) in a 76-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 26-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 26-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse Event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse Event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD). Patient registry ID was reported. No concomitant medications were reported. It was reported that, the patient received vaccine after the beyond use-by date. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 78,0
- Geschlecht
- U
- Eingang
- 31.12.2022
- Impfdatum
- 26.04.2022
- Beginn
- 26.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Patient that got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient that got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) in a 78-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 26-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 26-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient that got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient that got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient that got vaccinated after BUD). Patient registry ID was reported. No concomitant medication information was reported. No treatment information was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 70,0
- Geschlecht
- U
- Eingang
- 31.12.2022
- Impfdatum
- 26.04.2022
- Beginn
- 26.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse Event; patient got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse Event) in a 70-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 26-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 26-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse Event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse Event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (patient got vaccinated after BUD). No relevant concomitant medications were reported. No treatment information was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 77,0
- Geschlecht
- U
- Eingang
- 31.12.2022
- Impfdatum
- 26.04.2022
- Beginn
- 26.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse Event; Patient got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse Event) in a 77-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 26-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 26-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse Event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse Event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD). No concomitant medication details was reported. No treatment medication details was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 66,0
- Geschlecht
- U
- Eingang
- 30.12.2022
- Impfdatum
- 03.05.2022
- Beginn
- 03.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse reaction; Patient got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse reaction) in a 66-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 03-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse reaction). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse reaction) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse reaction) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD). No concomitant medications were reported. It was reported that, the patient received vaccine after the beyond use-by date. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 56,0
- Geschlecht
- U
- Eingang
- 30.12.2022
- Impfdatum
- 26.04.2022
- Beginn
- 26.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse Event; got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse Event) in a 56-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 26-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 26-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse Event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse Event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD). No concomitant medications were reported. It was reported that, the patient received vaccine after the beyond use-by date. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 82,0
- Geschlecht
- U
- Eingang
- 30.12.2022
- Impfdatum
- 26.04.2022
- Beginn
- 26.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse Event; patient got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse Event) in an 82-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 26-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 26-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse Event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse Event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (patient got vaccinated after BUD). No relevant concomitant medications were reported. No treatment information was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 11.11.2022
- Impfdatum
- 26.01.2022
- Beginn
- 07.11.2022
- Tage bis Beginn
- 285,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Asthenia
COVID-19
Pancytopenia
SARS-CoV-2 test positive
Systemic inflammatory response syndrome
Symptomtext
Patient received Moderna COVID vaccine on 2/11/21 (lot # 031L20A), 3/11/21 (lot # 001B21A), and 1/26/22 (lot # 084J21A). On 11/7/22, patient admitted to our inpatient facility (med/surg unit) with COVID-19 infection, generalized weakness, systemic inflammatory response syndrome, and pancytopenia. As of today (11/11/22), patient is still admitted in the med/surg unit.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Asthenia
- Hospital-Tage
- 4,0
- Labordaten
- COVID status positive 11/7/22.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- medical history significant for pancreatic adenocarcinoma stage III unresectable on chemotherapy and protein calorie malnutrition
- Andere Medikamente
- gabapentin, mirtazapine, ondansetron, Creon, prochlorperazine, sennosides/docusate,
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 14,0
- Geschlecht
- M
- Eingang
- 21.09.2022
- Impfdatum
- 07.03.2022
- Beginn
- 07.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product administered to patient of inappropriate age
Symptomtext
The patient received vaccine before authorized age.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 04.09.2022
- Impfdatum
- 27.04.2022
- Beginn
- 27.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The HCF consulted with the local Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. The HCF is working with the health dept. on a compliance improvement plan and has been reinstated vaccination privileges.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 04.09.2022
- Impfdatum
- 27.04.2022
- Beginn
- 27.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The HCF consulted with the local Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. The HCF is working with the health dept. on a compliance improvement plan and has been reinstated vaccination privileges.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 60,0
- Geschlecht
- M
- Eingang
- 04.09.2022
- Impfdatum
- 27.04.2022
- Beginn
- 27.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The HCF consulted with the local Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. The HCF is working with the health dept. on a compliance improvement plan and has been reinstated vaccination privileges.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 60,0
- Geschlecht
- M
- Eingang
- 04.09.2022
- Impfdatum
- 27.04.2022
- Beginn
- 27.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The HCF consulted with the local Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. The HCF is working with the health dept. on a compliance improvement plan and has been reinstated vaccination privileges.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 04.09.2022
- Impfdatum
- 20.04.2022
- Beginn
- 20.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Consulted with the Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare is working on a compliance improvement plan and has been reinstated vaccination privileges.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 04.09.2022
- Impfdatum
- 13.04.2022
- Beginn
- 13.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The HCF consulted with the local Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. The HCF is working with the health dept. on a compliance improvement plan and has been reinstated vaccination privileges.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 03.09.2022
- Impfdatum
- 04.05.2022
- Beginn
- 04.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Consulted with the local Dept. of Public Health and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Local Healthcare is working on a compliance improvement plan and has been reinstated vaccination privileges.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 03.09.2022
- Impfdatum
- 04.05.2022
- Beginn
- 04.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The HCF consulted with the local Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. The HCF is working with the health dept. on a compliance improvement plan and has been reinstated vaccination privileges.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 03.09.2022
- Impfdatum
- 04.05.2022
- Beginn
- 04.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The HCF consulted with the local Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. The HCF is working with the health dept. on a compliance improvement plan and has been reinstated vaccination privileges.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 03.09.2022
- Impfdatum
- 04.05.2022
- Beginn
- 04.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Healthcare facility consulted with the regulatory authority and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare facility is working with the regulatory authority on a compliance improvement plan and has been reinstated vaccination privileges.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 03.09.2022
- Impfdatum
- 04.05.2022
- Beginn
- 04.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Healthcare facility consulted with the regulatory authority and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare facility is working with the regulatory authority on a compliance improvement plan and has been reinstated vaccination privileges.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 03.09.2022
- Impfdatum
- 27.04.2022
- Beginn
- 27.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Consulted with the Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare is working on a compliance improvement plan and has been reinstated vaccination privileges.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 03.09.2022
- Impfdatum
- 27.04.2022
- Beginn
- 27.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Consulted with the Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare is working on a compliance improvement plan and has been reinstated vaccination privileges.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 03.09.2022
- Impfdatum
- 27.04.2022
- Beginn
- 27.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Consulted with the local Dept. of Public Health and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Local Healthcare is working on a compliance improvement plan and has been reinstated vaccination privileges.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 03.09.2022
- Impfdatum
- 27.04.2022
- Beginn
- 27.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Consulted with the local Dept. of Public Health and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Local Healthcare is working on a compliance improvement plan and has been reinstated vaccination privileges.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 17.08.2022
- Impfdatum
- 09.02.2022
- Beginn
- 14.08.2022
- Tage bis Beginn
- 186,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
COVID vaccine breakthrough case. Moderna 7/22/21 040C21A, 8/18/21 002F21A, and boosted 2/9/22 084J21A
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- Positive COVID test 8/14/22
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 08.08.2022
- Impfdatum
- 01.01.2022
- Beginn
- 01.06.2022
- Tage bis Beginn
- 151,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenia
COVID-19
Confusional state
Fall
SARS-CoV-2 test positive
Symptomtext
Pt presented to the hospital with a fall, confusion, and weakness. Found to be Covid +. Received Bebtelovimab
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Asthenia
- Hospital-Tage
- 5,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- depression, HLD, dementia
- Andere Medikamente
- apap, crestor
- Allergien
- codeine, macrodantin, statins
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 08.08.2022
- Impfdatum
- 28.01.2022
- Beginn
- 28.07.2022
- Tage bis Beginn
- 181,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Breakthrough case COVID-19 after fully vaccinated with 3 doses of Moderna.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- COVID-19 positive on 7/28/2022.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 57,0
- Geschlecht
- M
- Eingang
- 01.08.2022
- Impfdatum
- 29.04.2022
- Beginn
- 23.07.2022
- Tage bis Beginn
- 85,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Cough
Rhinorrhoea
SARS-CoV-2 test positive
Upper-airway cough syndrome
Symptomtext
I had a runny nose and a slight cough from post nasal drip. I went to the urgent care and was administered a rapid test which was negative. I was ordered to take a PCR test on July 24th for a vacation I was going on and that test came back positive. I began taking Paxlovid on the 26th and completed it yesterday. The medication helped to resolve all symptoms that I had and I have completely recovered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- COVID-19 PCR test -July 25th-Positive.
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- High Cholesterol
- Andere Medikamente
- Multi Vitamin; Vitamin B12; Probiotic; Statin
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 27.07.2022
- Impfdatum
- 09.02.2022
- Beginn
- 27.07.2022
- Tage bis Beginn
- 168,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
Symptomtext
Patient received 0.5ml when he should have received 0.25ml dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- Unknown
- Allergien
- listed no allergies on pre-screen/consent form
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 95,0
- Geschlecht
- M
- Eingang
- 19.07.2022
- Impfdatum
- 11.01.2022
- Beginn
- 11.07.2022
- Tage bis Beginn
- 181,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Metabolic encephalopathy
Symptomtext
Pt admitted to with metabloic encephalopathy, and covid. No covid treatment required. pt discharged home
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- htn, gerd, ckd,
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 92,0
- Geschlecht
- U
- Eingang
- 15.07.2022
- Impfdatum
- 19.01.2022
- Beginn
- 01.07.2022
- Tage bis Beginn
- 163,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Symptomtext
HOSPITALIZED WITH COVID
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- 14,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 14.07.2022
- Impfdatum
- 13.04.2022
- Beginn
- 12.07.2022
- Tage bis Beginn
- 90,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Hypersensitivity
SARS-CoV-2 test positive
Symptomtext
Began experiencing allergy-like symptoms the afternoon of Sunday, July 10. Symptoms worsened Monday, July 11. After positive at-home test, antivirals begun evening of July 12. Symptoms lessening as of Wednesday, July 13.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- Home rapid test taken evening of July 10 - result negative. Home rapid test taken morning of July 12 - result positive
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Obesity, migraines
- Andere Medikamente
- Ibuprofen
- Allergien
- Feldene
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
no adverse event vaccine given after expiration date. no expiration date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 54,0
- Geschlecht
- M
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event vaccine given after expiration date. no expiration date on vial or box .
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event vaccine given after expiration date. no expiration date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event vaccine given after expiration date. no expiration date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event vaccine given after expiration date. no expiration date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event vaccine given after expiration date. no expiration date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event vaccine given after expiration date. no expiration date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event vaccine given after expiration date. no expiration date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 64,0
- Geschlecht
- M
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event vaccination given after expiration date. no expiration date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event vaccine given after expiration date. no expiration date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event vaccine given after expiration date. no expiration date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event vaccination given after expiration date. no expiration date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse events vaccination given after expiration date. no expiration date on vial or box
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event vaccination given after expiration date. no expiration date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event vaccine given after expiration date. no expiration date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event vaccination given after expiration date. no expiration date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event vaccine given after expiration date. no expiration date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event vaccine given after expiration date. no vaccination date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event vaccination given after expiration date. no expiration date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 83,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event vaccine given after expiration date. no expiration date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 83,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event vaccine given after expiration date. no expiration date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 83,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event vaccine given after expiration date. no expiration date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event vaccine given after expiration date. no expiration date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 84,0
- Geschlecht
- M
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event vaccine given after expiration date. no expiration date on vial or box
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 85,0
- Geschlecht
- M
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event vaccine given after expiration date. no expiration date on vial or box
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
No adverse event. Vaccine given after expiration date. no expiration date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event vaccine given after expiration date. no expiration date on vial or box
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
No adverse event. Vaccine given after expiration date. no expiration date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 88,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event vaccine given after expiration date. no expiration date on vial or box
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 88,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event vaccine given after expiration date, no expiration date on vial or box
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 88,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event vaccine given after expiration date, no expiration date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 89,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event vaccine given after expiration date, no expiration date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 90,0
- Geschlecht
- M
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
No adverse event. Vaccine given after expiration date, no expiration date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 91,0
- Geschlecht
- M
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse events vaccine given after expiration, no expiration date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 92,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse events vaccine was given after expiration, no expiration date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 92,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event vaccine given after expiration date, no expiration date on vial or box!!!
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 93,0
- Geschlecht
- M
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
No adverse event vaccine given after expiration date, no expiration date on vial or box!!
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 93,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
No adverse event vaccine given after expiration date, no expiration date on vial or box!!
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 93,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
No adverse event vaccine given after expiration date, no expiration date on vial or box!!
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 93,0
- Geschlecht
- M
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
No adverse event vaccine given after expiration date, no expiration date on vial or box!
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 96,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
No Adverse event occurred. given after expiration date, no expiration date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 97,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
no adverse event Vaccine given after expiration date, no expiration date on vial or box.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 97,0
- Geschlecht
- F
- Eingang
- 10.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
given after expiration date. no reaction.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 10.06.2022
- Impfdatum
- 13.01.2022
- Beginn
- 14.05.2022
- Tage bis Beginn
- 121,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Confirmed breakthrough case COVID-19 (Moderna) 1 03/09/2021 Health Center - Moderna 036A21A COVID-19 (Moderna) 2 05/20/2021 Health Center - Moderna 047C21A COVID-19 (Moderna) 3 01/13/2022 Health Center - Moderna 084J21A
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- Positive Lab Covid test -- 5/14/2022
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 101,0
- Geschlecht
- F
- Eingang
- 09.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
none given after expiration date
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 06.06.2022
- Impfdatum
- 11.05.2022
- Beginn
- 11.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- mixed hyperlipidemia, vitamin d deficiency, cardiac murmur
- Andere Medikamente
- n/a
- Allergien
- macrodantin
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 06.06.2022
- Impfdatum
- 11.05.2022
- Beginn
- 11.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Adverse event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- Hypertension, mixed hyperlipidemia, depression, bladder caner, anxiety
- Andere Medikamente
- amlodipine 10 mg tab
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 06.06.2022
- Impfdatum
- 11.05.2022
- Beginn
- 11.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- Chronic constructive pericarditis, chronic kidney disease stage 4, crohn's disease, gout, hypertension, hyperlipidemia, ischemic optic neuropathy, left eye, idiopathic peripheral autonomic neuropathy, acquired absence of other specified parts of digestive tract (colectomy), anxiety, depression
- Andere Medikamente
- allopurinol 300 mg tab, amlodipine 10 mg tab, clonazepam 1 mg tab, clonidine 0.1 mg/24 hr weekly transdermal patch, potassium chloride ER 10 mEq tab, extended release, prednisone 5 mg tab, tadalafil 20 mg tab, trazodone 150 mg tab.
- Allergien
- NKNDA
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 06.06.2022
- Impfdatum
- 11.05.2022
- Beginn
- 11.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- Diabetes type 3, hypertension, anxiety, depression
- Andere Medikamente
- Metformin 500 mg, Alprazolam 0.5 mg tab, amlodipine 5 mg tab, carvedilol 12.5 mg tab, escitalopram 10 mg tab, valsartan 160 mg tab.
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 06.06.2022
- Impfdatum
- 11.05.2022
- Beginn
- 11.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- hypertension, mixed hyperlipidemia, Vitamin D deficiency, enlarged prostate with lower urinary tract symptoms.
- Andere Medikamente
- EC- naproxen 500 mg tab, delayed release, Lisinopril 5 mg tab, Tamsulosin 0.4 mg capsule
- Allergien
- Penicillins
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 27,0
- Geschlecht
- M
- Eingang
- 06.06.2022
- Impfdatum
- 11.05.2022
- Beginn
- 11.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- depression, anxiety, mixed hyperlipidemia
- Andere Medikamente
- Buspirone 5 mg tab, Emtricitanine 200 mg- tenofovir disoproxil furmarate 300 mg tab, Sertraline 50 mg tab.
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 88,0
- Geschlecht
- F
- Eingang
- 06.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Chronic kidney disease stage 3a, Non-follicular (diffuse) lymphoma, unspecified, unspecified site, Anxiety, hypertension, mixed hyperlipidemia, Prediabetes, hypertensive heart disease without heart failure.
- Andere Medikamente
- Bystolic 5 mg tab, furosemide 40 mg tab and losartan 100 mg tab.
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 06.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- hypertension, hypothyroidism, impaired fasting glucose
- Andere Medikamente
- Liothyronine 5 mcg tab, Metoprolol succinate ER 50 mg tab, extended release 24 hr, spironolactone 25 mg tab, valacyclovir 500 mg tab.
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 06.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- mixed hyperlipidemia, hypertension, osteoporosis, tricuspid valve disorder, nonrheumatic aortic (valve) , presence of left artificial hip joint.
- Andere Medikamente
- Atorvastatin 10 mg, Losartan 50 mg, Meloxicam 7.5 mg tablet, Metoprolol tartrate 25 mg tablet.
- Allergien
- Codeine Sulfate
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 06.06.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Mixed hyperlipidemia, Hypertension
- Andere Medikamente
- Irbesartan 150 mg-hydrochlorothiazide 12.5 mg tablet, Triamcinolone acetonide 0.1 % topical ointment, Multivitamin, Calcium with D.
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 03.06.2022
- Impfdatum
- 03.12.1955
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on Feb16-March 31st, 2022, from lot number 084J21A maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. No ill effect post administration was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 03.06.2022
- Impfdatum
- 28.02.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on Feb16-March 31st, 2022, from lot number 084J21A maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. No ill effect post administration was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 03.06.2022
- Impfdatum
- 28.02.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on Feb16-March 31st, 2022, from lot number 084J21A maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. No ill effect post administration was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 03.06.2022
- Impfdatum
- 28.02.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on Feb16-March 31st, 2022, from lot number 084J21A maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. No ill effect post administration was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 02.06.2022
- Impfdatum
- 28.02.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on Feb16-March 31st, 2022, from lot number 084J21A maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. No ill effect post administration was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 91,0
- Geschlecht
- F
- Eingang
- 02.06.2022
- Impfdatum
- 28.02.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on Feb16-March 31st, 2022, from lot number 084J21A maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. No ill effect post administration was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 61,0
- Geschlecht
- M
- Eingang
- 02.06.2022
- Impfdatum
- 16.03.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on Feb16-March 31st, 2022, from lot number 084J21A maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. No ill effect post administration was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 02.06.2022
- Impfdatum
- 02.03.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on Feb16-March 31st, 2022, from lot number 084J21A maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. No ill effect post administration was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 34,0
- Geschlecht
- M
- Eingang
- 02.06.2022
- Impfdatum
- 02.03.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on Feb16-March 31st, 2022, from lot number 084J21A maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. No ill effect post administration was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 02.06.2022
- Impfdatum
- 28.03.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on Feb16-March 31st, 2022, from lot number 084J21A maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. No ill effect post administration was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 02.06.2022
- Impfdatum
- 09.03.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on Feb16-March 31st, 2022, from lot number 084J21A maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. No ill effect post administration was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 02.06.2022
- Impfdatum
- 09.03.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on Feb16-March 31st, 2022, from lot number 084J21A maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. No ill effect post administration was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 02.06.2022
- Impfdatum
- 01.03.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on Feb16-March 31st, 2022, from lot number 084J21A maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. No ill effect post administration was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 36,0
- Geschlecht
- M
- Eingang
- 02.06.2022
- Impfdatum
- 07.03.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on Feb16-March 31st, 2022, from lot number 084J21A maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. No ill effect post administration was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 51,0
- Geschlecht
- M
- Eingang
- 02.06.2022
- Impfdatum
- 01.03.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on Feb16-March 31st, 2022, from lot number 084J21A maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. No ill effect post administration was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 34,0
- Geschlecht
- F
- Eingang
- 02.06.2022
- Impfdatum
- 02.03.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on Feb16-March 31st, 2022, from lot number 084J21A maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. No ill effect post administration was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- N/A.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 29,0
- Geschlecht
- M
- Eingang
- 02.06.2022
- Impfdatum
- 02.03.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on Feb16-March 31st, 2022, from lot number 084J21A maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. No ill effect post administration was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 37,0
- Geschlecht
- M
- Eingang
- 02.06.2022
- Impfdatum
- 02.03.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on Feb16-March 31st, 2022, from lot number 084J21A maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. No ill effect post administration was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 02.06.2022
- Impfdatum
- 02.03.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on Feb16-March 31st, 2022, from lot number 084J21A maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. No ill effect post administration was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 60,0
- Geschlecht
- M
- Eingang
- 02.06.2022
- Impfdatum
- 16.02.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 21,0
- Geschlecht
- F
- Eingang
- 02.06.2022
- Impfdatum
- 16.02.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on Feb16-March 31st, 2022, from lot number 084J21A maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. No ill effect post administration was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 02.06.2022
- Impfdatum
- 16.02.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on Feb16-March 31st, 2022, from lot number 084J21A maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. No ill effect post administration was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 41,0
- Geschlecht
- F
- Eingang
- 02.06.2022
- Impfdatum
- 16.02.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 88,0
- Geschlecht
- F
- Eingang
- 02.06.2022
- Impfdatum
- 16.02.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on Feb16-March 31st, 2022, from lot number 084J21A maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. No ill effect post administration was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 95,0
- Geschlecht
- F
- Eingang
- 02.06.2022
- Impfdatum
- 01.03.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on Feb16-March 31st, 2022, from lot number 084J21A maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. No ill effect post administration was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 93,0
- Geschlecht
- M
- Eingang
- 02.06.2022
- Impfdatum
- 01.03.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on Feb16-March 31st, 2022, from lot number 084J21A maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. No ill effect post administration was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 02.06.2022
- Impfdatum
- 28.02.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on Feb16-March 31st, 2022, from lot number 084J21A maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. No ill effect post administration was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 02.06.2022
- Impfdatum
- 28.02.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on Feb16-March 31st, 2022, from lot number 084J21A maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. No ill effect post administration was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 02.06.2022
- Impfdatum
- 07.04.2022
- Beginn
- 27.05.2022
- Tage bis Beginn
- 50,0
- Dosis
- 4
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Symptomtext
Return of Covid symptoms 5 days after stopping Paxlovid treatment. These included a very runny nose, cough, fatigue, migraine headache and night sweats.; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Return of Covid symptoms 5 days after stopping Paxlovid treatment. These included a very runny nose, cough, fatigue, migraine headache and night sweats.) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 vaccination. Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19 treatment. Concurrent medical conditions included Hypothyroidism, Depression, Arthritis and Allergy NOS (past drug history, name of the drug not reported.). Concomitant products included LEVOTHYROXINE SODIUM (LEVOTHYROXIN), CELECOXIB (CELEBREX) and ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication. On 07-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-May-2022, the patient started NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) at an unspecified dose. On 27-May-2022, the patient experienced COVID-19 (Return of Covid symptoms 5 days after stopping Paxlovid treatment. These included a very runny nose, cough, fatigue, migraine headache and night sweats.). At the time of the report, COVID-19 (Return of Covid symptoms 5 days after stopping Paxlovid treatment. These included a very runny nose, cough, fatigue, migraine headache and night sweats.) was resolving. Patient birth date was reported It had been reported that Covid symptoms included a very runny nose, cough, fatigue, migraine headache and night sweats. Wel butrin reported as Concomitant medication. It had been reported that he patient taken other medications/products within 2 weeks of starting COVID-19 treatment. Company comment: This spontaneous case concerns a 60-year-old female patient with no relevant medical history reported, who experienced the unexpected non-serious AESI event of COVID-19 unspecified days after receiving fourth dose of mRNA-1273 vaccine. It was reported that patient was treated with Paxlovid from 17-may-2022 to 22-may-2022. Patient had covid symptoms 5 days after stopping paxlovid treatment that included a very runny nose, cough, fatigue, migraine headache and night sweats.The current pandemic situation of COVID 19 may remain as confounder to the event Covid-19. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a 60-year-old female patient with no relevant medical history reported, who experienced the unexpected non-serious AESI event of COVID-19 unspecified days after receiving fourth dose of mRNA-1273 vaccine. It was reported that patient was treated with Paxlovid from 17-may-2022 to 22-may-2022. Patient had covid symptoms 5 days after stopping paxlovid treatment that included a very runny nose, cough, fatigue, migraine headache and night sweats.The current pandemic situation of COVID 19 may remain as confounder to the event Covid-19. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Allergy NOS (past drug history, name of the drug not reported.); Arthritis; Depression; Hypothyroidism
- Vorgeschichte
- -
- Andere Medikamente
- LEVOTHYROXIN; CELEBREX; LEXAPRO
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 62,0
- Geschlecht
- M
- Eingang
- 02.06.2022
- Impfdatum
- 15.04.2022
- Beginn
- 27.05.2022
- Tage bis Beginn
- 42,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
SARS-CoV-2 test
Symptomtext
COVID-19 virus test positive/COVID-19/Rhinorrhea/Throat irritation; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19 virus test positive/COVID-19/Rhinorrhea/Throat irritation) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 vaccination. No Medical History information was reported. On 15-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-May-2022 at 3:00 PM, the patient experienced COVID-19 (COVID-19 virus test positive/COVID-19/Rhinorrhea/Throat irritation). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 18-May-2022 to 23-May-2022 for COVID-19, at an unspecified dose and frequency. At the time of the report, COVID-19 (COVID-19 virus test positive/COVID-19/Rhinorrhea/Throat irritation) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-May-2022, SARS-CoV-2 test: tested negative one time (Negative) Tested negative one time. On 27-May-2022, SARS-CoV-2 test: strong positives (Positive) Strong positives. On an unknown date, SARS-CoV-2 test: tested negative three times on at home test (Negative) Tested negative three times on at home test, tested negative three times on at home test (Negative) Tested negative three times on at home test and tested negative three times on at home test (Negative) Tested negative three times on at home test. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The patient previously received a COVID-19 Vaccine. The indication for Paxlovid was reported as Treatment of COVID-19. Company Comment: This spontaneous case concerns a 62-year-old male patient, with no medical history reported, who experienced the unexpected AESI of COVID-19. The event occurred approximately 42 days after receiving the fourth dose of mRNA-1273 Vaccine. The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) for 5 days, however 4 days later, the patient had tested positive again for COVID-19. The outcome of the event was reported as unknown. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a 62-year-old male patient, with no medical history reported, who experienced the unexpected AESI of COVID-19. The event occurred approximately 42 days after receiving the fourth dose of mRNA-1273 Vaccine. The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) for 5 days, however 4 days later, the patient had tested positive again for COVID-19. The outcome of the event was reported as unknown. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- Test Name: COVID-19; Test Result: Negative ; Result Unstructured Data: Tested negative three times on at home test; Test Name: COVID-19; Test Result: Negative ; Result Unstructured Data: Tested negative three times on at home test; Test Name: COVID-19; Test Result: Negative ; Result Unstructured Data: Tested negative three times on at home test; Test Date: 20220527; Test Name: COVID-19; Test Result: Positive ; Result Unstructured Data: Strong positives; Test Date: 20220523; Test Name: PCR saliva test; Test Result: Negative ; Result Unstructured Data: Tested negative one time
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 01.06.2022
- Impfdatum
- 04.05.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 01.06.2022
- Impfdatum
- 04.05.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 92,0
- Geschlecht
- M
- Eingang
- 01.06.2022
- Impfdatum
- 04.05.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 01.06.2022
- Impfdatum
- 04.05.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 92,0
- Geschlecht
- F
- Eingang
- 01.06.2022
- Impfdatum
- 04.05.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post #18 vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 01.06.2022
- Impfdatum
- 04.05.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 01.06.2022
- Impfdatum
- 04.05.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 01.06.2022
- Impfdatum
- 27.04.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 01.06.2022
- Impfdatum
- 27.04.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 01.06.2022
- Impfdatum
- 27.04.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Chronic back pain, GERD, Anxirty, Insomnia, Hyperensive Kidney Disease, CKD, peripheral Neuropathy, HTN, PTSD, DJD,
- Andere Medikamente
- Ferrous Sulfate, Acetaminophen, Mirtazapine, Lisinopril, Panto
- Allergien
- N.K.D.A, Seasonal Allergies
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 01.06.2022
- Impfdatum
- 27.04.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 01.06.2022
- Impfdatum
- 27.04.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 01.06.2022
- Impfdatum
- 09.05.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 01.06.2022
- Impfdatum
- 09.05.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 95,0
- Geschlecht
- F
- Eingang
- 01.06.2022
- Impfdatum
- 09.05.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 01.06.2022
- Impfdatum
- 09.05.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 01.06.2022
- Impfdatum
- 09.05.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 01.06.2022
- Impfdatum
- 09.05.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 93,0
- Geschlecht
- M
- Eingang
- 01.06.2022
- Impfdatum
- 09.05.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 88,0
- Geschlecht
- F
- Eingang
- 01.06.2022
- Impfdatum
- 09.05.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- N/A.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 01.06.2022
- Impfdatum
- 09.05.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 01.06.2022
- Impfdatum
- 08.04.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 87,0
- Geschlecht
- F
- Eingang
- 01.06.2022
- Impfdatum
- 11.05.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 01.06.2022
- Impfdatum
- 11.05.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 01.06.2022
- Impfdatum
- 11.05.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 94,0
- Geschlecht
- F
- Eingang
- 01.06.2022
- Impfdatum
- 11.05.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 89,0
- Geschlecht
- F
- Eingang
- 01.06.2022
- Impfdatum
- 11.05.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 89,0
- Geschlecht
- M
- Eingang
- 01.06.2022
- Impfdatum
- 11.05.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 82,0
- Geschlecht
- F
- Eingang
- 01.06.2022
- Impfdatum
- 11.05.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 31.05.2022
- Impfdatum
- 04.02.2022
- Beginn
- 04.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
Product administered to patient of inappropriate age
Symptomtext
Patient was given an adult dose
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- Unknown
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- Unknown
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 31.05.2022
- Impfdatum
- 11.05.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 62,0
- Geschlecht
- M
- Eingang
- 31.05.2022
- Impfdatum
- 11.05.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 85,0
- Geschlecht
- M
- Eingang
- 31.05.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Hypertension; Hyperlipidemia; Gout; Chronic kidney stage, 3
- Andere Medikamente
- Colchicine 0.6 mg tab; Oxybutynin chloride 5 mg tab; Allopurinol 300 mg tab; Atenolol 50 mg tab; Fenofibrate 160 mg tablet; amlodipine 5 mg tab
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 83,0
- Geschlecht
- F
- Eingang
- 31.05.2022
- Impfdatum
- 18.05.2022
- Beginn
- 18.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Mixed hyperlipidemia; Hypertension; Chronic kidney disease, stage 4; Cerebrovascular disease, unspecified; Primary generalized osteoarthritis; Meniere's disease.
- Andere Medikamente
- Telmisartan 40 mg tab, Atorvastatin 40 mg tab, Torsemide 10 mg tab, Meclizine 25 mg tab, Multivitamin and Calcium.
- Allergien
- Sulfonamides, Amlodipine
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 62,0
- Geschlecht
- M
- Eingang
- 31.05.2022
- Impfdatum
- 04.05.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 57,0
- Geschlecht
- M
- Eingang
- 31.05.2022
- Impfdatum
- 20.04.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 31.05.2022
- Impfdatum
- 20.04.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 31.05.2022
- Impfdatum
- 20.04.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 60,0
- Geschlecht
- M
- Eingang
- 31.05.2022
- Impfdatum
- 20.04.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 31.05.2022
- Impfdatum
- 20.04.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 31.05.2022
- Impfdatum
- 20.04.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 31.05.2022
- Impfdatum
- 20.04.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 31.05.2022
- Impfdatum
- 20.04.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 31.05.2022
- Impfdatum
- 20.04.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 31.05.2022
- Impfdatum
- 20.04.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 36,0
- Geschlecht
- M
- Eingang
- 31.05.2022
- Impfdatum
- 20.04.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 31.05.2022
- Impfdatum
- 13.04.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 88,0
- Geschlecht
- M
- Eingang
- 31.05.2022
- Impfdatum
- 13.04.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 31.05.2022
- Impfdatum
- 13.04.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 31.05.2022
- Impfdatum
- 13.04.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer, Case MOD22-013894. The manufacturer tested the lot number 084J21A. Data revealed that the vaccine administered on April 1 to April 8, 2022 from lot number 084J21A likely maintained activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. The vaccine administered on April 9 to May 11, 2022 from lot number 084J21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration. We are working on contacting the patient and recommending re-vaccination. No ill effect post vaccination has been reported to our practice.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 31.05.2022
- Impfdatum
- 31.01.2022
- Beginn
- 11.05.2022
- Tage bis Beginn
- 100,0
- Dosis
- 4
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
SARS-CoV-2 test
Symptomtext
This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (COVID-19/Tested Omicron2 POS May 11th and 12th) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 vaccination. Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19 treatment. No Medical History information was reported. On 31-Jan-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-May-2022, the patient started NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) at an unspecified dose. On 11-May-2022, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (COVID-19/Tested Omicron2 POS May 11th and 12th). At the time of the report, COVID-19 (COVID-19/Tested Omicron2 POS May 11th and 12th) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-May-2022, SARS-CoV-2 test: positive (Positive) Positive. On 12-May-2022, SARS-CoV-2 test: positive (Positive) Positive. In May 2022, SARS-CoV-2 test: positive (Positive) Positive. On 19-May-2022, SARS-CoV-2 test: negative (Negative) Negative. On 20-May-2022, SARS-CoV-2 test: negative (Negative) Negative. No concomitant medication was reported. Reportedly, patient started feeling very sick when he started the Paxlovid. Within two days, he felt greatly improved and completed the Paxlovid. Then he was not feeling great on a day before reporting and tested positive again. On a reporting day in the morning, he took an a home Antigen test and was immediately Positive. Device Date was reported as 23-May-2022. No treatment information was provided. Company comment: This spontaneous case concerns a 59-year-old, male patient with no reported medical history who experienced the unexpected, non-serious adverse event of special interest of COVID-19 (with a positive SARS-CoV-2 test), which occurred 3 months and 11 days after receiving the fourth dose of mRNA-1273 vaccine. Patient tested positive for COVID-19(Omicron variant) and was prescribed with Nirmatrelvir, Ritonavir (Paxlovid) for 4 days. Within two days of medication patient felt improvement of symptoms. The patient tested negative 2 days after completing Paxlovid treatment. However a few days later patient complained of not feeling well, he re-tested positive for both test and via an antigen test kit which was self administered. The event has not yet resolved at the time of the report. The benefit-risk relationship of mRNA-1273 is not affected by this report. Sender's Comments: This spontaneous case concerns a 59-year-old, male patient with no reported medical history who experienced the unexpected, non-serious adverse event of special interest of COVID-19 (with a positive SARS-CoV-2 test), which occurred 3 months and 11 days after receiving the fourth dose of mRNA-1273 vaccine. Patient tested positive for COVID-19(Omicron variant) and was prescribed with Nirmatrelvir, Ritonavir (Paxlovid) for 4 days. Within two days of medication patient felt improvement of symptoms. The patient tested negative 2 days after completing Paxlovid treatment. However a few days later patient complained of not feeling well, he re-tested positive for both PCR test and via an antigen test kit which was self administered. The event has not yet resolved at the time of the report. The benefit-risk relationship of mRNA-1273 is not affected by this report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- Test Date: 202205; Test Name: test; Test Result: Positive; Result Unstructured Data: Positive; Test Date: 20220519; Test Name: PCR test; Test Result: Negative ; Result Unstructured Data: Negative; Test Date: 20220520; Test Name: PCR test; Test Result: Negative ; Result Unstructured Data: Negative; Test Date: 20220511; Test Name: Tested Omicron2 POS; Test Result: Positive ; Result Unstructured Data: Positive; Test Date: 20220512; Test Name: Tested Omicron2 POS; Test Result: Positive ; Result Unstructured Data: Positive.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 32,0
- Geschlecht
- M
- Eingang
- 29.05.2022
- Impfdatum
- 06.01.2022
- Beginn
- 25.05.2022
- Tage bis Beginn
- 139,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cerebral cyst
Cerebral ventricle dilatation
Magnetic resonance imaging head abnormal
Symptomtext
Patient has a history of a pseudotumor from 1998 (patient was 9 years old) that required a resection. Since being "immunized" patient has now had a recurrence of the brain cyst that will require a craniotomy in order to perform a resection of the cyst. Patient's vitals have been stable but he has not had surgery yet. Surgery is planned for Tuesday 5/31/22
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebral cyst
- Hospital-Tage
- -
- Labordaten
- MRI brain: 1.8 cm cystic lesion that is causing mild to moderate dilation of the lateral ventricle.
- Aktuelle Erkrankungen
- Hypertension
- Vorgeschichte
- Hypertension
- Andere Medikamente
- Norvasc
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 27.05.2022
- Impfdatum
- 19.05.2022
- Beginn
- 20.05.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Lymphadenopathy
Symptomtext
Swollen glands in left ear area and on the side of my left breast.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Lymphadenopathy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Multi vitamin; probiotic; Atorvastatin 10 mg; Estring
- Allergien
- Penicillin
- Vorherige Impfungen
- Extreme fatigue for the following two days after each of the following: Moderna 1st booster #053E21A given on 10/21/21; Moderna
- Staat
- CA
- Alter
- 64,0
- Geschlecht
- M
- Eingang
- 27.05.2022
- Impfdatum
- 21.04.2022
- Beginn
- 16.05.2022
- Tage bis Beginn
- 25,0
- Dosis
- 4
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Interchange of vaccine products
SARS-CoV-2 test
Vaccination failure
Symptomtext
Interchange of vaccine products; Relapse of COVID symptoms on May 16 and positive antigen test; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Relapse of COVID symptoms on May 16 and positive antigen test) and INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: Pfizer / BioNTech (Dose Number: 1 Batch/Lot No: EN6198 Location of injection: Arm Left Vaccine Administration Time: 10:00 AM) on 01-Mar-2021, Pfizer / BioNTech (Dose Number: 2 Batch/Lot No: ER8732 Location of injection: Arm Left Vaccine Administration Time: 10:00 AM) on 30-Mar-2021 and Pfizer / BioNTech (Dose Number: 3 Batch/Lot No: EW0183 Location of injection: Arm Left Vaccine Administration Time: 10:00 AM) on 05-Nov-2021. Past adverse reactions to the above products included No adverse event with Pfizer / BioNTech, Pfizer / BioNTech and Pfizer / BioNTech. Concurrent medical conditions included Drug allergy. Concomitant products included HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN HCTZ) and ATORVASTATIN for an unknown indication. On 21-Apr-2022 at 10:00 AM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-May-2022 at 9:00 PM, the patient experienced COVID-19 (Relapse of COVID symptoms on May 16 and positive antigen test). On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 04-May-2022 to 08-May-2022 for COVID-19 treatment, at a dose of 1 dosage form. At the time of the report, COVID-19 (Relapse of COVID symptoms on May 16 and positive antigen test) had not resolved and INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-May-2022, SARS-CoV-2 test: negative (Negative) first negative test was May 9. Consecutive negative tests from May 9 to May 15 (including a negative molecule test ('detect hub') on May 15th. On 15-May-2022, SARS-CoV-2 test: negative (Negative) Negative. On 16-May-2022, SARS-CoV-2 test: positive (Positive) on May 16 positive antigen test. On 19-May-2022, SARS-CoV-2 test: positive (Positive) Still testing positive on May 19th. It was reported that patient still testing positive on May 19th with nasal congestion as main symptom Company Comment: This spontaneous case of Interchange of vaccine products, concerns a 64-year-old male patient, with previous vaccinations of Pfizer/BioNTech, who experienced the unexpected AESI of COVID-19. The event occurred approximately 25 days after receiving the fourth dose of mRNA-1273 Vaccine (Primary doses and 1 booster - Pfizer/Biontech). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) for four days, however 8 days later, the patient had tested positive again for COVID-19. The outcome of the event was reported as not resolved. The patient's medical history of previous vaccinations of Pfizer/BioNTech vaccine, remain as confounders for the occurrence of the event. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.; Sender's Comments: This spontaneous case of Interchange of vaccine products, concerns a 64-year-old male patient, with previous vaccinations of Pfizer/BioNTech, who experienced the unexpected AESI of COVID-19. The event occurred approximately 25 days after receiving the fourth dose of mRNA-1273 Vaccine (Primary doses and 1 booster - Pfizer/Biontech). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) for four days, however 8 days later, the patient had tested positive again for COVID-19. The outcome of the event was reported as not resolved. The patient's medical history of previous vaccinations of Pfizer/BioNTech vaccine, remain as confounders for the occurrence of the event. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- Test Date: 20220509; Test Name: COVID-19 Antigen test; Test Result: Negative ; Result Unstructured Data: first negative test was May 9. Consecutive negative tests from May 9 to May 15 (including a negative molecule test ('detect hub') on May 15th; Test Date: 20220515; Test Name: COVID-19 Antigen test; Test Result: Negative ; Result Unstructured Data: Negative; Test Date: 20220516; Test Name: COVID-19 Antigen test; Test Result: Positive ; Result Unstructured Data: on May 16 positive antigen test; Test Date: 20220519; Test Name: COVID-19 Antigen test; Test Result: Positive ; Result Unstructured Data: Still testing positive on May 19th
- Aktuelle Erkrankungen
- Drug allergy
- Vorgeschichte
- -
- Andere Medikamente
- LOSARTAN HCTZ; ATORVASTATIN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 25.05.2022
- Impfdatum
- 28.02.2022
- Beginn
- 08.04.2022
- Tage bis Beginn
- 39,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Inappropriate schedule of product administration
Product storage error
Symptomtext
Vaccine was initially stored in the refrigerator on 11-Jan-2022 and was administered to patient on 08-APR-2022/ Dose administered after 30-day Use By Date; Dose 1 taken on 28-Feb-2022 and Dose 2 Taken on 08-Apr-2022; Vaccine was initially stored in the refrigerator on 11-Jan-2022 and was administered to patient on 08-APR-2022/ Dose administered after 30-day Use By Date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was initially stored in the refrigerator on 11-Jan-2022 and was administered to patient on 08-APR-2022/ Dose administered after 30-day Use By Date), PRODUCT STORAGE ERROR (Vaccine was initially stored in the refrigerator on 11-Jan-2022 and was administered to patient on 08-APR-2022/ Dose administered after 30-day Use By Date) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 taken on 28-Feb-2022 and Dose 2 Taken on 08-Apr-2022) in an 84-year-old female patient who received mRNA-1273 (Spikevax) (batch nos. 084J21A and 084J21A) for COVID-19 vaccination. No Medical History information was reported. On 28-Feb-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 08-Apr-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was initially stored in the refrigerator on 11-Jan-2022 and was administered to patient on 08-APR-2022/ Dose administered after 30-day Use By Date). 08-Apr-2022, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 taken on 28-Feb-2022 and Dose 2 Taken on 08-Apr-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was initially stored in the refrigerator on 11-Jan-2022 and was administered to patient on 08-APR-2022/ Dose administered after 30-day Use By Date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was initially stored in the refrigerator on 11-Jan-2022 and was administered to patient on 08-APR-2022/ Dose administered after 30-day Use By Date), PRODUCT STORAGE ERROR (Vaccine was initially stored in the refrigerator on 11-Jan-2022 and was administered to patient on 08-APR-2022/ Dose administered after 30-day Use By Date) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 taken on 28-Feb-2022 and Dose 2 Taken on 08-Apr-2022) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. Concomitant medication information was not provided by the reporter. The vial was initially stored in the refrigerator on 11-Jan-2022. The vial did not undergo any temperature excursions. The patient had not reported adverse reaction. Treatment information was not provided by the reporter. This case was linked to MOD-2022-569767 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 24.05.2022
- Impfdatum
- 28.02.2022
- Beginn
- 28.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
The vaccine was expired (more than 30 days it was in the fridge) and then stored in the fridge before administered; The patient administered dose that was more than 30 days after it was in the fridge; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patient administered dose that was more than 30 days after it was in the fridge) and PRODUCT STORAGE ERROR (The vaccine was expired (more than 30 days it was in the fridge) and then stored in the fridge before administered) in a 66-year-old female patient who received mRNA-1273 (Spikevax) (batch nos. 084J21A and 084J21A) for COVID-19 vaccination. No Medical History information was reported. On 28-Feb-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 28-Mar-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 28-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient administered dose that was more than 30 days after it was in the fridge). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vaccine was expired (more than 30 days it was in the fridge) and then stored in the fridge before administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The patient administered dose that was more than 30 days after it was in the fridge) and PRODUCT STORAGE ERROR (The vaccine was expired (more than 30 days it was in the fridge) and then stored in the fridge before administered) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. It was stated that the reporter had identified an issue that staff were not dating the boxes of vaccine when placed them in the fridge for storage. This lot number (084J21A) was received and placed in the fridge on 11-Jan-2022, which meant that all doses were administered more than 30 days after 11-Jan-2022 and were not in accordance with the EUA (Emergency Use Authorization). This includes 84 doses administered to 82 patients (as 2 patients received 2 doses from this lot more than 30 days after it was in the fridge). The reporter was further informed that the reporter team had accidentally administered expired Moderna COVID-19 vaccine to 18 patients: 9 patients on 09-May-2022 and 9 patients on 11-May-2022 (vaccine expired 05-May-2022). These patients were included in the spreadsheet. The vaccine in question had not experienced any temperature excursions. No reported adverse reaction of patient to the HCP (health care professional) knowledge. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 24.05.2022
- Impfdatum
- 28.02.2022
- Beginn
- 28.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
The vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 28-Feb-2022/Patient received expired dose after the 30 day use by date; The vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 28-Feb-2022/Patient received expired dose after the 30 day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 28-Feb-2022/Patient received expired dose after the 30 day use by date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 28-Feb-2022/Patient received expired dose after the 30 day use by date) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 vaccination. No Medical History information was reported. On 28-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (The vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 28-Feb-2022/Patient received expired dose after the 30 day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 28-Feb-2022/Patient received expired dose after the 30 day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 28-Feb-2022/Patient received expired dose after the 30 day use by date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 28-Feb-2022/Patient received expired dose after the 30 day use by date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. It was reported that the vial was initially stored in the refrigerator on 11-Jan-2022. The dose administered more than after 30 days. The vial did not undergo any temperature excursions. The patient had not reported adverse reaction to the HCP knowledge. No treatment information was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 62,0
- Geschlecht
- M
- Eingang
- 23.05.2022
- Impfdatum
- 26.01.2022
- Beginn
- 03.02.2022
- Tage bis Beginn
- 8,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Acute kidney injury
Asthenia
COVID-19
Chronic kidney disease
Computerised tomogram head normal
Hypophagia
Magnetic resonance imaging head normal
Mental status changes
Renal impairment
SARS-CoV-2 test positive
Symptomtext
Moderna COVID-19 Vaccine EUA: patient presented to emergency department (ED) with altered mental status and weakness with positive COVID test and acute kidney injury in setting of chronic kidney disease and poor oral intake. No evidence of pneumonia. Volume status corrected, received remdesivir, and medications adjusted resulting in improved mental status and renal function. Patient discharged to home medically stable.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute kidney injury
- Hospital-Tage
- 8,0
- Labordaten
- SARS-COV-2 positive; MRI brain: unremarkable; CT head: no acute process
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- lung transplant recipient, CAD< hypertension, patent foramen ovale, VTE, colon polyps, diverticulosis, GERD, CKD, anemia, restless leg, emphysema, lung nodules, sleep apnea
- Andere Medikamente
- acyclovir, amlodipine, balatacept, carvedilol, escitalopram, furosemide, gabapentin, Noxafil, prednisone, sodium bicarbonate tablet, Lokelma, Bactrim, tacrolimus, tobramycin inhaled,
- Allergien
- bupropion
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 51,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 01.03.2022
- Beginn
- 01.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
The vaccine was initially stored in the refrigerator on 11-Jan-2022 and administered on 01-Mar-2022; inadvertently administered expired dose of the Moderna COVID-19 vaccine (dose administered more than 30 days after storage in fridge); This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (inadvertently administered expired dose of the Moderna COVID-19 vaccine (dose administered more than 30 days after storage in fridge)) and PRODUCT STORAGE ERROR (The vaccine was initially stored in the refrigerator on 11-Jan-2022 and administered on 01-Mar-2022) in a 51-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 vaccination. No Medical History information was reported. On 01-Mar-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 01-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (inadvertently administered expired dose of the Moderna COVID-19 vaccine (dose administered more than 30 days after storage in fridge)). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vaccine was initially stored in the refrigerator on 11-Jan-2022 and administered on 01-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (inadvertently administered expired dose of the Moderna COVID-19 vaccine (dose administered more than 30 days after storage in fridge)) and PRODUCT STORAGE ERROR (The vaccine was initially stored in the refrigerator on 11-Jan-2022 and administered on 01-Mar-2022) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. Concomitant medication of the patient was not reported. The reporter reported that the staff were not dating the boxes of vaccine when placing them in the fridge for storage. This lot number (084J21A) was received and placed in the fridge on 11-Jan-2022, which means that all doses administered more than 30 days after 11-Jan-2022 and were not in accordance with the EUA. The vaccine in question did not experience any temperature excursions. The patient had not reported any adverse reaction. No treatment information was provided by the reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 95,0
- Geschlecht
- F
- Eingang
- 21.05.2022
- Impfdatum
- 01.03.2022
- Beginn
- 01.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered with expired Moderna vaccine) and PRODUCT STORAGE ERROR (Vaccine Placed in refrigerator on 11-Jan-2022 and administered on 01-Mar-2022) in a 95-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: Pfizer (Batch no: EL9265.) on 28-Jan-2021 and Pfizer (Batch no: EL9265.) on 18-Feb-2021. Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer. On 01-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered with expired Moderna vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine Placed in refrigerator on 11-Jan-2022 and administered on 01-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered with expired Moderna vaccine) and PRODUCT STORAGE ERROR (Vaccine Placed in refrigerator on 11-Jan-2022 and administered on 01-Mar-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. The patient received booster dose on 01-Mar-2022. The vaccine was placed in the fridge on 11-Jan-2022 and doses were administered more than 30 days after 11-Jan-2022. The vial did not experience any temperature excursions. No patient had reported adverse reaction. The patient did not report adverse reaction to the reporter's knowledge. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 21.05.2022
- Impfdatum
- 28.02.2022
- Beginn
- 28.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patients administered expired Moderna vaccine/all doses administered more than 30 days after 11-Jan-2022) and PRODUCT STORAGE ERROR (This lot number (084J21A) was received and placed in the fridge on 11-Jan-2022, and administered on 28-Feb-2022) in a 68-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 vaccination. No Medical History information was reported. On 28-Feb-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 28-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patients administered expired Moderna vaccine/all doses administered more than 30 days after 11-Jan-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (This lot number (084J21A) was received and placed in the fridge on 11-Jan-2022, and administered on 28-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patients administered expired Moderna vaccine/all doses administered more than 30 days after 11-Jan-2022) and PRODUCT STORAGE ERROR (This lot number (084J21A) was received and placed in the fridge on 11-Jan-2022, and administered on 28-Feb-2022) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. It was reported that reporter's team had accidentally administered expired Moderna COVID-19 vaccine to 18 patients: 9 patients on 9-May-2022 and 9 patients on 11-May-2022 (vaccine expired 5-May-2022). After further investigation it was identified that staff were not dating the boxes of vaccine when placing them in the fridge for storage. This lot number (084J21A) was received and placed in the fridge on 11-Jan-2022, which means that all doses administered more than 30 days after 11-Jan-2022 were not in accordance with the EUA. This included 84 doses administered to 82 patients (as 2 patients received 2 doses from this lot more than 30 days after it was in the fridge) administered between 16-Feb-2022 and 11-May-2022. The vaccine in question did not experience any temperature excursions. No treatment information was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 93,0
- Geschlecht
- M
- Eingang
- 20.05.2022
- Impfdatum
- 01.03.2022
- Beginn
- 01.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine was administered to the patient) and PRODUCT STORAGE ERROR (Vaccine was initially stored in refrigerator on 11-Jan-2022 and administered on 01-Mar-2022) in a 93-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 vaccination. Previously administered products included for Drug use for unknown indication: Pfizer (Dose 1 and Batch number as EL9265) on 28-Jan-2021; for Product used for unknown indication: Pfizer (Dose 2 and Batch number as EL9265) on 18-Feb-2021. Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer. On 01-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine was administered to the patient). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was initially stored in refrigerator on 11-Jan-2022 and administered on 01-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine was administered to the patient) and PRODUCT STORAGE ERROR (Vaccine was initially stored in refrigerator on 11-Jan-2022 and administered on 01-Mar-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. A pharmacist, the vaccine coordinator in their health care facility reported that they inadvertently administered expired dose of the Moderna COVID-19 vaccine. Date the vial was initially stored in the refrigerator was on 11-Jan-2022, which meant that all doses administered more than 30 days after 11-Jan-2022 were not in accordance with the EUA. The vial did not undergo any temperature excursions. They identified an additional issue that staff were not dating the boxes of vaccine when placing them in the fridge for storage. Patient received 1st booster dose on 01-Mar-2022 and not reported adverse reaction to the HCP's knowledge. No treatment medications were provided by the reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 20.05.2022
- Impfdatum
- 28.02.2022
- Beginn
- 28.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Vaccine was initially stored in the refrigerator on 11-Jan-2022 and was administered to patient on 28-Feb-2022; Vaccine was initially stored in the refrigerator on 11-Jan-2022 and was administered to patient on 28-Feb-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was initially stored in the refrigerator on 11-Jan-2022 and was administered to patient on 28-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine was initially stored in the refrigerator on 11-Jan-2022 and was administered to patient on 28-Feb-2022) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 vaccination. Previously administered products included for COVID-19 vaccination: Janssen (Dose-1 andLOT:1805020) on 08-Mar-2021. Past adverse reactions to the above products included No adverse reaction with Janssen. On 28-Feb-2022, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was initially stored in the refrigerator on 11-Jan-2022 and was administered to patient on 28-Feb-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was initially stored in the refrigerator on 11-Jan-2022 and was administered to patient on 28-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was initially stored in the refrigerator on 11-Jan-2022 and was administered to patient on 28-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine was initially stored in the refrigerator on 11-Jan-2022 and was administered to patient on 28-Feb-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication were reported. It was reported that the reporter had identified an additional issue that staff were not dating the boxes of vaccine when placing them in the fridge for storage. This lot number (084J21A) was received and placed in the fridge on 11-Jan-2022, which means that all doses administered more than 30 days after 11-Jan-2022are not in accordance with the EUA. Date the vial was initially stored in the refrigerator was 11-Jan-2022. The vial did not undergo any temperature excursions. Patient received first booster dose on 28-Feb-2022. Patient did not reported any adverse reactions. Treatment information was not provided by the reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 20.05.2022
- Impfdatum
- 09.05.2022
- Beginn
- 09.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Administered more than 30 days after 11-Jan-2022 are not in accordance with the EUA; 82 patients administered expired moderna vaccine/Vaccine was initially stored in the refrigerator on 11-Jan-2022 and was administered to patient on 09-May-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (82 patients administered expired moderna vaccine/Vaccine was initially stored in the refrigerator on 11-Jan-2022 and was administered to patient on 09-May-2022) and PRODUCT STORAGE ERROR (Administered more than 30 days after 11-Jan-2022 are not in accordance with the EUA) in a 63-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 vaccination. No Medical History information was reported. On 09-May-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 09-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (82 patients administered expired moderna vaccine/Vaccine was initially stored in the refrigerator on 11-Jan-2022 and was administered to patient on 09-May-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered more than 30 days after 11-Jan-2022 are not in accordance with the EUA). At the time of the report, EXPIRED PRODUCT ADMINISTERED (82 patients administered expired moderna vaccine/Vaccine was initially stored in the refrigerator on 11-Jan-2022 and was administered to patient on 09-May-2022) and PRODUCT STORAGE ERROR (Administered more than 30 days after 11-Jan-2022 are not in accordance with the EUA) outcome was unknown. Not Provided For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were provided. On 11-Jan-2022, the vial was initially stored in the refrigerator. Patient received first dose on 09-May-2022. The vaccine in question did not experience any temperature excursions. Patient did not reported any adverse reactions. No treatment medications were provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 20.05.2022
- Impfdatum
- 20.04.2022
- Beginn
- 20.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Vial was initially stored in refrigeratore on 11-Jan-2022 and administered on 20-Apr-2022; Vial was initially stored in refrigeratore on 11-Jan-2022 and administered on 20-Apr-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vial was initially stored in refrigeratore on 11-Jan-2022 and administered on 20-Apr-2022) and PRODUCT STORAGE ERROR (Vial was initially stored in refrigeratore on 11-Jan-2022 and administered on 20-Apr-2022) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 vaccination. Previously administered products included for Drug use for unknown indication: Janssen (LOT 1808609, Primary 1) on 31-Mar-2021, Pfizer (LOT FE3590 and Booster 1) on 24-Nov-2021. Past adverse reactions to the above products included No adverse event with Janssen and Pfizer. On 20-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vial was initially stored in refrigeratore on 11-Jan-2022 and administered on 20-Apr-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in refrigeratore on 11-Jan-2022 and administered on 20-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vial was initially stored in refrigeratore on 11-Jan-2022 and administered on 20-Apr-2022) and PRODUCT STORAGE ERROR (Vial was initially stored in refrigeratore on 11-Jan-2022 and administered on 20-Apr-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient received booster 2 of Moderna on 20-Apr-2022 No concomitant medications were reported. Date the vial was initially stored in the refrigerator was 11-Jan-2022. The vial did not undergo any temperature excursions. No patients had reported any adverse reactions No treatment medication were provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 20.05.2022
- Impfdatum
- 28.02.2022
- Beginn
- 28.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Vaccine was initially stored in the refrigerator on 11-Jan-2022 and was administered to patient on 20-Apr-2022; Patient received an expired vaccine on 28-Feb-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine on 28-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine was initially stored in the refrigerator on 11-Jan-2022 and was administered to patient on 20-Apr-2022) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: Janssen (Batch no: 1808609.) on 25-Mar-2021. Past adverse reactions to the above products included No adverse event with Janssen. On 28-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine on 28-Feb-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was initially stored in the refrigerator on 11-Jan-2022 and was administered to patient on 20-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine on 28-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine was initially stored in the refrigerator on 11-Jan-2022 and was administered to patient on 20-Apr-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No Concomitant product use was reported. The reporter stated that they initially called on 12-May-2022 and reported a total of 18 patients received expired doses after the 30 days Use by Date. On 17-May-2022, the reporter reported after doing further research, that the actual total number of patients that received expired doses after the 30 days use by date was 82 patients total and not 18 patients. The date the vial initially stored in the refrigerator was 11-Jan-2022 which means that all doses administered more than 30 days after 11-Jan-2022 were not in accordance with the university. Reportedly, the vial did not undergo any temperature excursions. The patient had not reported adverse reaction to the reporter's knowledge. No treatment information was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 20.05.2022
- Impfdatum
- 08.03.2022
- Beginn
- 08.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
The vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 08-Mar-2022; The vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 08-Mar-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 08-Mar-2022) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 08-Mar-2022) in an 81-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 vaccination. No Medical History information was reported. On 08-Mar-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 08-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (The vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 08-Mar-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 08-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 08-Mar-2022) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 11-Jan-2022 and administered on 08-Mar-2022) outcome was unknown. The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. It was reported that number of doses/vials: HCP reported 84 doses total administered to 82 patients total (2 of the patients received 2 doses from the same lot; their 1st and 2nd primary series dose from the same affected lot). Total number of vials not reported. The vial was initially stored in the refrigerator on 11-Jan-2022. Administration of vaccine from 16-Feb-2022 range through 11-May-2022 The vial did not undergo any temperature excursions. No treatment medication was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 94,0
- Geschlecht
- F
- Eingang
- 20.05.2022
- Impfdatum
- 11.05.2022
- Beginn
- 11.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
The vial was initially stored in the refrigerator on 11-Jan-2022 and administerd on 11-May-2022; Patient received expired dose after the 30 day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired dose after the 30 day use by date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 11-Jan-2022 and administerd on 11-May-2022) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 vaccination. Previously administered products included for Drug use for unknown indication: Janssen (Primary 1 dose and 207A21A.) on 20-Aug-2021. Past adverse reactions to the above products included No adverse event with Janssen. On 11-May-2022, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired dose after the 30 day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 11-Jan-2022 and administerd on 11-May-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired dose after the 30 day use by date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 11-Jan-2022 and administerd on 11-May-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. The patient received booster 1 dose. It was reported that the staff were not dating the boxes of vaccine when placing them in the fridge for storage. The vial was initially stored in the refrigerator on 11-Jan-2022. The dose administered more than 30 days after 11-Jan-2022 was not in accordance with a Regulatory Authority. The vial did not undergo any temperature excursions. The patient had not reported adverse reaction to the HCP knowledge. No treatment information was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 89,0
- Geschlecht
- M
- Eingang
- 20.05.2022
- Impfdatum
- 11.05.2022
- Beginn
- 11.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Vial was kept initially at refrigerator on 11-Jan-2022 but expired on 05-May-2022; Patients administered expired moderna vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients administered expired moderna vaccine) and PRODUCT STORAGE ERROR (Vial was kept initially at refrigerator on 11-Jan-2022 but expired on 05-May-2022) in an 89-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 vaccination. Previously administered products included for Drug use for unknown indication: Janssen (LOT- 1822809 and Primary 1) on 29-Oct-2021. Past adverse reactions to the above products included No adverse event with Janssen. On 11-May-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients administered expired moderna vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was kept initially at refrigerator on 11-Jan-2022 but expired on 05-May-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients administered expired moderna vaccine) and PRODUCT STORAGE ERROR (Vial was kept initially at refrigerator on 11-Jan-2022 but expired on 05-May-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient was administered with 1st booster of Moderna on 11-May-2022 No concomitant medications were reported. Date the vial was initially stored in the refrigerator was 11-Jan-2022. The vial did not undergo any temperature excursions. No patients had reported any adverse reactions No treatment medication were provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 20.05.2022
- Impfdatum
- 27.01.2022
- Beginn
- 28.03.2022
- Tage bis Beginn
- 60,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Inappropriate schedule of product administration
Product storage error
Symptomtext
Vaccine was initially stored in the refrigerator on 11-Jan-2022 and expired on 05-May-2022; second dose was adminstered after 2 months; Patient administered with expired moderna vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered with expired moderna vaccine), PRODUCT STORAGE ERROR (Vaccine was initially stored in the refrigerator on 11-Jan-2022 and expired on 05-May-2022) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose was adminstered after 2 months) in a 72-year-old female patient who received mRNA-1273 (Spikevax) (batch nos. 084J21A and 084J21A) for COVID-19 vaccination. No Medical History information was reported. On 27-Jan-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 28-Mar-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 28-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered with expired moderna vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose was adminstered after 2 months). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was initially stored in the refrigerator on 11-Jan-2022 and expired on 05-May-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered with expired moderna vaccine), PRODUCT STORAGE ERROR (Vaccine was initially stored in the refrigerator on 11-Jan-2022 and expired on 05-May-2022) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose was adminstered after 2 months) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. The pharmacist identified an additional issue that staff were not dating the boxes of vaccine when placing them in the fridge for storage. This lot number (084J21A) was received and placed in the fridge on 11-Jan-2022 which meant that all doses administered more than 30 days after 11-Jan-2022 which was not in accordance with the EUA. This included 84 doses administered to 82 patients (as 2 patients received 2 doses from the same lot more than 30 days after it was in the fridge). The vaccine was administered between 16-feb-2022 and 11-May-2022.Total number of doses/vials- HCP reported 84 doses Date the vial was initially stored in the refrigerator was 11-Jan-2022. The vial did not undergo any temperature excursions. No patients had reported any adverse reactions No treatment medication were provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 20.05.2022
- Impfdatum
- 20.04.2022
- Beginn
- 20.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Vial stored in refrigerator on 11-Jan-2022 and administered to the patient on 20-Apr-2022 post 30 days; Vial stored in refrigerator on 11-Jan-2022 and administered to the patient on 20-Apr-2022 post 30 days; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vial stored in refrigerator on 11-Jan-2022 and administered to the patient on 20-Apr-2022 post 30 days) and PRODUCT STORAGE ERROR (Vial stored in refrigerator on 11-Jan-2022 and administered to the patient on 20-Apr-2022 post 30 days) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (Batch number: EL9265 dose 1) on 29-Jan-2021 and PFIZER BIONTECH COVID-19 VACCINE (Batch number: EN6203 dose 2) on 19-Feb-2021. Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE. On 20-Apr-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vial stored in refrigerator on 11-Jan-2022 and administered to the patient on 20-Apr-2022 post 30 days). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial stored in refrigerator on 11-Jan-2022 and administered to the patient on 20-Apr-2022 post 30 days). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vial stored in refrigerator on 11-Jan-2022 and administered to the patient on 20-Apr-2022 post 30 days) and PRODUCT STORAGE ERROR (Vial stored in refrigerator on 11-Jan-2022 and administered to the patient on 20-Apr-2022 post 30 days) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. It was reported by pharmacist, the vaccine coordinator in their health care facility, that they inadvertently administered an expired dose of the Moderna Covid-19. Post further investigation of the issue, pharmacist identified an additional issue that staff were not dating the boxes of vaccine when placing them in the fridge for storage. This lot number 084J21A was received and placed in the fridge initially on 11-Jan-2022, which means that all doses administered more than 30 days after 11-Jan-2022 were not in accordance with the EUA. The vial did not undergo any temperature excursions. The patient did not report any adverse reaction to the health care professional's knowledge. No treatment medication was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 20.05.2022
- Impfdatum
- 27.01.2022
- Beginn
- 09.03.2022
- Tage bis Beginn
- 41,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Inappropriate schedule of product administration
Product storage error
Symptomtext
The vaccine was initially stored in the refrigerator on 11-Jan-2022 and administered on 09-Mar-2022; First dose administered on 27-Jan-2022 and second dose administered on 09-Mar-2022; inadvertently administered expired dose of the Moderna COVID-19 vaccine (dose administered more than 30 days after storage in fridge); This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (inadvertently administered expired dose of the Moderna COVID-19 vaccine (dose administered more than 30 days after storage in fridge)), PRODUCT STORAGE ERROR (The vaccine was initially stored in the refrigerator on 11-Jan-2022 and administered on 09-Mar-2022) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose administered on 27-Jan-2022 and second dose administered on 09-Mar-2022) in an 81-year-old female patient who received mRNA-1273 (Spikevax) (batch nos. 084J21A and 084J21A) for COVID-19 vaccination. No Medical History information was reported. On 27-Jan-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 09-Mar-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (inadvertently administered expired dose of the Moderna COVID-19 vaccine (dose administered more than 30 days after storage in fridge)) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose administered on 27-Jan-2022 and second dose administered on 09-Mar-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vaccine was initially stored in the refrigerator on 11-Jan-2022 and administered on 09-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (inadvertently administered expired dose of the Moderna COVID-19 vaccine (dose administered more than 30 days after storage in fridge)), PRODUCT STORAGE ERROR (The vaccine was initially stored in the refrigerator on 11-Jan-2022 and administered on 09-Mar-2022) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose administered on 27-Jan-2022 and second dose administered on 09-Mar-2022) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. Concomitant medication of the patient was not reported. The reporter reported that the staff were not dating the boxes of vaccine when placing them in the fridge for storage. This lot number (084J21A) was received and placed in the fridge on 11-Jan-2022, which means that all doses administered more than 30 days after 11-Jan-2022 and were not in accordance with a Regulatory Authority. The vaccine in question did not experience any temperature excursions. The patient had not reported any adverse reaction. No treatment information was provided by the reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
